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Abstract 
Ageing is a major socioeconomic concern and a risk factor in most diseases. As such, a better 
understanding of the ageing process could provide major insights into many disease treatments and 
prognoses. It is still not completely clear why organisms age, though multitudes of theories exist. 
There is large variation within and between species in lifespan and ageing progression. Superior 
maintenance of cognitive and physical function with age and avoidance of age-related morbidities is 
known as successful ageing. Understanding how this successful ageing occurs could be key to 
manipulating the ageing phenotype and mitigating age-related morbidity. 
Caloric restriction has been shown to increase lifespan in a number of organisms and delay 
the ageing phenotype. This is regarded as the most robust intervention for the extension of lifespan 
to date. Caloric restriction is difficult to implement in humans, so the use of drugs that mimic the 
effects of caloric restriction are needed to take advantage of this intervention. We performed a 
microarray analysis of nematode worms (Caenorhabditis elegans) undergoing caloric restriction or 
being treated with predicted caloric restriction mimetics. These compounds act similarly to caloric 
restriction, but a large number of differentially expressed genes were observed between treatments 
and calorically restricted worms. This suggests that these compounds act through distinct mechanisms 
to caloric restriction. This was principally due to variations in worm development likely caused by 
varying levels of developmental delay. In addition to this developmental caveat, cell cycle and cell 
surface genes were found to be differentially expressed in a number of comparisons particularly with 
worms treated with the caloric restriction mimetic rapamycin. 
 The naked mole rat (Heterocephalus glaber, NMR) is the longest-lived rodent, living over 30 
years. It is also cancer resistant. This lifespan is considerably longer than similarly sized mice (Mus 
musculus) at up to 4 years and comes with a delayed ageing phenotype. NMR cells have been reported 
to be more resistant to DNA damage, which is thought to be a major contributor to ageing and cancer. 
We hypothesise that this DNA damage resistance is responsible for the NMR’s long-lived and cancer-
resistant phenotype. By studying cells derived from these animals, comparative studies can be 
performed to identify potential causes for the observed differences in lifespan. As DNA damage is 
thought to be a causative factor in ageing we performed survival assays and calculated LD50 (the dose 
at which 50% of the cells die, known as the ‘lethal dose 50’) values for two DNA damaging compounds, 
camptothecin and chromium (vi) oxide in mouse and NMR cells. NMR cells appear to have higher LD50 
values for both compounds and hence are more resistant as has been previously shown. NMR cells 
surviving treatment were also less prone to become irreversibly senescent. RNAseq was performed 
on the mouse and NMR primary fibroblast treated with camptothecin or chromium (vi) oxide. NMR 
3 
 
skin fibroblasts appear to show reduced expression of DNA damage repair genes, in contrast to what 
has been reported previously in NMR liver cells. Functional enrichment revealed significant differences 
at the cell surface between the two species. Cell adhesion genes were found to be expressed 
significantly greater in the NMR. NMR cells were shown to adhere to a culture plate more slowly than 
mouse cells after genotoxic treatment, confirming differences in cellular adhesion dynamics. We 
conclude that differences in mouse and NMR phenotype are not down to differences in DNA damage 
repair gene expression. Instead, we propose the hypothesis that the observed differences in cell 
surface chemistry contribute to the NMR’s cancer-resistant phenotype. 
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Chapter 1: Introduction 
1.1 Ageing 
 One of the major challenges facing the developed world is how to deal with the ageing 
population. The proportion of elderly individuals is increasing and, as such, the cost to support them 
increases. Ageing, defined here as the progressive decline in cellular and organismal function over 
time, is a major risk factor for many complex chronic diseases such as cancer. Additionally, age can 
serve as a risk factor for infectious diseases and injury due to poorer immune responses and wound 
healing in elderly individuals. The aim of ageing research is to identify why we age, to develop 
interventions that could slow the ageing process to improve the quality of life of elderly individuals 
and to reduce the economic burden of the ageing population.  
It is still unclear why organisms age at all, however, a number of theories have been proposed. 
Possibly the most promising and widely accepted is the free radical theory of ageing proposed over 
60 years ago (1). This theory states that ageing is a result of cellular damage caused by reactive oxygen 
species (ROS). ROS are oxygen-containing free radicals (molecules with an unpaired electron) and are 
produced primarily in the mitochondria (90% of ROS) (2). During oxidative phosphorylation, oxygen is 
reduced to water by the addition of four electrons. The addition of one, two or three electrons only, 
known as partial reduction, results in the production of superoxide ion, hydrogen peroxide and 
hydroxyl radicals, respectively. Additionally, ionising radiation, typically ultraviolet radiation can also 
generate ROS by removing an electron from water to generate hydroxyl radicals. These ROS damage 
the cell through redox reactions with cellular components as the free radical takes electrons to 
complete its electron pair. This can happen to lipids, proteins and nucleic acids. 
 Lipid peroxidation occurs when the free radical steals an electron from a lipid in the cell, 
typically at the lipid bilayer of cellular membranes. The lipid molecule becomes a free radical as a 
result and in turn, steals an electron from another molecule in a chain reaction through the 
membrane. This can damage the membrane and end products of this lipid peroxidation can go on to 
damage DNA (Deoxyribonucleic acid) (3). Oxidation of the amino acids in proteins can result in changes 
to the protein’s 3D structure and hence alter the protein’s ability to function and prevent enzymatic 
functionality (4, 5). This oxidation can also result in cross-linking, aggregation and fragmentation of 
the proteins (5). ROS also damage DNA, resulting in loss of nucleotides, modification of the bases and 
strand breaks. Any damage to the DNA that is not repaired can result in mutations and cell death. DNA 
damage is thought to be a major contributing factor to ageing and cancer. ROS can be removed by the 
activity of antioxidants which give up an electron to complete the free radical’s electron pair. 
Alternatively, enzymes can act to neutralise specific ROS; the main enzymes are superoxide dismutase, 
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catalase, and Glutathione peroxidase, which act on superoxide, hydrogen peroxide and hydroxyl 
radical, respectively.   
Evidence for the free radical theory of ageing mainly comes in the form of correlations of 
increased oxidative damage with age and decreased levels of oxidative damage in longer-lived animals 
(6-8). However, studies in which levels of antioxidants are altered either through genetic intervention 
or feeding of antioxidants have given mixed results. For example, low doses of the antioxidant vitamin 
E extended lifespan in Drosophila melanogaster, but larger doses did not (9). ROS are important 
signalling molecules (10, 11) and so some ROS are required for basic cellular functions. Some long-
lived animals show exceptionally high levels of oxidative stress, bringing this theory into question (12). 
Alternative, but not necessarily mutually exclusive, theories of ageing consider the ageing 
process to be genetically coded. The developmental theory of ageing states that genes that promote 
survival and early reproductive success (typically through fast growth and development) will be 
selected for even if they have deleterious effects in later life as evolutionary selection acts primarily 
at reproduction (13). This would explain why diseases such as Huntington’s disease that are autosomal 
dominant and lethal can persist because the gene is passed on before the disease develops. Evidence 
for this theory comes from the large number of genes that affect lifespan. According to the GenAge 
database (build 18), a database of ageing associated genes, there are over 2,000 genes that are known 
to affect lifespan or ageing when individually manipulated (14). 
Ageing seems to occur in a similar fashion between different species with several hallmarks 
of ageing present in different species. The following nine hallmarks of ageing appear conserved 
between different species: genomic instability, epigenetic alterations, loss of proteostasis, 
mitochondrial dysfunction, deregulated nutrient sensing, telomere shortening, cellular senescence 
(described in detail in Chapter 5.1.2), altered intercellular communication, and stem cell exhaustion 
(15). 
DNA damage accumulates over time and hence increases with age (16). Defects in DNA 
damage repair genes can result in premature ageing diseases, linking DNA damage and ageing (17). 
DNA damage may lead to mutations that, in turn, can inhibit the gene’s function and hence result in 
cellular dysfunction. Accumulation of such damaged cells would lead to tissue dysfunction and hence 
ageing. DNA damage and the repair of DNA damage will be discussed in more detail in Chapter 1.3. In 
addition to changes to the DNA itself, changes to epigenetic markers are also associated with ageing. 
There are several common changes in these markers with increased age in mammals, such as 
increased histone H4K16 acetylation (18). Genetic alterations of genes affecting methylation or 
acetylation of DNA or histone proteins have been shown to increase lifespan (19). 
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Defects in proteostasis, the maintenance of appropriate levels of correctly folded proteins, 
have been associated with ageing and some ageing-associated diseases (20).  Proteostasis involves 
the activity of protein stabilisers called chaperones that promote correct protein folding, and 
mechanisms of protein degradation to remove misfolded proteins. Decreased chaperone activity 
through mutations have been shown to decrease lifespan (21), and increased chaperone activity has 
been shown to increase lifespan (22, 23). Protein degradation pathways show decreased activity with 
age (24, 25). One such pathway, chaperone-mediated autophagy, has been shown to be required for 
lifespan extension in flies treated with caloric restriction mimetics (26). 
A number of nutrient sensing pathways have been found to alter lifespan; these are described 
in more detail in Chapter 1.1.1.  
Mitochondria, which were discussed earlier in this chapter, are a major source of ROS. As 
organisms age the efficiency of the electron transfer chain decreases, leading to greater electron 
leakage, ROS generation and decreased ATP (adenosine triphosphate) production (27). ROS-induced 
damage to the mitochondria may increase the amount of ROS it produces, thus forming a positive 
feedback loop.  
The regeneration of tissues with fresh cells is reduced in ageing individuals. This is due to 
decreased stem cell function that would otherwise serve to renew tissues. This functional attrition has 
been shown in mouse studies to affect a wide array of tissues, including the skin (28), bone (29), and 
brain (30), among others. For example, haematopoietic stem cells (HSCs) show reduced proliferation 
with age which may result in anaemia, myeloid malignancies and reduced competency of the adaptive 
immune system due to a preferential shift away from the lymphoid lineage (31, 32).  HSCs show an 
increased level of signalling lymphocytic activation molecule family member 1 (Slamf1) expression 
with age. Slamf1 is a membrane glycoprotein that is thought to mediate bacterial detection and 
phagocytosis (33). Isolation of HSC’s expressing low or high levels of Slamf1 through florescence-
associated cell sorting allowed the selective transplantation into lethally irradiated congenic recipient 
mice. Both high and low Slamf1 expressing cells showed HSC activity. However, cells expressing high 
Slamf1 showed a bias towards the myeloid cell lineage (31). In older age, fewer cells of the adaptive 
immune system will be available, and hence the adaptive immune system will be less capable of 
mediating an immune response. Studies with mouse HSCs have shown that the decrease in 
proliferation that occurs with age correlates with increased DNA damage and p16 expression as 
detected by quantitative PCR (qPCR) (34, 35). HSCs derived from p16 knockout mice showed increased 
proliferative capacity compared to wild-type HSC of the same age (35). It is not simply the increase of 
stem cell proliferation that is beneficial to organismal health, but also maintenance of appropriate 
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levels of proliferation and quiescence. An increase in stem cell proliferation can be detrimental to 
tissue maintenance by exhausting the stem cell niche and ultimately reducing the proliferative 
capacity later on in life.  This has been shown in p21-deficient mice in which levels of HSC and neural 
stem cells were increased in young animals, but this ultimately led to decreased levels later in life 
compared to wild-type mice, resulting in susceptibility to myelotoxic insults (36, 37). Similarly, 
fibroblast growth factor 2 (FGF2) signalling in old muscle tissue was shown to promote stem cell 
proliferation and depletion that was rescued by inhibition of FGF2 (38). Transferring young stem cells 
into ageing individuals can increase lifespan and reduce degenerative phenotypes in mice, even in 
tissues in which donor cells are not detected (39). This suggests an additional mechanism by which 
stem cells may rejuvenate tissues, potentially through the activity of secreted factors. This idea is 
backed up by parabiosis experiments in which the vasculature of old and young mice is connected. 
Old skeletal muscle stem cells typically show decreased proliferation with age due to reduced Notch 
signalling. However, exposure to young serum has been shown to increase proliferation and notch 
signalling within these cells in old mice (40). It should be noted that this process also appears to work 
in reverse, with one study looking at neural stem cells in young mice showing decreased neurogenesis, 
neural stem cell abundance, and learning in young mice when connected to old mice (41). Finally, the 
lifespan extending intervention, caloric restriction, or treatment with caloric restriction mimetics 
(described in more detail in Section 1.1.1) can affect stem cell activity. Studies in mouse skeletal 
muscle have shown enhanced availability of muscle stem cells and muscle repair in both young and 
old animals undergoing caloric restriction (42). Similarly, treatment with rapamycin, a compound 
thought to be a caloric restriction mimetic, improved haematopoiesis and self-renewal of HSC in old 
mice through inhibition of mTOR (mammalian target of rapamycin) and reduction in p16 expression 
(43). The maintenance of stem cell activity is affected by the other hallmarks of ageing, such as DNA 
damage, which has been implicated in limiting the regenerative capacity of stem cells with genes, such 
as Ataxia Telangiectasia Mutated (ATM) that serves to maintain genomic stability being implicated in 
protecting stem cell populations (44). Similarly, nutrient sensing pathways, such as mTOR (as 
described in Section 1.1.1) and insulin growth factor (IGF) signalling pathway (described in Section 
1.1.1), have also been seen to affect stem cell functionality with reduced IGF signalling resulting in 
lower stem cell activity in serially transplanted HSCs (45). 
Ageing is associated with an increased level of inflammation and inflammatory signalling. 
Increasing such inflammation results in a premature ageing phenotype in mice (46). Additionally, 
inhibition of one such inflammatory pathway, the NF-κB (nuclear factor kappa-light-chain-enhancer 
of activated B cell) pathway, led to the rejuvenation of ageing skin in transgenic mice (47). Interleukin 
6 is a proinflammatory cytokine and has been shown to accumulate in sera with age (48, 49). Studies 
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in elderly people have indicated that higher levels of interleukin 6 correlate with increased risk of 
death and morbidity (50, 51). A study in mice showed that this increase is reduced in mice undergoing 
caloric restriction (49). Taken together this indicates inflammation is both a causative factor and a 
resulting symptom of ageing and such would form a positive feedback loop promoting the ageing 
process. 
Clearly, ageing is a complex multi-factorial process. Fortunately, the above factors appear 
interlinked with treatments aimed to improve one aspect, such as modifying nutrient sensing pathway 
activity, having widespread effects on other aspects of the ageing phenotype.  
 
1.1.1 Caloric restriction 
 The environment of an organism can also affect lifespan. Caloric restriction, the reduction in 
food intake without malnutrition, can extend lifespan. This was first discovered in the 1930s in white 
rats that were restricted in calorie intake from birth or after weaning (52), though the level of feed 
restriction in this study was not consistent as the researchers were aiming to maintain a given weight. 
This lifespan extension has been confirmed in an array of other species, including, yeast, worms, and 
mice (53-55) indicating a conserved mechanism. Not only is lifespan extended, but so is health span, 
in that age-related diseases such as cancer develop later (56). This was first shown in adult-onset 
restriction in rats 50 years after an initial study in which mice on ab libitum or ~77% or ~58% ab libitum 
diets were shown to have decreased cancer incidence and slower age-related declines in the immune 
system through assays such as immunofluorescent labelling of T cells (57, 58). Caloric restriction may 
not be as ubiquitous as previously thought, however, as some species and mice strains appear 
resistant to the life-extending effects of caloric restriction and in some cases have reduced lifespan 
(59, 60). Caloric restriction without malnutrition is difficult to implement, and different methods can 
have different effects and even stimulate different genetic pathways (61). Additionally, caloric 
restriction has a number of side effects including reduced muscle mass and depression, and as such is 
unlikely to be adopted by humans even if proven effective (62, 63).  
Studies in model organisms may not be representative of humans due to evolutionary 
dissimilarities. Rhesus monkeys, however, are an excellent model to represent humans as their 
genome shares approximately 93% sequence identity with that of humans (64). They also possess 
similar age-related pathologies as experienced by humans, for example, cataracts (65). Two major 
studies started in the 1980s that raised rhesus monkeys on either approximate ad libitum or caloric 
restriction (~30% reduction in calorie intake) diets are providing interesting results. One of these 
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studies conducted by the University of Wisconsin (UW) found that caloric restriction reduced both 
age-related and all-cause mortality (66). However, the other study conducted by the National Institute 
on Ageing (NIA), concluded that caloric restriction did not affect either age-related or all-cause 
mortality (60). These differences in the results are likely due to a number of differences between the 
two studies. Firstly, though both studies provided an approximately 30% reduction in calories, the 
method of calculating this amount varied between the studies. Furthermore, the actual food provided 
and its percentage make up of carbohydrates, protein and fat differed between the two studies. The 
UW study created an ad libitum value for each individual by monitoring food intake over 3-6 month 
and reduced this value by 30% to induce CR, whereas the NIA study used established data on rhesus 
monkey nutrition (67) to predict an ab libitum value based on the size and age of the individuals and 
reduced this value by 30% in caloric restriction conditions. Additionally, feeding regimes in the NIA 
study resulted in one study groups (old females) having similar food intake between control and caloric 
restriction treated individuals which would result in lower levels of CR. Secondly, the origin of the 
animals used varied with the UW using only India derived animals and the NIA study using both India 
and China derived animals which show both genetic and physiological variation (68, 69). Finally, the 
level of medical treatment provided to animals with known conditions varied with the UW study 
treating conditions and the NIA study not until later in the study when this was changed. This lack of 
treatment would account for non-age-related morbidity and mortality particularly in non-breeding 
females that are prone the potentially fatal endometriosis (70) (this was reduced in the UW study by 
using females that had already had children). In addition to changes in survival, both studies reported 
improvements in the health of the animals on caloric restriction with improved fasting glucose and 
reduced cancer incidence. Taken together these studies highlight not only the difficulty of studying 
caloric restriction but also the difficulty of implicating this rigorous intervention in higher order 
mammals; as the same reduction in calories performed in a slightly different way may give very 
different results. Furthermore, these studies support the idea that caloric restriction may provide 
health benefits in the evolutionarily similar humans. 
The use of organisms in research provided ethical, as well as financial challenges particularly 
in higher organisms such as mice and monkeys. Hence an alternative method of studying caloric 
restriction is often used whereby the effects are monitored in cell culture. Caloric restriction is induced 
in cell culture by exposing the cells to serum derived from animals undergoing caloric restriction. One 
such study exposed rat, human and mouse cells to serum derived from rats or rhesus monkeys 
undergoing either caloric restriction or ab libitum feeding. This study found cells exposed to serum 
from caloric restriction animals had increased oxidative and heat stress resistance, which was partially 
removed by supplementation of IGF-1 (71). This is what we would expect from cells undergoing caloric 
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restriction as IGF-1 is reduced in caloric restriction, as we will discuss later in this section. This indicates 
these cells are responding as though they are undergoing caloric restriction and hence can serve as a 
model for study into the mechanisms of caloric restriction. 
 The evolutionary rationale for this increased lifespan in response to reduced calorie intake is 
as follows. While food is bountiful, an organism should maximise growth and reproduction to produce 
offspring which will have a better chance of surviving while food is in good supply. However when 
food is limited, and the organism is hence calorically restricted, the focus shifts to survival to endure 
the period of scarcity and survive until food becomes more prevalent. During such famine, it makes 
little sense to focus on unnecessary growth or to produce offspring that will likely starve. 
 Caloric restriction mimetics aim to emulate the life-extending effect of caloric restriction 
without these side effects or the need to change diet. A number of compounds have been identified 
as caloric restriction mimetics, such as rapamycin, allantoin (72) (described in more detail in Section 
2.1.1) and NMN (nicotinamide mononucleotide). NMN is essentially a precursor to NAD+ 
(nicotinamide adenine dinucleotide) that in turn boosts DNA damage repair through binding of DBC1 
(deleted in breast cancer 1) inhibiting its inhibition of PARP1 (Poly ADP-ribose polymerase 1) that 
contributes to BER (described in Section 1.3) (73). Treatment with NMN boosts NAD+ levels which are 
seen to decline with age (74). Additionally, NMN treatment may activate SIRT1 (sirtuin 1) by providing 
SIRT1 with its rate limiting substrate NAD+ (74). SIRT1 contributes to caloric restriction (discussed later 
in this section). Despite a lack of data on the effects of NMN treatment on lifespan directly this 
candidate caloric restriction mimetic is currently undergoing stage one human clinical trials to assess 
the safety and bioavailability of NMN in human treatment (75). 
 The exact mechanism of caloric restriction is still not clear, but a number of pathways have 
been implicated (76). Perhaps unsurprisingly these pathways feature nutrient-sensing components. 
 The first genetic pathway shown to affect lifespan is the IGF-1 signalling pathway first 
identified in Caenorhabditis elegans (C. elegans) when temperature-sensitive mutations of daf-2 (an 
IGF-1 receptor ortholog) were found to increase lifespan by approximately double in worms. These 
worms also showed prolonged movement and pharyngeal pumping which have been shown to decline 
with age, indicating slower ageing (77). This lifespan extension was shown to require daf-16 which is 
a FOXO (Forkhead box protein) family transcription factor (77). The FOXO transcription factor family 
is conserved between invertebrates and mammals, but where C. elegans have one FOXO transcription 
factor (DAF-16), mammals have four, (FOXO1, 3, 4 and 6) (78). A reduction in IGF-1 signalling is 
observed during caloric restriction of rats showing that pathways are conserved in mammals (79). 
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Growth hormone receptor (GHR) knockout mice have reduced IGF-1 and have reduced cancer 
incidence and increased lifespan, as do growth hormone deficient Ames dwarf mice (80, 81). These 
experiments indicate the importance of IGF-1 in lifespan extension and also identify growth hormone 
(GH) and GHR as upstream components of the IGF-1 pathways. IGF-1 deficient mice do not have 
further increased lifespan when on caloric restriction, showing the necessity of IGF-1 in caloric 
restriction (81). High serum IGF-1 is also associated with cancer risk in humans (81). GH is produced in 
the pituitary gland and can bind to GHR in the liver to stimulate IGF-1 production; this has been 
confirmed in cultured rat hepatocytes (82). This explains the observations in GHR knockout mice and 
Ames dwarf mice. IGF-1 is transported around the body via the circulatory system allowing access 
throughout the body, which explains how this pathway can have profound systemic effects in multiple 
tissues. IGF-1 binds its receptor, insulin-like growth factor 1 receptor (IGF1R) or insulin receptor alpha 
(IR-A), at the cell membrane. According to the human protein atlas, a database of protein expression 
and localisation within the human body, IGF1R is present in a wide array of tissues including liver, skin, 
the digestive system, and the respiratory system (83). IGF1 binding to these receptors results in 
activation of phosphoinositide 3-kinase (PI3K), which in turn activates protein kinase B (AKT) via 
phosphorylation. This activity was shown through immunoprecipitation of AKT derived from muscle 
cells with or without PI3K activity and with or without IGF-1 exposure (84). 
Active AKT phosphorylates the FOXO proteins inhibiting their activity. This was first shown in 
the C. elegans (85, 86), but has subsequently been shown in mammals as well (87-89). When 
phosphorylated, these FOXO bind 14-3-3 chaperone proteins and become sequestered in the 
cytoplasm. The creation of FOXO-GFP fusion proteins has confirmed this nuclear exclusion for FOXO 1 
and 3, however, this was not seen in response to AKT activity in FOXO6 (90). Furthermore, in situ 
hybridisation has shown FOXO6 expression appears limited to the nervous system (90). A 30% 
reduction in calorie intake resulted in no difference in lifespan in mice that were Foxo3+/- or Foxo3-/-. 
However, these mice did show a decreased incidence of cancer (91). This indicated that Foxo3 is 
required for the life-extending effect of caloric restriction, but not the cancer-preventive effect. A 
similar experiment that looked at a heterozygous Foxo1 knock out mouse strain found the opposite 
effect, with caloric restriction having the same effect on lifespan, but a loss of the anti-cancer effect 
of caloric restriction in the mutant mice (92). This suggests that Foxo1 is required for the anti-cancer 
effects of caloric restriction, but not the lifespan-extension effects. One of the response genes 
confirmed to be only upregulated in the wild-type mice in response to caloric restriction was p21, 
suggesting this to be a gene responsible for the anti-cancer effects of caloric restriction (92). FOXO1 
and 3 are repressed through deacetylation directly and deacetylation of a transcriptional coactivator 
p300 by the SIRT1 protein (93). This is counter-intuitive as caloric restriction has been shown to induce 
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SIRT1 expression (94, 95) and SIRT1 knockout mice do not live any longer on caloric restriction 
compared to control mice (96). This suggests that SIRT1 may serve to limit FOXO activity to appropriate 
levels to facilitate longevity. This idea is backed up by experiments in Akt −/− mice that have increased 
FOXO expression; these mice were shown to be more sensitive to damage-induced apoptosis and 
genotoxic stress (97). This is likely due to inappropriate entry into apoptosis as a result of increased 
FOXO activity. SIRT1 may also act through deacetylation of the DNA damage repair factor KU70 to 
prevent apoptosis and promote autophagy (94, 98). IGF-1’s role in caloric restriction has been brought 
into question as chronic reduction in serum IGF-1 has been observed to have deleterious effects on 
health and lifespan (99). 
Polymorphisms of FOXO3 have been shown to be positively associated with increased life-
spans in humans through genotyping studies on centenarian (100 or more years old), or long-lived 
(95-106 year old) populations and young control individuals (100, 101). A similar study looking at 761 
Chinese centenarians and 1,056 younger controls also identifies polymorphisms in FOXO1 that were 
negatively correlated with lifespan in females (102). These studies highlight the significance of the 
FOXO transcription factors in human longevity. 
By combining 75 genome-wide expression profiles (derived from 5 different studies), it has 
been indicated that daf-16 upregulates 1,663 genes and downregulates 1,733 genes (103). These 
upregulated genes were enriched for those involved with oxidation reduction and carbohydrate 
metabolism. The downregulated genes were enriched for growth, reproduction and development. A 
similar meta-analysis looking at 12 immunoprecipitation followed by sequencing (ChIP-seq) datasets 
found ~7,000 genes were targeted by FOXO transcription factors in mice (104). These genes showed 
enrichment for apoptosis, p53 signalling, oxidative stress and metabolism. These results imply 
increased oxidative stress resistance, which may prolong lifespan by prevention of cellular damage in 
accordance with the free radical theory of ageing (detailed in Section 1.1), may be the key mode of 
action in these genes. 
In addition to inhibition of the FOXO transcription factors, AKT also phosphorylates and 
inactivates tuberous sclerosis2 (TSC2) that would otherwise inhibit mTOR (105). Hence the reduction 
in IGF-1 signalling would result in increased TSC2 activity and hence reduced mTOR activity. The C. 
elegans homolog of mTOR is let-363, also known as TOR (target of rapamycin). RNAi knock down of 
TOR increases adult lifespan (106). Caloric restriction decreased mTOR expression and activity in mice 
(95, 107). The mTOR protein associates with others to form one of two complexes known as mTOR 
complex 1 and 2 (mTORC1 and 2). In mice, reduced mTORC1 (in the form of double heterozygous 
29 
 
mutations for mTOR and Target of rapamycin complex subunit (Mlst8)) results in increased lifespan 
(108).  Inhibition of mTOR in rat cells results in decreased protein synthesis, cell cycle arrest and 
selective apoptosis of some types of tumour cells (109). 
Autophagy has been shown to be necessary for lifespan extension through caloric restriction 
or genetic manipulations of IGF-1 and TOR (110). Impaired autophagy through reduction of key 
regulator genes results in accelerated ageing in a wide array of species including flies, worms and rat 
cells (111-113). Autophagy decreases with age in human and rat cell cultures (114). Increased 
autophagy is sufficient to increase lifespan in many organisms including human cells (115, 116).  
Another signalling pathway that may play a role in caloric restriction and ageing is the Ras 
signalling pathway. Ras can be thought of as inactive (GDP (Guanosine-diphosphate) bound) or active 
(GTP (Guanosine-triphosphate) bound). Active Ras bind to effector molecules including Raf that 
initiates a phosphorylation cascade via MEK (Mitogen-activated protein kinase kinase), mitogen-
activated protein kinase (MAPK) and extracellular signal-regulated kinase (ERK). Studies in mice 
undergoing a 20% reduction in calorie intake have shown a reduction in both Ras and MAPK (117). It 
is yet to be determined if this reduction in Ras signalling is necessary or sufficient for lifespan 
extension. Ras is capable of binding PI3K, activating it (118) and ERK can promote the phosphorylation 
and subsequent degradation of FOXO3 (119). This indicates that this pathway can inhibit FOXO 
transcription factor activity and hence inhibit longevity. In addition, ERK has been shown to 
phosphorylate TSC2, inhibiting its ability to inhibit mTOR (120). Hence Ras signalling has the capacity 
to limit lifespan by interacting with both the IGF-1 and mTOR pathways. Ageing tissues show elevated 
MAPK and ERK activity (121), though it is not clear if this is a cause or consequence of ageing. Inhibition 
of RAS by the generation of knock out mutants of RASGRF1 (a RAS activator) increases lifespan in mice 
(122), supporting the idea that this pathway inhibits longevity. 
AMP-activated protein kinase (AMPK) is, as the name suggests, a protein kinase that is 
activated by binding with AMP (adenosine monophosphate) (123). Its activity is reduced by binding to 
ATP and hence AMPK acts as an energy sensor, becoming active when the ratio of AMP to ATP 
increases. It primarily acts to maintain the energy balance of the cell through a number of 
mechanisms. In muscle cells, active AMPK increases glucose uptake by promoting translocation of the 
glucose transporter GLUT4 to the plasma membrane (124). Glycogen synthesis is decreased through 
phosphorylation of glycogen synthase (125), and fatty acid oxidation is increased through 
phosphorylation of cetyl-coA carboxylase (ACC) by active AMPK (126). In C. elegans AMPK is necessary 
for the lifespan-extending effects of caloric restriction (127) and rats experiencing caloric restriction 
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(40% calorie reduction) had increased AMPK activity in older age compared to controls (128). AMPK 
increases SIRT1 activity indirectly by increasing the availability of NAD+, a rate-limiting substrate for 
SIRT1 (129). AMPK can also affect FOXO signalling, as it has been shown to directly phosphorylate 
FOXO3 in 6 locations promoting its activity (130). Finally, AMPK is a potent inhibitor of mTOR. This 
inhibition acts through phosphorylation of Raptor (a component of the TORC1 complex) (131) and 
TSC2 (a regulator of mTOR) (132). Taken together, this shows AMPK to be a potent regulator of ageing 
pathways and shows the interconnected nature of these CR-related pathways.  
Caloric restriction induces the activity of NRF2 (Nuclear factor like 2) which activates various anti-
oxidant pathways and mice deficient in NRF2 lose the cancer-protecting effect of caloric restriction, 
but not the life-extending effect (133).  
1.1.2 Successful ageing 
 Rowe and Kahn’s model of successful ageing (134) states that successful ageing constitutes 
low probability of disease and disease-related morbidities, high cognitive and physical functional 
capacity and active engagement of life. It has been proposed that ‘positive spirituality’, the level of life 
satisfaction, be added to the model, as centenarians do not meet the conventional requirements for 
successful ageing (135, 136). This model is focused on successful ageing in humans and factors such 
as active engagement or positive spirituality are not relevant or difficult to assess in other organisms. 
Hence, for the purpose of this thesis successful ageing is defined as the maintenance of cognitive and 
physical function with age and avoidance of age-related morbidities in a manner that is greater than 
expected. Caloric restriction can be considered a model of successful ageing as it delays age-related 
morbidities (56). Additionally, long-lived organisms that elicit delays in age-related morbidity 
development are also considered to be successfully ageing.  
 
1.1.3 Cancer 
Cancer, so called because of solid tumours’ similarity in appearance to a crab, with a central 
mass and leg-like vasculature at the edges, is a key age-related morbidity and major source of 
mortality responsible for 7.98 million deaths in 2010 (137). It is the uncontrolled growth of cells with 
the potential to spread to other parts of the body. As such, benign tumours which do not spread are 
not classed as cancer.  
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Cancer is a very diverse disease that is typically categorised by the cell type of origin to give 
five broad categories. These are carcinomas (arising from epithelial cells), sarcoma (arising from 
connective tissues), lymphomas and leukaemias (arising from haematopoietic cells), blastomas 
(arising from precursor cells or embryonic tissues) and germ cell tumours (arising from pluripotent 
germ cells). These vary further between specific cell type, and even cancer cells within the same 
tumour can show genetic variation (138). 
Cancer can be caused by a wide array of factors including pathogens, chemicals, ionising 
radiation and hormones (139). Ultimately cancer is caused by genetic mutations and/or epigenetic 
abnormalities (140).  
There are a number of natural barriers cells must overcome to become cancerous. Cells 
usually require growth signals such as hormones to grow and divide. However, cancer cells can grow 
without such external signals. They do so by either producing these signals themselves, losing activity 
of growth-inhibiting pathways or through the excessive activity of growth-promoting pathways (141). 
These cancer cells must also be insensitive to both external and internal anti-growth signals. Cells can 
normally only replicate a limited number of times, this is known as the Hayflick limit (142). This is due 
to the repetitive DNA sequences at the end of chromosomes called telomeres being shortened after 
each round of division. This shortening can extend into the coding region of the chromosome resulting 
in crisis that kills most cells. Cancer cells are thought to overcome this through the expression of 
telomerase that replace the lost telomeres (143). Abnormal cells that are damaged or infected by 
pathogens are removed through apoptosis, the process of cellular self-destruction, but cancer cells 
that are often malformed do not undergo apoptosis. This may be due to defects in damage detection 
or apoptosis initiation (144). Cancerous cells can be removed by both the innate and adaptive immune 
system (145, 146). Hence, cancer cells must evade the immune system. This may be done through 
disabling aspects of the immune system through TGF-β (Transforming growth factor beta) or other 
immunoregulatory factors or potentially through recruitment of regulatory immune cells (147-149). 
Cancer cells need to undergo metabolic changes that also facilitate greater growth rates (150). Finally, 
cancer cells need to induce angiogenesis and lymphangiogenesis to provide oxygen and nutrients to 
the tumour, remove waste and facilitate metastasis (151, 152).  
Cancer kills through inhibition of key biological functions, for example, a tumour in the lungs 
can prevent oxygen absorption, or through major disruptions in homeostasis such as hypercalcemia 
induced by various lymphomas and leukaemias (153). 
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1.2 Model organisms in ageing  
There is a great deal of plasticity in the rate of ageing between different species. For example, 
the longest-lived mammal, the bowhead whale is predicted to live for 211 years. This is around a 
hundred times longer than the lifespan of the shortest-lived mammal, the forest shrew, that lives for 
only 2.1 years (values from AnAge, a database of ageing and life history in animals) (14). In nature, a 
positive trend is observed by which body size and lifespan correlate (Figure 1.1) (154). Evolutionarily, 
this makes sense as larger animals would take longer to grow and reach sexual maturity and their 
larger size would mean they would be less susceptible to predation. The lower the level of predation, 
the greater the selective pressure for longer life. From this trend, we can create a longevity quotient 
(LQ) as a measure of how well an animal matches this trend. An LQ of 1 would indicate that an animal 
lives as long as we would expect based on its size, a higher value indicates a long-lived animal that 
may have unique anti-ageing mechanisms. Birds for example often have a longer lifespan than we 
would expect based off body mass alone, as do bats. This has likely evolved because of their ability to 
avoid predators by flying (155).  Humans are also an exception to the rule, living to 122 years. This 
gives us an LQ of around 4 meaning we can live up to four times longer than we would expect based 
on our body size alone, which is in part due to our advanced healthcare.  
 
 
 
Figure 1.1. Plot of natural log-transformed maximum lifespan (tmax) and body mass (M) of all 
mammals, birds, reptiles and amphibians in AnAge (n=1,456). Taken with permission from (154). 
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1.2.1 Caenorhabditis elegans 
When studying ageing, it is often useful to study short-lived animals, to identify why they are 
so short-lived, but also to allow experiments aiming to observe changes in lifespan to be completed 
within a researcher’s career and/or lifetime. Caenorhabditis elegans is a soil-dwelling nematode worm 
found worldwide and are mostly self-fertilising, egg-laying hermaphrodites, though some males are 
present in the population (<0.2%) (156). C. elegans have a maximum lifespan of ~58 days (14), are 
approximately 1mm long, are easy to maintain in large numbers and have a well-annotated, 
sequenced genome making them excellent model organisms. Additionally, they are transparent 
making observations of internal tissues and cells possible in living organisms. Worms kept at lower 
temperature live longer until a certain threshold (54) showing clear plasticity of lifespan within this 
species. The C. elegans lifecycle is well documented (Figure 1.2). Eggs hatch after about 9 hours post-
laying. The newly hatched worms (known as L1s) undergo multiple moults during which a new life-
stage-specific cuticle is formed, and the old cuticle is shed (157). Worms become adults after 4 moults. 
As C. elegans has an invariant number of somatic cells, studies have tracked the lineage of each cell 
from fertilisation to adulthood (158, 159). Developing worms can enter a developmentally-arrested 
dauer diapause stage, which is considered to be an un-ageing state. Worms can survive in this dauer 
state for up to four months and then have the same adult lifespan once development continues. 
Entering this dauer state can essentially increase the worm’s lifespan by up to ~200%. Genetic 
interventions can also affect lifespan, for example, a mutation of the insulin IGF-1 receptor, daf-2 can 
result in approximately doubled lifespan (77). This lifespan effect was discovered in C. elegans and 
later found to control longevity in flies and mice showing that discoveries in C. elegans may also apply 
to other organisms, potentially even humans (160). There are 838 genes in GenAge that are associated 
with ageing in C. elegans (14).  
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Figure 1.2. Caenorhabditis elegans lifecycle at 22°C. Blue numbers indicate the time spent at each life 
stage; red text indicates factors that can result in developmental arrest. Only the hermaphrodite 
adult is shown. Taken with permission from (161). 
 Caloric restriction can increase worm lifespan by up to 150% depending on the 
method used to induce caloric restriction (61). The simplest method of caloric restriction and the 
method used in this study is to use eat-2 mutant worms. The ligand-gated ion channel eat-2 is 
located post synoptically in the pharyngeal pump, controlling the rate of pump contraction (162, 
163). Mutation of eat-2 results in decreased pharyngeal pumping and hence decreased food intake, 
inducing caloric restriction (61, 163, 164). Caloric restriction can also be induced by dilution of food 
source (E. coli (Escherichia coli)), use of chemically defined liquid media or reducing E. coli growth by 
reducing peptone in agarose plates (61). Eat-2 mutants are long-lived, and this lifespan extension 
does not require daf-16 or AMPK (61, 164). Caloric restriction by dilution of E. coli or peptone, 
however, does require both daf-16 and AMPK (61). This indicates that these methods of caloric 
restriction have varying mechanisms and that comparisons between them may be inaccurate. E. coli 
often accumulates in the pharynx and intestine of older worms (165). Feeding worms E. coli that 
have been killed through antibiotic treatment or UV exposure, or E. coli treated with bacteriostatic 
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agents that prevent its proliferation increases worm lifespan (165, 166). It is thought this mortality is 
caused by the production of toxins in proliferating E. coli and hence it is plausible that reduced 
intake of E. coli in caloric restriction could result in a lifespan increase, in part through reduced E. coli 
build up. Hence performing caloric restriction on worms provided with killed E. coli removes this 
confounding factor and has been shown to increase lifespan (72, 167). It is also of note that E. coli 
serve not only as a source of calories but also essential nutrients. Therefore caloric restriction 
through reduced E. coli intake also reduces the intake of these nutrients and hence caloric restriction 
through this method in C. elegans is often referred to as dietary restriction.  
 
1.2.2 Heterocephalus glaber 
Heterocephalus glaber (Figure 1.3) also known as 
the naked mole rat (NMR) is the longest-lived rodent 
with a lifespan of 31 years (LQ = 4.9) which is much larger 
than the similarly sized mouse, Mus musculus with a 
lifespan of only 4 years (LQ = 0.7) (14, 168, 169). This 
lifespan is longer than we would expect based on the 
NMR’s body size and has likely evolved as a result of a 
number of different traits. NMRs are native to the horn 
of Africa and are subterranean, living in burrows that 
protect them from both predators and extremes in 
temperature reducing early mortality. They have limited 
ability to thermoregulate and have a lower body temperature then mice; they typically move to 
different areas of the burrow or huddle to keep warm allowing for lower basal metabolism (170, 171). 
NMRs are remarkably resistant to hypoxia surviving at 5% oxygen with no observed ill effects. Mice, 
however, die after 10 minutes at 5% oxygen. Additionally, NMRs are capable of surviving for 18 
minutes under total anoxia (no oxygen) (172). This increased survival is down to a shift to anaerobic 
metabolism of fructose, likely an adaption to living in burrows that frequently have poor ventilation 
and hence reduced oxygen content (172). This adaption further reduces the risk of mortality in the 
NMR’s subterranean niche. NMRs are eusocial animals living in colonies with one breeding female (the 
queen) and one to three breeding males. These breeders are further protected from predation by the 
workers, and since these are the only individuals that reproduce, a long lifespan will be selected for. 
In addition to their long lifespan, the NMR seems to be cancer resistant, with some colonies having no 
observed incidences of cancer (173, 174).  The breeding females also show no decline in fertility with 
age and NMRs appear healthy even at old age and hence NMRs are considered to exhibit negligible 
Figure 1.3. A sleeping NMR 
colony. Centre is the pregnant 
queen (12). 
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senescence (174). NMRs also appear resistant to DNA damage as skin fibroblasts from NMRs treated 
with DNA damaging agents require a higher dose to kill half of the cells (LD50) than fibroblasts from 
mice (175). These traits have been attributed to a number of features. 
NMR’s resistance to cancer has been suggested to be due in part to high molecular mass 
hyaluronan (HA) (176). This extracellular substance is five times larger in NMR compared to mice. It 
likely evolved to allow the NMR skin to be more stretchable for squeezing through tunnels. It may act 
as a physical barrier preventing cell over-growth or may act through its strong interaction with CD44 
on the surface of the cell to activate anti-cancer pathways. 
NMRs have been shown to have better translational accuracy than mice, with fewer incorrect 
amino acids being incorporated in newly-synthesised proteins than mice, with a similar rate of 
synthesis (177). This increased accuracy would result in a more stable proteome and hence could 
result in longer lifespan by reducing the rate of defective protein accumulation. 
NMRs have high levels of the proteins NRF2 and p53 that may play a central role in longevity. 
The transcription factor NRF2 acts in response to stresses such as oxidative stress. In response to 
oxidative stress, NRF2 is translocated to the nucleus of the cell to activate transcription of various 
antioxidant response elements (ARE) (178). NMR cells have a higher basal level of NRF2 compared to 
mice and the increase observed in response to oxidative stress is larger than that in mice (179). p53 is 
capable of regulating cell cycle, cellular senescence and DNA responses, and increasing p53 activity 
has been shown to both increase cancer resistance and lifespan in mice (180, 181). 
Fibroblasts derived from NMRs have shown remarkable resistance to oncogenic 
transformation. Induced expression of the oncogenes SV40 large T antigen (TAg) and RasG12V together 
is sufficient to induce full malignant transformation of mouse and rat cells (182, 183). However, when 
this oncogenic combination is expressed in NMR cells, they fail to form colonies in soft agar (an assay 
for tumorigenicity) and rapidly undergo crisis when transplanted into immunodeficient mice (184, 
185). Crisis is a period of genomic instability in which most if not all cells die and is caused by excessive 
shortening of the telomeres due to excessive proliferation. This crisis phenotype was rescued by the 
addition of human telomerase reverse transcriptase (185). This rapid entry of cells into crisis after 
oncogenic transformation may be an important defence mechanism against cancer in the NMR.  
NMR cells show decreased or halted proliferation when in contact with other cells (186). This 
is termed contact inhibition of proliferation (will henceforth be referred to as contact inhibition). NMR 
cells have been reported to undergo contact inhibition at a much lower cell density than those from 
mice or humans (184). This early contact inhibition requires p53 and pRB (retinoblastoma protein) 
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tumour suppressor pathways, as well as signalling via p16 (184). This early contact inhibition may 
provide an extra layer of protection against cancer by preventing excessive cell growth. A study of 
NMR skin and lung fibroblasts showed they divided slower than those derived from mice (187). This 
study found a population doubling time of 8.13 days in NMR while mice were found to have a 
population doubling time of 3.46 days. Additionally, this study concluded that neither mouse nor NMR 
cells undergo replicative senescence as this was not detected after 200 days of cell culture. However 
replicative senescence may still occur under different conditions or after further cell divisions. This 
study grew both cell lines at 5% CO2 and 3% oxygen, but mouse cells were grown at 37ᵒC, and NMR 
cells were grown at 35ᵒC which may affect the results (187). This study combined data from 4 inbred 
mice and 1 wild mouse. Another study looking at growth rates in skin and lung fibroblasts from NMR 
and mouse cells used the same temperature of 37ᵒC to grow the cells and examined the growth rate 
at 21 and 3% oxygen. This study also examined data from inbred lab strains and wild-derived mice 
separately. NMR fibroblasts showed a population doubling time of 6.26 days at low oxygen and 12.62 
at high oxygen, while lab mice had a population doubling time of 2.68 days at low oxygen and 11.92 
days at high oxygen (188) and wild-derived mice had a population doubling time of 3.66 days at low 
oxygen and 5.97 days at high oxygen. NMR fibroblasts appear to divide slower than those derived 
from mice in a consistent manner under varying conditions. The increased sensitivity to oxygen of 
NMR cells to wild mouse cells is likely a result of their natural environment in burrows that may have 
low oxygen contents. The increased sensitivity of lab mouse strains may be due to loss of oxidative 
resistance genes due to inbreeding. 
The NMR nuclear and mitochondrial genomes have been sequenced with a sequencing depth 
of 98.6% and over a 20-fold assembly (189). This sequencing has provided a number of insights about 
the NMR’s remarkable features. For example, 244 pseudogenes were identified, and these showed 
enrichments for terms including visual perception. Loss of gene activity in such genes may explain the 
poor sight of NMRs that arose as a result of living in dark tunnels. By looking at positively-selected 
genes, we can glean information regarding the evolution of particular traits. This study found 141 
positively-selected genes (at a false discovery rate of 0.05). These include the genes Tep1 (telomerase 
associated protein 1), a telomerase component and Terf1 (Telomeric repeat-binding factor 1), a 
telomeric repeat binding factor. Terf1 has been shown to regulate telomere length in a human tumour 
cell line with increased activity shortening telomere length and decreased activity increasing this 
length (190). The study also looked at genes that possessed amino acid residues unique to NMR when 
compared to homologs from 36 different vertebrates (including humans, mice and rats). Top2a (DNA 
topoisomerase 2-alpha), a DNA topoisomerase, was one such gene. TOP2A along with TERF1 and TEP1 
form a 5-protein complex that regulates telomere length (191). Changes in telomere maintenance 
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may be relevant to both the NMR’s lifespan and cancer resistance, as telomere shortening limits the 
number of divisions a cell can undergo and hence can prevent cancerous cell overgrowth. Additional 
genes found to possess unique polymorphisms include the DNA damage repair enzyme AP 
endonuclease 1 (Ape1) (discussed in Section 1.3) which is involved in Base excision repair (BER). BER 
is the DNA repair pathway responsible for repairing UV-induced DNA damage and alterations of such 
genes may explain the NMR’s perceived susceptibility to UV-induced DNA damage (175). This study 
also looked at p16, a gene shown to be required for NMR cell culture’s early contact inhibition. They 
found low similarity between exon three between mouse and NMR and predicted stop codons in exon 
2 resulting in a shorter (14Kd) protein, but functional domains were thought to be preserved. Such 
changes may affect the activity of this protein to facilitate its role in early contact inhibition. Genome 
sequencing can identify candidate genes for further research such as genes present in only NMRs, 
genes with polymorphisms and genes that have undergone positive selection. Such genes may 
contribute to the unique traits found in the NMR.  
The use of RNA sequencing, a technique that identifies the expression levels of an organism’s 
genes (detailed in Section 1.4) has been conducted on NMR cells (189, 192, 193). One study that 
looked at RNAseq data from brain, liver and kidney in 4 and 20-year-old NMRs showed fewer changes 
between the two groups compared to data in humans or mice that looked at young and old organisms 
(189). For example, only 24 genes changed in expression with age in the brain, compared to54 in 
humans, and two of these genes had an opposite change in expression in NMRs. Smad3 (SMAD family 
member 3) is downregulated in the human brain sample but upregulated in NMR brains with age. 
Smad3 modulates cell cycle progression and hence may contribute to the NMR’s cancer resistance by 
modulating correct cell cycle progression. 
Another study extracted liver cells from 3 young NMRs (2-3 years) and 3 wild mice (6.5 
months) for RNAseq (192). This study was conducted before the availability of the NMR genome, and 
hence orthologs were mapped to the mouse genome via the Basic Local Alignment Search Tool 
(BLAST) (194). This resulted in the caveat that genes with reduced expression in the NMR relative to 
mice may simply have poor coverage from the assembly used. As such, only genes with increased 
expression in NMR were identified. An interesting gene found to be upregulated in this study is alpha2-
macroglobulin (A2m). A2m shows a positive correlation with age in humans and has been associated 
with Alzheimer’s disease with inherited deletions increasing the risk of developing Alzheimer’s (195, 
196). This suggests a protective role of A2m and may contribute to the NMR’s apparent resistance to 
age-related morbidities. Among the over-expressed genes, those related to the mitochondria were 
overrepresented (66 genes) and included the ageing-related gene succinate dehydrogenase 
cytochrome b560 subunit. Mutation of this gene decrease lifespan in C. elegans and can promote 
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tumorigenesis is mouse cell cultures (197, 198). In accordance with the free radical theory of ageing, 
changes to the mitochondria that are the primary source of ROS may affect the rate of ageing. NMRs 
show higher levels of markers of oxidative stress to proteins (cysteine oxidation observed in liver cells 
(199) and protein carbonyls observed in multiple tissues (200)), lipids (isoprostanes detected in urine 
and malondialdehyde detected in liver samples (201)), and DNA (8-oxo-2′deoxyguanosine (8-oxo-dG) 
(200)) than mice. Hence NMRs seem to have a high basal level of oxidative stress (12), suggesting this 
is not the case. The largest change in expression found in this study was a 300-fold increase in 
epithelial cell adhesion molecule (EPCAM). This is counter-intuitive as EPCAM is associated with cancer 
through inhibition of cadherin cell adhesion and promoting cell cycle progression (202). Such a large 
difference in expression of a gene involved in cell adhesion may suggest a contributory role to the 
NMR’s exceptional phenotype as cell adhesion can affect cell cycle, and cancer development (detailed 
in Section 5.1.1). 
An RNAseq study compared NMR, mouse and human liver cells derived from 3 different 
individuals per species. This study used the inbred Balb/C mouse strain as opposed to wild-derived 
mice which is less comparable to wild animals and hence differences in gene expression may be due 
to this inbreeding. The availability of a sequenced NMR genome allowed for data on genes with lower 
expression in NMRs to be utilised unlike the previous study in NMR liver cells. This study focused on 
DNA damage genes and found upregulation of DNA damage genes, particularly those involved in 
homologous recombination and non-homologous end joining (NHEJ) (193). This increased expression 
of genes involved in repairing double-strand breaks (DSB) may explain why NMR fibroblasts seem 
particularly resistant to agents that induce DSB (175). 
As NMRs are typically 8-10cm long and live in colonies that contain 20-300 (average of 75) 
individuals, it is more practical to study their cells and extrapolate back to the animal. Fibroblasts can 
easily be grown in culture flasks with appropriate media to allow for study outside the animal. We 
predict that the NMR’s apparent DNA damage resistance is integral to their long lifespan and cancer 
resistance. 
1.3 DNA damage and repair  
DNA can be damaged by both endogenous and environmental factors, and estimations in mice 
predict that, under normal conditions, cells undergo ~14,000 – 22,000 DNA lesions per day (203). DNA 
damage if unrepaired can induce apoptosis, senescence and create mutations that can lead to cellular 
dysfunction and hence cancer and ageing. Defects in DNA repair pathways can cause premature 
ageing syndromes which, as the name suggests, show an accelerated ageing phenotype supporting 
the idea that ageing is at least in part caused by DNA damage (17).  
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 The main source of endogenous DNA damage is ROS. ROS oxidise DNA resulting in oxidised 
bases, abasic sites and strand breaks (204). Environmental sources of DNA damage include chemical 
agents, viruses and ionising radiation. The main form of radiation organisms are exposed to is UV 
radiation, which primarily induces cyclopurines and (6-4) photoproducts.  
Oxidised bases are, as the name suggests, nucleotide bases that are oxidised. This can lead to 
mutations. One study, focusing on 8-oxo-dG, which is often used as a biomarker for oxidative stress, 
found that 8-oxo-dG led to mutations (single base deletions, G:C to T:A or G:C to C:G transversions or 
larger deletions) 14% of the time (205). Oxidised bases are repaired via BER. 
Abasic sites are points in DNA in which the nucleotide base is lost, leaving the DNA backbone 
intact. These occur due to either spontaneous hydrolysis of the N-glycosyl bond, or through deliberate 
enzymatic cleavage of this bond to remove inappropriate bases (206, 207).  These sites can block 
transcription and DNA replication making them cytotoxic (208). Additionally, these sites are mutagenic 
leading to many single base substitutions (209). Abasic sites can also give rise to single-strand breaks 
(208). Abasic sites are repaired primarily by BER, but nucleotide excision repair (NER) may also play a 
role. 
Strand breaks, which include both single and double-strand breaks, are breaks in the DNA 
backbone. Single-strand breaks (SSB) are caused either by damaging agents or as an intermediate of 
BER. SSB can result in mutations and chromosomal aberrations (210). If DNA containing an SSB 
undergoes replication, DSB may be formed. SSB are repaired through BER. DSB may form as a result 
of DNA damaging agents either directly or indirectly or as an intermediate in normal biological 
processes. DSB can induce apoptosis, mutations and chromosomal rearrangements (211, 212). 
Chromosomal rearrangements caused by DSB have been associated with some forms of cancer (213, 
214). DSB are repaired through NHEJ, microhomology-mediated end joining (MMEJ), and homologous 
recombination. 
Cyclopurines form when carbon 5 (C5) of ribose in DNA is turned into a free radical (loses an 
electron). C5 takes an electron from the C8-N7 double bond resulting in C5-C8 bond, distorting the 
nucleotides shape and hydrogen bonding with its adjacent nucleotide (215). Accumulation of 
cyclopurines can block mammalian RNA polymerase II and replicative DNA polymerases and can result 
in misincorporation of the adjacent nucleotide during DNA replication (216, 217). Cyclopurines are 
repaired through NER. 
(6-4) photoproducts form when two pyrimidine bases on DNA strand undergo a 
photochemical reaction with UV radiation and bond to each other as opposed to their adjacent bases 
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(218). This can result in misincorporation of adjacent bases, typically an adenine being paired with 
cytosine resulting in a CC to TT mutation after replication. (6-4) photoproducts are repaired through 
NER. 
DNA adducts are points in the DNA with a chemical agent covalently attached. A wide array 
of DNA adduct and DNA adduct inducing compounds have been identified and the severity of the 
damage these induce to DNA varies between them (219). DNA adducts can induce mutations either 
during error-prone DNA repair or DNA replication at the adduct site (220). The method of repair also 
varies between adducts. Mismatch repair (MMR) (221), NER (222), BER (223), and a chemical reaction 
by which O6-Methylguanine DNA methyltransferase removes methyl and ethyl adducts from guanine 
bases (224) have all been identified as removing DNA adducts. 
DNA crosslinking occurs when a DNA nucleotide is covalently linked via a DNA crosslinking 
agent to a nucleotide from either the same strand (intrastrand crosslinking) or opposite strand 
(interstrand crosslinking). Intrastrand crosslinks can result in mutations as nucleotide bases are often 
misincorporated in the opposite strand during DNA synthesis (225, 226). Interstrand crosslinking holds 
the two strands together blocking transcription and DNA replication. Interstrand crosslinks can be 
repaired through NER (227). The repair of intrastrand crosslinking depends on the cell’s position in the 
cell cycle. During late S or G2 phase where an intact sister chromatid is available, a combination of 
NER and homologous repair act to remove the crosslink (228). When an intact sister chromatid is not 
available, NER is utilised to remove the lesion from one strand, and new DNA is synthesised using the 
remaining strand as a template (229, 230). This remaining strand is then removed and the gap filled 
as before. This DNA synthesis utilises lesion bypass DNA polymerase which has a relatively high 
mutation rate (230, 231). 
DNA damage cannot simply be replaced like other cellular components; it must last the 
lifespan of the cell, and hence any damage to the cell’s DNA needs to be repaired. As DNA is so vital 
to an organism’s survival, a number of sophisticated mechanisms have evolved to repair DNA damage. 
During NER, appropriate DNA damage is recognised, and a short single-strand of DNA 
containing the lesion is removed, leaving the undamaged strand intact. DNA polymerase then replaces 
the removed strand using the intact strand as a template. Then DNA ligase connects the newly 
synthesised strand to the end of the old strand. There are two types of NER, global genome NER 
(ggNER) that occurs anywhere in the genome and transcription-coupled NER (tcNER) that occurs on 
the transcribed strand of active genes. DNA damage needs to be detected before it can be repaired. 
For ggNER this recognition is performed by the XPC complex (232) that has been shown to be made 
up of xeroderma pigmentosum group C (XPC), either RAD23A or RAD23B and centrin 2 through co-
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immunoprecipitation analysis (233). This complex binds to DNA with a greater affinity at site of DNA 
damage. This has been shown through biochemical assays using purified XPC complex, and have 
shown increased binding at 6-4 photoproducts (232), abasic sites (234) and N-acetyl-2-aminofluorene 
adducts (235). This XPC binds poorly to UV-induced cyclobutane pyrimidine dimers (CPD) even though 
these are repaired through ggNER, hence additional factors are required for damage detection. UV-
damaged DNA-binding protein (UV-DDB) is a protein complex made up of DNA-binding protein 1 and 
2 (DDB1 and 2) (236, 237). Purified UV-DDB has been shown to bind CPD and 6-4 photoproducts (238). 
UV-DDB contributes to the CRL4DDB2 complex (made up of DDB2, DDB1, Cullin-4 (CUL4) and Ring-Box 
1 (RBX1)) that also serves as damage sensor (239). Detection of DNA damage in tcNER is initiated by 
stalling of RNA polymerase II.  The CRL4CSA complex (made up of CSA-DDB1-CUL4-RBX1) is recruited to 
the site of damage and acts similarly to the CRL4DDB2 complex. These GRL4 complexes promote 
ubiquitination of histone proteins, clearing them from the site of damage (239). Both tcNER and ggNER 
result in the recruitment of the TFIIH complex that is made up of 10 proteins, and acts to promote 
unwinding and opening of the DNA strand into an open bubble structure (240). This open structure 
allows incisions to be made by the endonucleases ERCC1-XPF (Excision Repair Cross-Complementation 
Group 1 - Excision Repair Cross-Complementation Group 4) and XPG (DNA repair protein 
complementing XP-G cells). ERCC1-XPF is thought to perform the initial 5’ incision and XPG the later 
3’ incision ~24-32 bases away (241, 242). Xeroderma pigmentosum group A protein (XPA) and 
replication protein A (RPA) act to prevent cleavage in the undamaged strand by preferentially binding 
it (243). The damaged strand is released and replaced by DNA polymerases. The 3’ nick is then ligated 
by DNA ligase. 
Mechanistically NER and BER are very similar: both cut out a single-strand of DNA containing 
DNA damage and replace the strand using DNA polymerase and DNA ligase. Their main difference is 
how the damage is recognised. NER proteins recognise distortions in the DNA structure, whereas BER 
relies on specific glycosylases to detect the lesion and cut the base out to create an abasic site or 
create a single-strand break marking the strand for BER. BER can remove a single base (short patch) 
or multiple bases (long strand). Humans possess at least 11 glycosylases. The glycosylases gently nip 
the DNA strand while scanning them causing the strand to bend, which at sites of damaged bases 
cause the base to pop out of the DNA strand and enter the glycosylases binding site in a process known 
as ‘base flipping’(244). Mono-functional glycosylases rely on a water molecule to act as a nucleophile 
and attack the aromatic carbon of the target base resulting in an abasic site. Bi-functional glycosylases 
exhibit enzymatic cleavage of the base and cut the DNA strand leaving a single-strand break. Next, the 
abasic site has an incision made at its 5’ side by endonucleases, if not already done by bi-functional 
glycosylases. The major endonuclease responsible for these incisions in mammals is the 
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APE1endonuclease which accounts for >95% of this activity (245). APE1 can also remove blocking 
groups, such as 3’- phosphoglycolate, and creates a 3’-OH group required for repair (246). The missing 
base is replaced by DNA polymerase. POLβ is the primary polymerase responsible for short patch BER 
though POLL can also fulfil this role (247, 248). In long patch BER, more nucleotides (~2-12) are 
replaced. POLδ and POLε perform strand displacement synthesis in which new bases are made, and 
the old ones are essentially pushed out the way creating an overhang in the old strand. This allows the 
creation of multiple new bases when only a single base gap is present. These polymerases are aided 
by proliferating cell nuclear antigen (PCNA) that serves as a processivity-promoting factor (249). The 
overhang is then removed by structure-specific nucleases; this is primarily flap endonuclease 1 (FEN1) 
(250). Finally, the newly synthesised strand is ligated to the rest of the strand. In short patch BER this 
is primarily done by DNA ligase I, and in long patch BER, this is primarily done by DNA ligase IIIα (251). 
DNA ligase IIIα requires X-ray repair cross-complementing protein 1 (XRCC1), a scaffold protein (252). 
In additionPARP1 is thought to contribute to this relegation step in select types of damage as these 
are repaired with reduced capacity when PARP1 is inhibited (253). It is not clear how PARP1 acts in 
BER but may serve to stabilise XRCC1 (254).  
Homologous recombination occurs when a double-strand break is present when sister 
chromatids are available to be copied. First, both 5’ ends of the DNA break are cut away in a process 
known as resection. This creates unpaired single-strand DNA which can now invade the DNA of the 
identical sister chromatin, and anneal to the equivalent section of DNA. DNA polymerase then adds 
the DNA to the 3’ end. This occurs for both strands of the broken DNA. With all the gaps filled in, the 
strands can either be ligated to the DNA strand to which they were originally connected or more 
commonly to the strand of the other chromatid resulting in crossover. Homologous recombination 
repair begins with pre-synapsis in which 3’ overhang is generated at the DSB. Some sources of strand 
breaks, such as ionising radiation, result in modified bases at the 5’ and 3’ end of the break. Such 
modifications need to be removed and this is done by the MRX (Meiotic Recombination 11 (MRE11), 
Rad50 and Xrs2) complex and exonuclease 1 (EXO1) in saccharomyces cerevisiae (MRX is replaced with 
the MRN complex in mammals, as Nijmegen Breakage Syndrome 1 (NBS1) replaces Xrs2) which is not 
required for repair of DSBs that lack these modifications (255-257). RPA binds ssDNA (single-stranded 
DNA) and inhibits the formation of secondary structure to facilitate homologous repair (258). Rad51 
binds to ssDNA forming a helical nucleoprotein filament on the DNA (259). This binding requires the 
activity of co-factors including Rad52, and complexes of Rad51 paralogs (XRCC2, XRCC3, RAD51B, 
RAD51C and RAD51D) (260, 261). Deletion of any of these paralogs results in inhibition of delivery of 
Rad51 to the DNA strand (260). BRCA1 (breast cancer associated 1) and 2 also contributes to the 
activity of Rad51, as they are capable of direct binding (262, 263). Mutations of BRCA1 and 2 are 
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associated with cancer (a disease in part caused by DNA damage) (264), decreased homologous 
recombination (265-267) and decreased Rad51 accumulation in response to DNA damage (268, 269). 
Next homology is searched for before invasion of the homologous DNA takes place and is 
collectively termed synapsis. The RPA/Dmc1 filament around the ssDNA forms a complex with the 
DNA strand of the sister chromatin to allow invasion by the ssDNA and allows searching for homology 
through annealing of the bases. The final stage, termed post-synapses, involves the generation of new 
DNA and relegation of the DNA strands. Rad54 aids the formation of the Rad51 DNA complex but also 
serves to remove Rad51 from the ssDNA after successful homologous annealing (270). This allows the 
entry of DNA polymerase to extend the 3’ end of the invading DNA strand. From here homologous 
recombination diverges into 2 distinct pathways; the Double-Strand Break Repair (DSBR) pathway and 
the Synthesis-Dependent Strand Annealing Pathway (SDSA). In SDSA the DNA strand retreats from the 
invaded dsDNA and re-anneals to its original DNA strand. In DSBR the ssDNA that did not invade the 
dsDNA anneals to its homologous sequence in the invaded DNA forming a ‘double Holliday junction’. 
This annealing means that both strands are connected and to resolve this an enzyme, termed a 
resolvase, is required to cut both junctions in either the opposite (resulting in crossing over) or the 
same direction. In mammals, Gen Endonuclease Homolog 1 (GEN1), Crossover Junction Endonuclease 
(MUS81)-Essential Meiotic Structure-Specific Endonuclease 1 (EME1), and Structure-Specific 
Endonuclease Subunit 1 and 4 (SLX1 and 4) have been implicated as filling this role (271). Finally, the 
DNA is reconnected by DNA ligase 1 to produce two intact strands of dsDNA (272). PARP1 appears to 
have a regulatory role in HR as PARP1 knock out cells show increased Rad51 loci formation but 
otherwise normal homologous recombination (273). 
NHEJ occurs when double-strand breaks form and no DNA copies exist to serve as a template. 
Instead, overhangs at the break site are used that will be homologous to the opposing overhang and 
are known as microhomologies. If these are not present, then MMEJ occurs, which is essentially the 
same as NHEJ except the DNA is cut away to create these overhangs. Typically, this is less accurate as 
it can lead to deletions of the DNA between the microhomologies. The first step in NHEJ is binding by 
the Ku heterodimer (Ku70 and Ku80, also known as XRCC5 and 6) to the broken DNA strand. Ku, when 
bound to DNA, has a greater binding capacity for other proteins including the nuclease DNA-
dependent protein kinase catalytic subunit (DNA-PKcs) in complex with Artemis, polymerase μ and λ, 
and DNA ligase 4 in complex with XRCC4-Like Factor (XLF) and XRCC4 (274). Hence Ku recruits and 
stabilises the enzymatic components required for NHEJ. Artemis possesses a 5’ endonuclease activity, 
and the Artemis, DNA-PKcs complex possesses both 5’ and 3’ endonuclease activity (275). This 
complex can bind DNA strand ends but does so with greater affinity when the Ku complex is present 
(276). DNA-PKcs autophosphorylates itself and Artemis when bound to the DNA, facilitating Artemis’ 
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endonuclease activity and causing conformational changes that facilitate binding of other NHEJ 
proteins (277, 278). Additionally, this complex is capable of opening up hairpin loops that are 
necessary for NHEJ (275). The endonuclease activity creates overhangs in the DNA structure. The 
polymerases μ and λ act to extend the DNA strand after annealing in a template-dependent manner 
and polymerase μ can act template-independently to create random microhomologies (279). These 
polymerase can display template slippage that can result in repeats forming which is often seen in 
NHEJ (274). Once homology and annealing have been achieved it is the job of DNA ligase 4 to ligate 
the DNA strands together in a manner that is dependent on XRCC4 activity (280). DNA ligase 4 can also 
ligate blunt ends together (281). XLF stimulates XRCC4-DNA ligase 4’s ability to ligate the DNA strand 
(282). XRCC4-DNA ligase 4 shows remarkable flexibility. It can mediate ligation on a single-strand of 
the double-stranded DNA which is useful if the other strand is unligatable (283). It can ligate across 
gaps (279). Finally, it can ligate incompatible DNA that lacks homology (284). 
MMR aims to detect and correct mismatched bases. A number of proteins act to detect these 
errors, but the question remains as to which is the correct base and which the error. In gram-negative 
bacteria, differences in stand methylation mark the newly synthesised DNA strand and hence which 
side the error is on. In eukaryotes, the picture is less clear, but it is thought that nicks in the newly 
synthesised strand serve this stand-labelling role (285).  Recognition of DNA damage in humans is 
conducted by two heterodimers of mutS homolog (hMSH) 2 with either hMSH3 or hMSH6 to form the 
complexes hMutSβ or hMutSα, respectively (286). These complexes recruit more components of the 
repair pathway including heterodimeric complexes of MutL homolog (hMLH) 1 with PMS1 protein 
homolog (hPMS) 2, hPMS1, or hMLH3 to form hMutLα, hMutLβ, or hMutLγ, respectively. Only hMurlα 
contributes to MMR and acts to make an incision 5’ of the mismatch. Additionally, the hMutS 
complexes recruit PCNA that interacts with hMSH2, 3 and 6 (287). This PCNA interaction is required 
for 3’ nick detected MMR but not for 5’ nick detected MMR (288). This is due to the activity of EXO1 
that is capable of 5’ mismatch excision in the presence of hMutSα or hMutSβ in complex with RPA 
(289) but requires the MutLα endonuclease activity that is activated by PCNA and replication factor C 
(RFC) (290). EXO1 removes bases from the point of the hMutLα incision beyond the mismatch in a 5’-
3’ direction (290). After excision of the mismatched bases, pol δ is recruited to resynthesise the 
removed bases. Finally, DNA ligase 1 reconnects the DNA strands. RPA appears to be involved at all 
stages of MMR, binding to the nicked DNA, stimulating DNA excision and facilitating DNA resynthesis 
(291). 
DNA damage repair is not a perfect process. Damaged DNA can be repaired but the 
appropriate epigenetic markers may not be replaced, or inappropriate ones may be added which could 
result in inappropriate activation or inactivation of genes (292). If the DNA cannot be repaired, the cell 
46 
 
will most commonly undergo apoptosis, removing itself and the risk of cancer its DNA damage brings. 
Alternatively, the damaged cell may become senescent, exiting the cell cycle to prevent the spread of 
any mutations into daughter cells.  
 Throughout the cell cycle, there are a number of checkpoints. Among other things these allow 
the cell to check for DNA damage. When DNA damage is detected the cell cycle can be arrested and 
stopped at these points giving the cell chance to repair DNA damage and mutations before DNA 
replication which can result in mutations become permanent.  
The detection, repair and overall cellular response to DNA damage require a large number of 
genes. In the relatively simple Escherichia coli, it is suggested that over 1,000 genes are involved in 
responding to DNA damage (293). A different response requires different genes, and so, by monitoring 
what genes are active in DNA damage-resistant organisms responding to DNA damage, we can glean 
information of how to resist DNA damage more effectively. However, with so many genes that could 
potentially be involved, a transcriptome-wide approach is required.  
1.4 Functional genomics 
 In a cell, DNA stores information on how to create all the proteins a cell will create, and hence 
how the cell functions. This information is transcribed into RNA, and this RNA is in turn translated into 
a protein that will go on to perform its given function. Not all genes are active at once, however, and 
which genes are active depends on what the cell is doing. By analysing the cells transcribed RNA, also 
known as the transcriptome, we can identify what is happening in the cell. Doing this when the cell is 
responding to a DNA-damaging agent can tell us how the cell responses to DNA damage. There are 
two well-used methods for analysing the transcriptome: microarrays and RNA sequencing. 
Microarrays are basically a solid surface with thousands of distinct spots. Each spot contains 
many copies of one specific strand of single-stranded DNA bound to the surface. These DNA strands 
known as probes are specifically designed to correspond to a section of a gene. All the RNA from a 
number of cells is extracted and reversed, transcribing it into cDNA (complementary DNA). The cDNA 
is then labelled with a fluorescent marker. Multiple samples can be labelled with a different coloured 
marker and pooled pair-wise together. This is then washed over the microarray allowing the cDNA to 
anneal to the corresponding probe. The microarray is then imaged to detect fluorescence; if RNA for 
a specific gene is present in the original sample and hence was being expressed in the cell, then the 
cDNA will be left bound to the spot(s) that corresponded to that gene and the fluorescent label will 
be visible. If the gene was present in both starting samples, then a combination of the fluorescence 
will be detected, and by detecting the ratio of fluorescence, we can say how much more a gene is 
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active in one sample than the other. Microarray analysis has successfully been applied to the study of 
ageing. For example, the use of microarrays analysis in long-lived daf-16 mutant C. elegans identified 
a number of genes that were found to affect lifespan (294). 
RNA sequencing (RNAseq) takes a different approach. There are various forms of RNAseq, and 
the field is still evolving. It is beyond the scope of this thesis to detail all methods and their merits, and 
so the basic method used in our analysis will be explained only (for further information the reader is 
directed to (295, 296)). As before, RNA is extracted from the chosen cells. The RNA sample will contain 
a large amount of ribosomal RNA (rRNA) (over 90%) which will saturate the results and so is removed. 
This RNA is amplified, and coding RNA is purified typically by targeting the poly-A tail. This is 
accomplished by passing the sample over magnetic beads coated with poly T oligonucleotides. The 
RNA is then fragmented and reverse transcribed to cDNA. Second generation sequencing is then 
employed to sequence these fragments. Computational analysis can detect which genes are present 
and in what quantities. RNAseq has been successfully implemented to monitor changes in the 
transcriptome of mouse brains at different ages and found previously unknown genes providing new 
candidates for further study (297). RNAseq has also been successfully used in analysing the NMR 
transcriptome in comparison to mouse and human cell lines. Such studies have identified increased 
expression of DNA damage, oxidoreduction and mitochondria-associated genes in NMR liver cells 
(192, 193).  
Both technologies are widely used, and the appropriateness of each technology depends on 
the user’s desired application. However, RNAseq offers a number of advantages over microarrays.  
RNAseq analyses the absolute amount of gene expression by counting the number of reads in a 
sample, but microarrays only analyse the relative amount of expression between different samples 
(298).  RNAseq offers a greater dynamic range in expression values as microarrays rely on 
fluorescence, where high expression values can lead to signal saturation, and background noise can 
obscure lower expression values (295, 299, 300). Unlike RNAseq, microarrays do not analyse the whole 
transcriptome; they only analyse the presence of transcripts that have specific probes on the array 
and as such may miss non-coding RNA such as microRNAs (miRNA), which can be detected and are 
often discovered by RNAseq (300, 301). RNAseq can be used to identify mRNA (messenger RNA) 
complexities overlooked by microarrays such as SNPs and different splice isoforms including 
undiscovered isoforms (299, 300, 302).  Finally, RNAseq can potentially be used on samples from any 
organism, unlike microarrays which require the organism to have a sequenced genome, microarrays 
made specifically for that genome and a high-quality annotation of the genome as any un-annotated 
genes will not be added to the microarray and hence would be missed by the analysis.  
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When studying ageing through gene expression data, three major caveats must be considered. 
First, RNA levels do not necessarily correlate with protein levels due to post-translational mechanisms 
such as suppression of mRNA by miRNA, and protein degradation (303-305). Additionally, the 
presence of a protein does not necessarily correlate with protein activity as post-translational 
modification may render the protein inactive. Second, genes that are being expressed may not be 
related to the underlying mechanism of ageing but instead to specific age-related diseases or be 
expressed in response to the ageing phenotype (306). Finally, complex multi-cellular organisms such 
as mammals have many different cell types that may not age in the same way or at the same rate, and 
it has already been indicated that different organs have different ageing-specific gene expression 
profiles (307). With these caveats in mind, these approaches still have the capacity to provide major 
insights into the ageing process (294, 297).  
1.5 Aims 
 The overall aim of this thesis is to better understand successful ageing and avoidance of age-
related morbidities, notably cancer. To this end we studied two models of successful ageing, caloric 
restriction in the nematode worm C. elegans and the naturally long-lived rodent Heterocephalus 
glaber.  
Firstly, we analyse caloric restriction and candidate caloric restriction mimetic treatment in C. 
elegans. We performed a microarray on eat-2 mutant worms, a caloric restriction model and worms 
treated with either rapamycin or allantoin that have been shown to extend lifespan in C. elegans (72). 
The aim of this experiment was to identify possible mechanisms and genes involved in these lifespan 
extensions. Additionally, we aimed to determine how similarly these caloric restriction mimetics acted 
to caloric restriction. 
 Next, building on previously published work (179) we examined the response of NMR cells 
exposed to the DNA damaging agents camptothecin and chromium (vi) oxide in comparison to that of 
mouse cells. These experiments serve to confirm the reproducibility of previous work and provide 
lethal dose 50 values with which to perform further experiments. Furthermore, these experiments 
provide a biological context for gene expression analysis.  
 To further our understanding of the processes taking place in the treated cells, RNAseq 
analysis was conducted on cells recovering from exposure to the genotoxic compounds. This analysis 
was designed to identify differences in how these species respond to such toxic stimuli in the hopes 
of identifying superior protective mechanisms in the NMR that may contribute to their increased 
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lifespan and cancer-resistant phenotype. We focused our analysis initially on DNA damage genes as 
previous findings (193) suggested an increased expression of such genes in NMR cells. 
 Finally, to test the results of the RNAseq analysis that suggested differences in cellular 
adhesion and cell cycle progression between the NMR and mouse, both flow cytometry and adhesion-
based assays were conducted. These assays aimed to provide evidence that the observed differences 
in gene expression translated into observable differences in the cellular phenotype. Such differences, 
if observed, would confirm the initial findings and support the hypothesis that they are important in 
the NMR’s long lifespan and/or cancer resistance.   
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Chapter 2: Caenorhabditis elegans microarray analysis 
2.1 Introduction   
 In order to evaluate successful ageing, this chapter will examine the lifespan extending 
intervention, caloric restriction, in the nematode worm C. elegans. This examination will be at the 
functional genomics level to identify biological pathways or components important in caloric 
restriction-induced lifespan extension. We can consider organisms undergoing caloric restriction as a 
model of successful ageing. Any identified difference induced by this intervention may be essential for 
inducing successful ageing.  
 To achieve this goal, a microarray analysis was conducted on C. elegans undergoing caloric 
restriction or treatment with caloric restriction mimetics that have been shown to increase worm 
lifespan. A functional enrichment was performed on differentially-expressed genes to identify if genes 
involved in a particular process or pathway were enriched within the sample.  
2.1.1 Caloric restriction in C. elegans 
 Caloric restriction is the most robust longevity intervention to date, capable of altering 
lifespan in a wide array of organisms including the nematode worm C. elegans (53-55). In addition to 
its capacity to increase lifespan, caloric restriction also reduces the risk of age-related morbidities such 
as cancer and can hence be considered a model of successful ageing (56). In reality, caloric restriction 
is thought to have a number of side effects and is difficult to maintain. Therefore, the use of caloric 
restriction mimetics, compounds that induce the beneficial effects of caloric restriction, are an 
attractive alternative through which humans could reap the benefits of longevity enhancement, 
without dealing with the difficult lifestyle and side effects (63, 308).  
 Caloric restriction mimetics were identified by us previously by using the gene expression 
profiles of rat cells exposed to sera from rats or rhesus monkeys undergoing caloric restriction and 
finding compounds that induce a similar profile in the Connectivity Map (version 2), a database of 
gene expression profiles in various human cells in response to different drugs (72, 309). In our previous 
study, wild-type worms and eat-2 mutant worms that are long-lived and are deemed a caloric 
restricted model due to reduced feeding (61), were grown on nematode growth media that contained 
the candidate caloric restriction mimetics. The ligand-gated ion channel eat-2 is located in the 
pharyngeal pump and is responsible for controlling the rate of pump contraction (162, 163). This 
pharyngeal pump facilitates food uptake by the worm; mutations of eat-2 result in a decreased rate 
of pharyngeal pumping and hence decrease levels of food intake, inducing caloric restriction and 
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increasing lifespan (61, 163, 164). Allantoin and rapamycin increased the lifespan of wild-type worms 
(by 21.9 and 18.9%, respectively) but not the worms undergoing caloric restriction (72). If two 
different mechanisms were acting on lifespan, we would expect to see an additive effect on lifespan. 
Calorically restricted worms showed no additional lifespan increase when treated with these 
compounds, which suggests these two lifespan interventions act through similar mechanisms, and 
hence that these compounds are acting as caloric restriction mimetics. Additionally, worms treated 
with rapamycin and allantoin showed increased health-span, the period of an organism’s lifespan 
during which they are considered healthy and free of major morbidity. This was detected as a slower 
rate of decline in pharyngeal pumping which is known to decline with age and is often used as a marker 
of ageing (72, 77). If the compounds of study acted in a manner distinct from caloric restriction, we 
would expect to see a synergistic increase in lifespan of eat-2 worms treated with the compounds. 
 Rapamycin treatment has been shown to increase lifespan in different organisms from yeast 
to mammals (26, 310-312). Treatment with rapamycin has overlapping effects with caloric restriction 
in mice supporting the idea that it is a caloric restriction mimetic (107). Rapamycin inhibits TOR/let-
363 (313), and manipulation of the TOR pathway is sufficient to induce the effects seen in rapamycin 
treatment. This indicates that TOR inhibition is the primary mode of action for rapamycin-induced 
lifespan extension (312, 314, 315). Treatment with rapamycin has been shown to delay the onset of 
age-related diseases in mice (316, 317) and C. elegans (72). 
Allantoin is poorly studied in the context of ageing but has been shown to increase lifespan 
and prolong health-span in C. elegans (72). Allantoin has been shown to bind to the Imidazoline 
receptors I1R and I2R, inducing beneficial effects on energy regulation, lipid homeostasis and 
improving insulin resistance via the AMP kinase pathway (318-322). However, C. elegans does not 
appear to contain any Imidazoline receptors. It is possible that these receptors exist but they or their 
function as an Imidazoline receptor has not been discovered. Allantoin is thought to be produced 
naturally in C. elegans as a by-product of the reaction between uric acid and ROS (323).  Hence 
allantoin may act as part of a feedback mechanism by which high levels of ROS result in high levels of 
allantoin which signals the presence of this high level of ROS to promote appropriate antioxidant and 
potentially life-extending pathways. 
In 1998, C. elegans became the first multi-cellular organism to have its genome sequenced 
(324). This genome is now well annotated, and hence we now know the sequence of most if not all 
genes in the C. elegans genome. This allows for transcriptome-wide studies such as microarray 
analyses which require these sequences to make the probes on the array’s surface. By hybridising 
52 
 
cDNA created from RNA extracted from C. elegans we can identify which genes are up or 
downregulated in response to a chosen stimuli, such as rapamycin and allantoin treatment. 
2.2 Aims  
 Microarray analyses identify the relative gene expression between samples for nearly all 
genes in an organism’s genome. To our knowledge, no such analysis has been conducted on the well-
known caloric restriction mimetic rapamycin or the newly discovered caloric restriction mimetic 
allantoin. By studying microarray data from worms treated with allantoin or rapamycin, we hope to 
be able to identify how differently these two compounds act from each other and caloric restriction.  
Caloric restriction mimetics are unlikely to elicit the exact same response as caloric restriction itself, 
and hence by evaluating the overlap in responses, we can identify essential components that 
contribute to successful ageing. Additionally, caloric restriction mimetics may act through unique 
pathways opening up new potential mechanisms to exploit to prevent ageing. A better understanding 
of how caloric restriction mimetics work may aid in the discovery and development of new such 
compounds.  
2.3 Materials and methods 
2.3.1 Worm strains and cultures 
N2 wild isolate and eat-2 (DA465) strains were provided by the Caenorhabditis Genetics Centre 
(CGC), which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). The eat-2 
mutants have reduced neuronal signalling due to the loss of the Eat-2 nicotinic acetylcholine receptor 
resulting in decreased pharyngeal pumping that induces a caloric restriction-like state by restricting 
feeding. All strains were grown at 20°C on standard nematode growth medium (NGM) as described in 
‘WormBook’ (325) with E. Coli OP50 as a food source.  
NGM plates were prepared up to 2 weeks in advance (stored at 4ᵒC until use) and contained 
roughly 30ml of agar. OP50 streak plates were created from E. coli liquid culture already established 
in the lab on LB agar. This streak plate was used to seed all future liquid cultures and was stored at 
4ᵒC.  LB broth (thermofisher ref:12780052) was inoculated by scraping a sterile pipette tip over a 
colony on the streak plate and placing this in the LB broth. This was incubated at 37ᵒC overnight to 
create a stock solution. For live E. coli plates, 200µl of the overnight stock solution was pipetted to the 
centre of the plate and gently spread with a sterile glass spreader. These plates were left overnight at 
room temperature to allow E. coli growth before use or storage at 4ᵒC. For killed E. coli plates stock 
solutions were made up to 20% ethanol and stored overnight at 4ᵒC. This solution was irradiated with 
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UV radiation in a Bio-Rad GS gene linker set at 0–999mJ/cm2 power 10 times to finalise the killing of 
the E. coli. This solution was centrifuged at 3,000g for 5 minutes and the supernatant replaced with 
LB broth at half the original volume. 1.5ml of killed stock was added to NGM plates and spread with a 
sterile spreader and allowed to dry in a sterile laminar flow hood to dry for 3 hours. Additional killed 
E. coli solution was added as needed. C. elegans stocks were maintained by cutting a 1 by 1cm square 
of agar from plates with low food and a high worm population to a fresh NGM plate with live E. coli 
using aseptic technique. This was performed as needed (approximately twice a week). 
2.3.2 Drug concentrations 
Rapamycin (ref. R0395), allantoin (ref. 93791) and FUDR (ref. F0503) were purchased from 
Sigma Aldrich, Dorset. The drug under study was added to 30ml NGM to give the final concentration 
of either 10µM rapamycin or 250µM allantoin. These concentrations were chosen as they have 
previously been shown to increase lifespan in C. elegans (72) and were originally determined by taking 
values seen in previous studies in worms, cells in the Connectivity Map and invertebrates (26, 309, 
326). Another member of the lab group treated worms with variations of these doses and monitored 
for increased mortality. The highest concentration used in a preliminary experiment (not shown) that 
did not result in increased worm mortality was used for the study; however, it was later found that 
for some drugs the induced mortality was likely the result of increased levels of dimethyl sulfoxide 
(DMSO) which is known to be toxic in C. elegans at high concentrations (327) and hence the dosages 
used may be lower than the maximum non-lethal dose.  
 
2.3.3 Gene expression analysis 
Gene expression analysis was performed 72 hours after the worms were transferred to drug-
containing NGM plates with killed E. coli to allow plenty of time for the compounds to induce changes 
in gene expression. Worms were treated with the drugs when in the L4 stage as this time point has 
been used for lifespan assays with the two drugs (72). Whole worms were washed from the plate with 
distilled water and spun down at 3,000rpm for 2 minutes. Afterwards, the worms were re-suspended 
in 400µl Trizol reagent (ThermoFisher, 15596026), and then transferred to 2ml screw cap tubes 
containing 1ml 0.1mm glass beads. Worms were lysed in a powerlyser at 4,000rpm for two 30 second 
runs, chilling the tubes on ice after each run. RNA was then extracted as per the manufacturer’s 
instructions with a QIAGEN RNeasy extraction kit. Each condition was run in triplicate. 
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RNA samples were sent to the Liverpool Centre for Genomic Research, to be run on the 
microarrays in a manner outlined here. The samples were analysed in terms of quality and quantity 
using an Agilent 2100 Bioanalyser RNA 6,000 Nano Chip. Samples were labelled using the Affymetric 
GeneChip 3@ IVT Express labelling kit as per the manufacturer’s instructions. 200ng of total RNA was 
input into the labelling reaction. Following amplification, 15ug of RNA was fragmented, and 12.5ug of 
fragmented, labelled RNA was hybridised onto Affymetrix GeneChip C. elegans Genome Arrays as per 
the manufacturer’s instructions. These were hybridised for 16 hours at 45°C and 60rpm in an 
Affymetrix hybridisation oven 640. Hybridised arrays were washed using Affymetrix Hybridisation 
wash and stain kit on a GeneChip Fluidics station 450 and scanned using an Affymetrix GeneChip 
scanner 3,000 7G. Affymetrix GeneChip Command Console Software was used to generate .CEL files. 
This raw data was delivered to our lab group and has been submitted to Gene Expression Omnibus 
(GEO) under the accession GSE64336. 
Analysis of gene expression data was initially completed by a member of our lab group with 
the Affymetrix® Transcriptome Analysis Console. Data pre-processing (using Robust Multi-array 
Average (RMA) normalisation) and quality control metrics were performed using Affymetrix® 
Expression Console™ and manually inspected afterwards. Finally, they performed expression analysis 
for each two pair-wise conditions.  
The output of this analysis was received by myself, and Benjamini correction for multiple 
testing (328) (P < 0.05) was applied. This resulted in a slightly lower number of differentially expressed 
genes in most cases. 
Comparisons involving N2 controls were an exception to this pattern as N2 controls appeared 
to be affected more by noise. This was likely due to higher variability in gene expression in the N2 
control population compared to populations with pathological or drug-induced conditions. Surveying 
various worm datasets from experiments submitted to GEO revealed that in many cases there is a 
striking number of genes differentially expressed between N2 worm samples from different 
experiments (data not shown). In order to include differentially expressed genes that were only 
marginally significant in our subsequent analysis, we included all genes with a p-value of p<0.05, and 
fold change > 2.0. This was in line with our previous methods that focussed on finding pathways 
potentially associated with ageing and longevity (329). 
Functional enrichment analysis was performed using DAVID 6.7 (330). The worm genome was 
used as the background with default settings for all analysis. Multiple hypothesis testing was carried 
out using Benjamini correction (P < 0.05).  
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2.4 Results 
From the microarray, we found no or very few (less than 10) genes differentially expressed 
after FDR correction for a p-value of p<0.05 with a fold change of 1.5 or higher in any comparison with 
N2 control worms (Table 2.1). By performing a basic principle component analysis (Figure 2.1), we can 
see there was a large amount of variation between N2 control samples. This variation likely explains 
why so few genes were detected as differentially expressed. The other samples were much less varied 
which may be a result of the drug treatment itself that may be inducing the same specific gene 
expression profile in all the worms. 
 
Figure 2.1. PCA plot of microarray data. Each cube represents an RNA sample used in the microarray 
analysis. N2 controls (yellow) show large amounts of variation which can be seen by the distance of 
each point from one another. Credit Robi Tacutu for this image. 
Array-array correlation plots using Pearson’s correlation (331) for all microarray comparisons 
were obtained using R (332) (Figure 2.2). The lowest correlation seen was between rapamycin treated 
N2 worms and all other treatments except untreated N2 worms with a score of ~0.92-0.96.  
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Figure 2.2. Pearson’s correlation of the signal (using RMA-normalised gene-level signals) between 
samples, obtained from the Affymetrix Expression Console. Credit Robi Tacutu for this image. 
 
Due to large variations in our N2 control samples, we cannot accurately comment on changes 
in gene expression from control samples. Treatment of eat-2 mutants with rapamycin only resulted in 
457 genes differentially expressed with a fold change of at least 1.5 and p<0.05 after FDR correction. 
This may in part be due to the reduced intake of rapamycin by the eat-2 worms. Eat-2 mutant worms 
have a pharyngeal pumping rate of 20% that of wild-type N2 worms, however eat-2 food uptake is 60-
80% that of N2 worms (333). Using a dose double that used in the microarray showed similar changes 
in lifespan indicating that the drug is taken up sufficiently to influence lifespan and hence should affect 
gene expression (72). Wild-type worms treated with rapamycin showed a large change in gene 
expression (6,378 genes) compared to eat-2 controls indicating that rapamycin induces lifespan 
extension through pathways that are more distinct from those in caloric restriction. Perhaps the 
response to caloric restriction masks responses to rapamycin in eat-2 worms. N2 worms treated with 
allantoin showed relatively low changes in gene expression (1,188 genes) indicating more overlap 
between allantoin and caloric restriction pathways. N2 worms treated with allantoin showed 
remarkably similar gene expression to eat-2 worms treated with rapamycin (only 76 differentially 
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expressed genes). This may indicate a common response of the animals against substances they would 
not usually be exposed to at the high doses provided in this study. Allantoin and rapamycin seem to 
act distinctly as N2 worms treated with these compounds showed the largest number of differentially 
expressed (DE) genes (8,335 genes). Given the larger overlap of allantoin with caloric restriction and 
apparent difference of rapamycin and caloric restriction, it makes sense that there would be a large 
difference between the two compounds.  
Table 2.1. Genes up (↑) or down (↓) regulated in the different comparisons with an FDR corrected p-
value of p<0.05 and fold change of 1.5. Row vs. column. 
vs N2 control eat-2 control N2 rapamycin  eat-2 
rapamycin 
N2 allantoin 
N2 control - 1↑ 
0↓ 
0↑ 
7↓ 
0↑ 
0↓ 
0↑ 
0↓ 
eat-2 control 0↑ 
1↓ 
- 3,099↑ 
3,279↓ 
232↑ 
225↓ 
598↑ 
590↓ 
N2 
rapamycin 
7↑ 
0↓ 
3,279↑ 
3,099↓ 
- 3,920↑ 
3,541↓ 
4,188↑ 
4,147↓ 
eat-2 
rapamycin 
0↑ 
0↓ 
225↑ 
232↓ 
3,541↑ 
3,920↓ 
- 67↑ 
9↓ 
N2 allantoin 0↑ 
0↓ 
590↑ 
598↓ 
4,147↑ 
4,188↓ 
9↑ 
67↓ 
- 
 
Table 2.2. Genes up (↑) or down (↓) regulated in the different comparisons with an FDR corrected p-
value of p<0.05 and fold change of 1.5 that are present in DAVID. Row vs. column. 
 
 Only one gene was significantly differentially expressed after FDR correction between 
untreated N2 and eat-2 worms. This was the alpha catulin ctn-1 which was up regulated in eat-2 
worms with a fold change of 6.45. ctn-1 was also up regulated in allantoin treated N2 worms compared 
to rapamycin-treated eat-2 worms, eat-2 controls and N2 worms treated with rapamycin, and down 
vs N2 control eat-2 control N2 rapamycin  eat-2 
rapamycin 
N2 allantoin 
N2 control - 
 
1↑ 
0↓ 
0↑ 
7↓ 
0↑ 
0↓ 
0↑ 
0↓ 
eat-2 control 0↑ 
1↓ 
- 
 
2,622↑ 
2,881↓ 
207↑ 
216↓ 
531↑ 
559↓ 
N2 
rapamycin 
7↑ 
0↓ 
2,881↑ 
2,622↓ 
- 3,400↑ 
2,992↓ 
3,613↑ 
3,498↓ 
eat-2 
rapamycin 
0↑ 
0↓ 
216↑ 
207↓ 
2,992↑ 
3,400↓ 
- 61↑ 
9↓ 
N2 allantoin 0↑ 
0↓ 
559↑ 
531↓ 
3,498↑ 
3,613↓ 
9↑ 
61↓ 
- 
58 
 
regulated in N2 worms treated with rapamycin compared to eat-2controls and eat-2 worms treated 
with rapamycin. ctn-1 is a poorly studied gene but its mammalian homologue, α‐catulin, shares 
sequence homology to α‐catenin, an adhesion molecule, which suggests a potential role of ctn-1 in 
cell adhesion (334). CTN-1 localises to the cell membrane in various muscle tissues in C. elegans and 
has been shown to be required for localisation of proteins into dense bodies (335, 336). The 
dysfunction of one such protein the BK channel has been associated with a number of age-related 
conditions such as hypertension and erectile dysfunction (337, 338). A study using human cancer cells 
found that knocking out ctn-1 induced senescence in these cells through both p53 dependent and 
independent mechanisms (339). Gene expression profiling through microarray analysis found this 
reduced ctn-1 expression reduced the expression of genes associated with the cell cycle, DNA damage 
response and DNA damage repair. This could indicate increased DNA damage control in eat-2and 
allantoin treated worms which could contribute to their long lifespan. As such, ctn-1 may be an 
important gene in ageing.  
 Rapamycin treatment of N2 worms only resulted in 7 differentially expressed genes, all of 
which were down regulated. The most down-regulated gene wasaff-1 (AF4/FMR2 family member) 
with a fold change of -5.54. aff-1 is located on the plasma membrane but is associated with worm 
development in late L4 worms, and hence the difference in expression observed may simply be a result 
of a developmental delay in treated worms (340). The pseudogenes T20D4.17 and F39E9.1 were the 
most statistically significant genes and were thought to be regulated by the ageing-associated genes 
DAF-12 and DAF-2, respectively (341). This may indicate an ageing-associated function of these 
pseudogenes or may simply be indicative of DAF-12 and DAF-2 signalling.  
 Unfortunately, due to high levels of variation in the N2 control samples no genes were found 
to be differentially expressed significantly after correcting for multiple testing in Allantoin treatment. 
The most significantly differentially expressed gene was the downregulated gene Asm-3 (acid 
sphingomyelinase). Inactivation of Asm-3 has been shown to extend adult lifespan in C. elegans via 
the DAF-2/AGE-1 signalling pathway (342). Hence downregulation of this gene may contribute to 
increased lifespan, though this downregulation may only be detected by chance as it is not significant 
after FDR correction.  
A functional enrichment of the comparisons with at least 100 genes was performed using 
DAVID 6.7 (Table 2.3-2.4) (330). In a number of comparisons, we observed terms related to 
development, such as ‘GO:0003006~reproductive developmental process’. It could be that these 
drugs were inducing this expression, but they may be delaying the growth of the worms so that it 
appears to be the case. Both caloric restriction and rapamycin treatment delay development and if 
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allantoin is acting as a caloric restriction mimetic it may have similar developmental effects (315). The 
delay caused by these treatments may not be equal, and so the reproductive development of recently 
developed L4 worms entering adulthood may not progress equally between treatments. This 
developmental caveat could also explain a number of other enriched terms such as 
‘GO:0042302~structural constituent of cuticle’ and ‘GO:0002009~morphogenesis of an epithelium’ 
which include collagen genes that change in expression throughout worm development (Figure 2.3). 
 
Figure 2.3. Representation of expression in two collagen genes (dpy-10 and dpy-5) through 
development. Messenger RNA from collagen genes fluctuate throughout worm development. There 
is a sharp change in expression of these genes in the three days following the L4 moult (third blue 
arrow), and hence any delay in development will result in different levels of collagen expression. 
Taken with permission from Wormbook (343). This representative image has no Y-axis values as this 
image serves only to indicate the time scale of expression fluctuations. 
The eat-2 control worms, compared to allantoin treated N2 worms, showed only two 
significantly enriched clusters for downregulated genes, ‘GO:0042302~structural constituent of 
cuticle’ as discussed above and ‘IPR012885:F-box associated type 2’ (Table 2.3). F-box proteins often 
bind SKP1 (S-phase kinase-associated protein 1) and other proteins to form SKP1-cullin-F-box protein 
ligases (SCFs). These SCFs are involved in an array of activities from nutrient sensing in yeast, to cell 
cycle regulation and developmental regulation in animals including C. elegans (344). This may tie in 
with differences in worm development. Upregulated genes produced more significantly enriched 
clusters (Table 2.4) including, ‘GO:0010259~multicellular organismal ageing’. This term, including 
many heat shock proteins, likely encompasses other terms involving heat shock factors. This would 
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indicate these genes associated with ageing are more active in the allantoin treated worms indicating 
a deviation in life-extending pathways between the two treatments. Of these genes, only 4 were found 
in GenAge (14) (hsp-12.6, hsp-1, hsp-16.48, and hsp-49) and all were found to be pro-longevity. The 
remaining terms are more general. Saposin B domains are often involved in enzymatic activities. 
‘IPR009007:Peptidase aspartic, catalytic’ could indicate turnover of proteins or could be a contributor 
to the change in collagen we see in the upregulated genes.  
The N2 worms treated with allantoin compared to N2 worms treated with rapamycin had very 
broad terms for both upregulated and downregulated genes (Table 2.3-2.4) which are not helpful at 
identifying differences between the two treatments. Additionally, we saw terms that may indicate 
differences in the rate of development progression (e.g. ‘IPR002486:Nematode cuticle collagen, N-
terminal’).   
The eat-2 worms treated with rapamycin compared to untreated eat-2 worms had only 2 
statistically significant clusters upregulated, but both terms refer to ageing (Table 2.3). The genes from 
these groups contain only 4 genes that are present in GenAge and are all considered pro-longevity 
genes. This indicates that rapamycin had an effect in these worms even if a change in lifespan is not 
observed. The only significantly downregulated cluster is ‘IPR002486:Nematode cuticle collagen, N-
terminal’ which may indicate that rapamycin is affecting the rate of development in eat-2 worms 
(Table 2.4). 
The eat-2 worms compared to N2 worms treated with rapamycin showed upregulated terms 
that may indicate a difference in developmental progression (Table 2.3). Terms regarding 
chromosomes and cell cycle may indicate that rapamycin treatment is altering the rate of cell division 
or this may be a result of differences in the progression of development. Downregulated terms 
included ‘IPR000731:Sterol-sensing 5TM box’, this sterol-sensing domain is involved in a variety of 
processes including cholesterol homeostasis, cytokinesis and cell signalling (Table 2.4). This may play 
into the cell division terms we saw upregulated.  
The overlap between genes differentially expressed between eat-2 control and rapamycin-
treated worms and genes differentially expressed between eat-2 control worms and rapamycin-
treated N2 worms was examined (Figure 2.4). This may allow the identification distinctions between 
eat-2 induce longevity and that induced from rapamycin treatment. There were 79 consistently 
upregulated and 51 consistently downregulated genes between the two comparisons. Functional 
enrichment analysis revealed that the upregulated genes were enriched for heat shock factors 
(enrichment score: 6.88). Enrichment scores were generated by DAVID. This score was derived from 
the p-values of the individual terms within the functional cluster. A score of 1.3 or higher is equivalent 
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to p≤0.05. Heat shock factors that often act as protein chaperones to prevent misfolding to maintain 
a stable proteome are associated with ageing in C. elegans (345, 346). Heat shock proteins have also 
been shown to be regulated by the IGF signalling pathway, a known caloric restriction pathway 
(discussed in Section 1.1.1) (345)). Downregulated genes were enriched for terms such as DNA 
binding, histone proteins, methylation and the nucleosome (enrichment score: 18.26). Histones 
control the density of the DNA structure, and the modification of these proteins facilitates access to 
the DNA by proteins necessary for transcription and DNA damage repair (reviewed in (347)). This may 
indicate that rapamycin treatment increases lifespan preferentially by increased heat shock protein 
activation whereas eat-2 mutation increased lifespan through alteration of gene expression and or 
DNA damage responses. 
 
Figure 2.4. Venn diagram comparing up and downregulated genes between eat-2 control and 
rapamycin-treated worms and between eat-2 control worms and rapamycin-treated N2 worms. Key 
EC eat-2 control, ER eat-2 treated with rapamycin, NR rapamycin treated N2 worms. 
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When comparing eat-2 worms treated with rapamycin and N2 worms treated with rapamycin 
we again saw changes in terms that may be attributed to changes in the rate of development, such as 
‘GO:0003006~reproductive developmental process’ (upregulated) and ‘IPR000535:Major sperm 
protein’ (downregulated) (Table 2.3-2.4).  
The overlap between genes differentially expressed between eat-2 and N2 worms treated 
with rapamycin and genes differentially expressed between eat-2 control worms and rapamycin-
treated N2 worms was examined (Figure 2.5). There were 2,299 consistently upregulated and 2,806 
consistently downregulated genes. Functional enrichment of upregulated genes revealed multiple 
functional clusters regarding cell cycle with clusters including terms such as cell cycle (enrichment 
score: 10.97), DNA replication (enrichment score: 8.88), and ‘mitotic spindle midzone’ (enrichment 
score: 3.80). This indicates increased cell cycle activity in N2 worms relative to eat-2 worms without 
rapamycin treatment. Caloric restriction has been shown in mice to reduce cell proliferation rates 
(348). Downregulated genes were enriched for a number of enrichment clusters. These included 
clusters including terms referring to, the cytoskeleton (enrichment score: 17.49), protein 
phosphorylation (enrichment score: 11.89 and 6.08), collagen (enrichment score: 10.00), and histone 
proteins (enrichment score: 5.37). Changes in the cytoskeleton could indicate morphological changes, 
cell division or cell adhesion which may play into ageing (detailed in Section 5.1.1). As described earlier 
in this section histones may indicate alterations in DNA damage responses. This highlights potential 
differences in the two life-extending conditions eat-2 mutation and rapamycin treatment. 
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Figure 4.5. Venn diagram comparing up and downregulated genes between rapamycin-treated eat-2 
and N2 worms and between eat-2 control worms and rapamycin-treated N2 worms. Key EC eat-2 
control, ER eat-2 treated with rapamycin, NR rapamycin-treated N2 worms. 
 
In these comparisons we saw a number of terms appearing multiple times; this is in part due 
to the broad nature of the terms which can encompass a wide range of activates but also may be due 
to a potential caveat in which the treatments may be causing changes in the rate of worm 
development.  
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Table 2.3. Representative terms from the top five FE clusters, gene counts and the enrichment scores 
for the clusters from upregulated genes. Terms were selected that best represented all the terms in 
the cluster.*Enrichment score generated by DAVID. This score is derived from the p-values of the 
individual terms within the functional cluster. A score of 1.3 or higher is equivalent to p≤0.05. 
 Term Count 
Enrichment 
score* 
eat-2 con 
vs. allantoin 
N2  
 
GO:0005576~extracellular region 32 7.92 
IPR008139:Saposin B 11 7.05 
GO:0010259~multicellular organismal aging 19 3.66 
IPR009007:Peptidase aspartic, catalytic 7 3.56 
IPR001436:Alpha crystallin/Heat shock protein 8 3.35 
N2 allantoin 
vs. N2 Rapa 
 
IPR000242:Protein-tyrosine phosphatase, receptor/non-
receptor type 48 12.5 
GO:0007218~neuropeptide signalling pathway 34 9.95 
GO:0005576~extracellular region 88 9.44 
IPR002486:Nematode cuticle collagen, N-terminal 56 8.42 
GO:0005856~cytoskeleton 61 6.17 
eat-2 
control vs. 
eat-2 Rapa 
 
IPR001436:Alpha crystallin/Heat shock protein 6 4.45 
GO:0007568~aging 12 3.88 
GO:0006732~coenzyme metabolic process 6 1.76 
GO:0003700~transcription factor activity 14 1.52 
GO:0040018~positive regulation of multicellular 
organism growth 9 1.35 
eat-2 
control vs. 
N2 Rapa 
 
IPR012885:F-box associated type 2 92 20.7 
GO:0002009~morphogenesis of an epithelium 91 7.48 
GO:0003006~reproductive developmental process 192 7.14 
GO:0007049~cell cycle 108 6.85 
GO:0005694~chromosome 35 6.47 
eat-2 Rapa 
vs. N2 Rapa 
 
GO:0007049~cell cycle 148 17.0 
IPR012885:F-box associated type 2 83 12.0 
GO:0003006~reproductive developmental process 235 10.8 
GO:0002009~morphogenesis of an epithelium 109 9.41 
GO:0006260~DNA replication 33 8.61 
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Table 2.4 Representative terms from the top five FE clusters, gene counts and the enrichment scores 
for the clusters from downregulated genes. Terms were selected that best represented all the terms 
in the cluster. *Enrichment score generated by DAVID. This score is derived from the p-values of the 
individual terms within the functional cluster. A score of 1.3 or higher is equivalent to p≤0.05. 
 Term Count 
Enrichment 
score* 
eat-2 con 
vs. allantoin 
N2  
 
IPR012885:F-box associated type 2 56 31.5 
GO:0042302~structural constituent of cuticle 18 4.40 
GO:0000279~M phase 16 2.32 
IPR016181:Acyl-CoA N-acyltransferase 5 1.59 
PIRSF038285:cuticle collagen 10 1.41 
N2 allantoin 
vs. N2 Rapa 
 
IPR012885:F-box associated type 2 105 23.8 
GO:0007049~cell cycle 163 21.5 
GO:0003006~reproductive developmental process 265 16.8 
GO:0002009~morphogenesis of an epithelium 124 14.3 
GO:0022402~cell cycle process 142 13.4 
eat-2 
control vs. 
eat-2 Rapa 
 
IPR002486:Nematode cuticle collagen, N-terminal 16 6.40 
IPR016638:Uncharacterised protein family UPF0376 4 2.14 
PIRSF038285:cuticle collagen 6 1.71 
cel00982:Drug metabolism 4 1.60 
IPR004045:Glutathione S-transferase, N-terminal 4 1.30 
eat-2 
control vs. 
N2 Rapa 
 
IPR002486:Nematode cuticle collagen, N-terminal 80 19.0 
IPR000387:Dual-specific/protein-tyrosine phosphatase, 
conserved region 43 11.1 
GO:0005576~extracellular region 84 7.50 
IPR000731:Sterol-sensing 5TM box 17 5.41 
GO:0006793~phosphorus metabolic process 172 4.95 
eat-2 Rapa 
vs. N2 Rapa 
 
IPR000242:Protein-tyrosine phosphatase, receptor/non-
receptor type 50 14.5 
IPR000535:Major sperm protein 44 7.18 
GO:0007218~neuropeptide signalling pathway 27 6.54 
GO:0005576~extracellular region 82 5.81 
IPR000731:Sterol-sensing 5TM box 17 5.56 
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GeneDR (349), a database of dietary restriction related genes lists 60 genes related to caloric 
restriction in C. elegans. The list of significantly differentially expressed genes was searched for these 
genes to identify changes in pathways important to caloric restriction.  Allantoin treated worms had 
17 caloric restriction-related genes upregulated compared to rapamycin-treated worms which only 
had 5 genes comparatively upregulated when compared to each other (Table 2.5). By looking at the 
level of overlap between genes differentially expressed in rapamycin-treated N2 worms relative to 
eat-2 controls and to allantoin treated worms we saw a significant overlap of 16 caloric restriction 
related genes (up: p=0.005, down: p=4.61E-10) indicating high similarity between caloric restriction 
and allantoin treatment which can be seen from the low number of differentially expressed genes 
between eat-2 controls and allantoin treated N2 worms. Notably, the genedaf-16, which is required 
for some forms of caloric restriction’s lifespan extension, is upregulated in allantoin treated N2 worms 
and eat-2 worms compared to rapamycin-treated N2 worms.  
 
Table 2.5 Genes associated with caloric restriction in C. elegans in GenDR that are up (↑) or down 
(↓) regulated in the different comparisons with an FDR corrected p-value of p<0.05. No genes were 
present in comparisons with N2 controls. Row vs. column. 
Vs eat-2 control N2 rapamycin  eat-2 rapamycin N2 allantoin 
eat-2 control - 6↑ 
13↓ 
2↑ 
0↓ 
3↑ 
0↓ 
N2 rapamycin 13↑ 
6↓ 
- 16↑ 
4↓ 
17↑ 
5↓ 
eat-2 rapamycin 0↑ 
2↓ 
4↑ 
16↓ 
- 0↑ 
0↓ 
N2 allantoin 0↑ 
3↓ 
5↑ 
17↓ 
0↑ 
0↓ 
- 
  
Due to the variation in our control samples, no genes were differentially expressed when 
comparing to N2 controls after FDR correction. If we discount this correction for multiple testing, we 
get considerably more genes marked as significantly differentially expressed; however, care must be 
taken when analysing such data as these genes may be significant purely by chance. This was done for 
all comparisons to N2 controls to give more useful numbers of genes (Table 2.6). 
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Table 2.6. Number of up (↑) or down (↓) regulated genes in each condition as compared to N2 
control with an uncorrected p value of 0.05. Row vs. columns.  
Vs eat-2 control N2 rapamycin  eat-2 rapamycin N2 allantoin 
N2 control 152↑ 
273↓ 
1,594↑ 
1,770↓ 
672↑ 
428↓ 
525↑ 
352↓ 
 
 Rapamycin treatment of N2 worms resulted in a large number of differentially expressed 
genes (>3,000 genes), more than rapamycin treatment of eat-2 worms relative to N2 controls (~1,000). 
By conducting a Fisher’s exact test of independence, we found a significant overlap of 13 upregulated 
genes (p=2.20E-9) but not of downregulated genes. Additionally, there was a significant proportion of 
genes with opposite gene expression. 
 To determine if allantoin and rapamycin are acting similarly, the proportion of differentially 
expressed genes in both treatments relative to N2 controls was assessed. There were more genes that 
showed directionally similar changes in expression that we would expect by chance (15 genes, up: 
p=2.14E-10, down: p=4.61E-4). This would suggest similar action, but it was also found that the 
proportion of genes with opposite expression (156 genes) was also far greater than would be expected 
by chance, suggesting very different modes of action but perhaps with a similar underlying core 
mechanism.  
 Comparing eat-2 worms to N2 worms showed relatively few differentially expressed genes 
(425 genes). By comparing the proportion of genes that overlap with either rapamycin or allantoin 
induced expression we can assess how similar these compounds are acting to caloric restriction. 
Allantoin treatment shows a significant number of genes with overlapping expression in the same 
direction (37 genes, up: p=1.01E-12, down: p=1.04E-4). There were a few genes with opposite 
expression but this was not more than we would expect by chance. This suggests similarity between 
allantoin treatment and caloric restriction. Rapamycin treatment, however, showed a significant 
proportion of overlapping gene expression for upregulated genes only (p=0.009) with a significant 
proportion of genes with opposite gene expression. This suggests rapamycin is acting in a fashion more 
removed from caloric restriction. 
A functional enrichment was performed on these differentially expressed genes (Table 2.7-
2.8). As before a number of developmental terms such as ‘GO:0003006~reproductive developmental 
process’ were differentially expressed indicating a delay in worm development.  
Rapamycin treatment of N2 worms induced upregulation of DNA metabolic processes that 
includes DNA damage repair, suggesting rapamycin may improve this process. Additionally, terms 
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regarding the cell cycle were upregulated. Terms downregulated by rapamycin treatment included a 
number referring to the cell surface such as ‘GO:0044421~extracellular region part’ and ‘glycoprotein’. 
Additionally, protein dephosphorylation was downregulated which may indicate cellular signalling as 
protein phosphorylation can control protein activity.  
Eat-2 worms showed no significantly enriched terms for upregulated genes that do not relate 
to development. Downregulated terms again included those related to the extracellular component 
of the cell, such as ‘glycoprotein’ and ‘IPR016186:C-type lectin-like’. Terms regarding lipase activity 
are also downregulated though this may be a direct consequence of decreased food uptake and hence 
lipid uptake. Eat-2 worms treated with rapamycin showed almost exactly the same terms for 
downregulated genes which may reflect the low number of differentially expressed genes between 
these two conditions. Upregulated genes produced few significantly enriched clusters. Terms 
regarding the cytoskeleton may suggest cell motility or restructuring of the cell shape. Terms regarding 
major sperm protein affect sperm motility though the relevance of this is not clear. 
Allantoin treatment showed upregulation of cell surface-related terms such as 
‘GO:0007166~cell surface receptor linked signal transduction’. No downregulated clusters are 
statistically significant but include terms referring to the cell cycle that are upregulated in rapamycin 
treatment.  
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Table 2.7. Representative terms from the top five FE clusters, gene counts and the enrichment scores 
for the clusters from upregulated genes without FDR correction. Terms were selected that best 
represented all the terms in the cluster.*Enrichment score generated by DAVID. This score is derived 
from the p-values of the individual terms within the functional cluster. A score of 1.3 or higher is 
equivalent to p≤0.05. 
 Term Count 
Enrichment 
score* 
N2 control 
vs. 
rapamycin 
up 
 
GO:0051301~cell division 53 11.7 
GO:0007049~cell cycle 78 8.1 
GO:0003006~reproductive developmental process 130 6.9 
GO:0006259~DNA metabolic process 43 6.6 
GO:0060429~epithelium development 60 6.1 
N2 control 
vs. eat-2 up 
 
GO:0042302~structural constituent of cuticle 35 32.7 
cuticle 10 6.4 
GO:0040002~collagen and cuticulin-based cuticle 
development 3 0.9 
GO:0008238~exopeptidase activity 3 0.4 
GO:0002119~nematode larval development 13 0.3 
N2 control 
vs. eat-2 
rapamycin 
up 
 
IPR000535:Major sperm protein 17 5.3 
cytoskeleton 13 3.8 
IPR008574:Protein of unknown function DUF856, 
Caenorhabditis species 5 3.8 
GO:0030968~endoplasmic reticulum unfolded protein 
response 5 2.5 
IPR001628:Zinc finger, nuclear hormone receptor-type 21 2 
N2 control 
vs. N2 
allantoin up 
 
GO:0007166~cell surface receptor linked signal 
transduction 21 4.2 
IPR008574:Protein of unknown function DUF856, 
Caenorhabditis species 5 3.9 
GO:0005576~extracellular region 24 2.9 
IPR000535:Major sperm protein 10 2.4 
IPR002486:Nematode cuticle collagen, N-terminal 11 1.7 
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Table 2.8. Representative terms from the top five FE clusters, gene counts and the enrichment scores 
for the clusters from downregulated genes without FDR correction. Terms were selected that best 
represented all the terms in the cluster.*Enrichment score generated by DAVID. This score is derived 
from the p-values of the individual terms within the functional cluster. A score of 1.3 or higher is 
equivalent to p≤0.05. 
 Term Count 
Enrichment 
score* 
N2 control 
vs. N2 
rapamycin 
down 
 
GO:0006470~protein amino acid dephosphorylation 37 10.8 
IPR002486:Nematode cuticle collagen, N-terminal 44 10 
glycoprotein 67 7.9 
GO:0018996~molting cycle, collagen and cuticulin-based 
cuticle 43 5.9 
GO:0044421~extracellular region part 18 4.3 
N2 control 
vs. eat-2 
down 
 
glycoprotein 24 11.4 
IPR008139:Saposin B 9 7.3 
GO:0016298~lipase activity 10 5.4 
Secreted 17 4.7 
IPR016186:C-type lectin-like 12 3.8 
N2 control 
vs. eat-2 
rapamycin 
down 
 
glycoprotein 33 11 
IPR016186:C-type lectin-like 22 6.4 
GO:0016298~lipase activity 11 5.5 
Protease 17 5.4 
IPR008139:Saposin B 8 4.8 
N2 control 
vs. N2 
allantoin 
down 
 
GO:0005777~peroxisome 5 1.9 
IPR001810:Cyclin-like F-box 15 1.7 
GO:0007530~sex determination 5 1.7 
GO:0007049~cell cycle 11 1.4 
GO:0034470~ncRNA processing 6 1.2 
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The Connectivity Map can be visualised using Mantra 2.0 (Figure 2.6) (350, 351). By doing so for all the 
compounds studied in depth in (72), we observed that rapamycin (also known as sirolimus) induced 
similar expression profiles to the other compounds in human cells. Allantoin, however, is more distant 
with no connections at the cut off used (0.75). This distance reflects the high number of differentially 
expressed genes between the two treatments. A cut off of 0.75 was used as lower cut-offs provided 
too many connections to glean useful information. The distance value between nodes was calculated 
by combining the output of a rank-aggregation analysis and gene set enrichment analysis; the lower 
the value, the more similar the gene expression profile with 0.8 being considered significant (350). 
 
 
Figure 2.6. Mantra 2.0 analysis. Each square represents one of the drugs under investigation in (72). 
Each numbered line represents the similarity of induced gene expression profile in the Connectivity 
Map. Geldanamycin, rapamycin (sirolimus), and LY-294002 seem to be relatively similar in their 
induced gene expression profiles. Trichostatin A is more distinct with only an indirect connection to 
these drugs. The analysis used a 0.75 cut off due to larger cut-offs producing too many nodes to 
discern any useful information. 
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2.5 Discussion 
Rapamycin is a well-documented caloric restriction mimetic; however, in this study, it appears 
to act comparatively less similar to caloric restriction than allantoin. There are a greater number of DE 
genes in rapamycin-treated N2 worms than allantoin treated N2 worms, compared to eat-2 controls. 
This shows that allantoin has a more similar effect on gene expression to caloric restriction.  
As discussed above, caloric restriction and caloric restriction mimetics have the potential to 
delay development (315), and a large portion of the change in gene expression seen in this study 
related to developmental processes. This may simply reflect treatment induced variation in 
organismal development. Alternatively, it could be that these genes affect lifespan as suggested by 
the developmental theory of ageing, by which genes acting to promote healthy growth and 
development in early life act to promote ageing in later life (13, 352). If the former is the case, then it 
is not clear if other differentially expressed terms are seen as a consequence of differences in 
developmental progression. To identify which of these scenarios is correct the experiment would need 
to be repeated in older worms that are no longer undergoing developmental changes. 
In addition to terms clearly related to development, we see multiple terms regarding cell cycle 
and the cell surface or extracellular space. Changes in cell cycle progression between successfully 
ageing organisms such as those treated with the compounds in this study and wild-type animals may 
support the ‘reproductive-cell cycle theory of ageing’. This theory states that hormones that control 
growth and reproduction early in life later induce ageing via cell cycle signalling (353). This theory is 
supported by clinical evidence suggesting a role of hormonal alterations in the cell cycle in a number 
of age-related diseases including cancer, heart disease and osteoporosis (354, 355). Changes regarding 
the cell surface have been seen in fibroblast in vitro ageing previously (356, 357) though it is not clear 
if the changes we see in this analysis are a cause or consequence of delayed ageing. 
Both compounds have been shown to upregulate ageing and caloric restriction related genes 
as would be expected from two caloric restriction mimetics. Interestingly daf-16 is upregulated in 
allantoin treated N2 worms compared to rapamycin-treated N2 worms but not eat-2 worms, further 
supporting the similarity between allantoin treatment and caloric restriction. daf-16 is required for 
lifespan extension via the IGF-1 signalling pathway (349). Interestingly daf-16 is required for lifespan 
extension through some methods of caloric restriction but not through eat-2 mutation (61, 164). In 
eat-2 controls, daf-16 is significantly more expressed than in rapamycin-treated N2 worms indicating 
that daf-16 is not involved in rapamycin-induced life extension which has been shown to be the case 
(72). This would also indicate a role for daf-16 in eat-2 lifespan, which may be the case as daf-16; eat-
2 double mutants have been shown to have a slight decrease in lifespan compared to eat-2 mutant 
73 
 
worms, indicating a small non-essential contribution to this lifespan extension (164). Follow up work 
looking at daf-16 mutants treated with allantoin showed similar results with daf-16 not being essential 
for the lifespan extension but with a lower increase (19.7%) in daf-16 mutant lifespan compared to N2 
treated worms (21.9%) (72). Additionally, heat shock factors that are associated with ageing in C. 
elegans (346) were found to be differentially expressed in both allantoin and rapamycin treatment 
suggesting similarities in the core mechanism of these compounds.  
Allantoin showed significant overlap with eat-2 worms indicating similar modes of action. 
Rapamycin showed significant overlap of only upregulated genes and a significant number of genes 
with gene expression changes opposite that seen in eat-2 worms. 
There are a number of caveats that must be considered when reviewing this work. Firstly 
mRNA levels do not necessarily correlate with protein levels (303-305). Another potential caveat is 
that only one dosage has been investigated. Different doses may have different effects, as has been 
shown for the supposed caloric restriction mimetic metformin, in which some doses increased N2 
lifespan, but decreased eat-2 lifespan (358). The doses used in this assay have however been shown 
to be sufficient to increase lifespan in N2 worms and have no effect in eat-2 worms. The use of eat-2 
worms as a model of caloric restriction may be limiting as other methods of caloric restriction 
induction show different levels of lifespan extension and gene expression (61) and worms are exposed 
to the caloric restriction effect of being eat-2 their entire life as opposed to the late-life treatment of 
the drugs in this study. Furthermore, only one time point (72 hours) post-treatment was studied. This 
time point is very short and does not allow the analysis of chronic treatment and how such treatment 
affects normal age-related changes in gene expression. This time point was chosen as the initial 
treatment provides the greatest exposure to the compounds of interest, while 72 hours provides the 
worms with time to appropriately respond to the treatment. Hence, we predicted that changes in 
gene expression would be at their most pronounced. Finally, pathways that affect ageing in C. elegans 
may not be conserved in mammals, and physiological differences could also affect drug activity (359). 
It would be interesting to run lifespan experiments in mice with allantoin to see if the lifespan 
extension is conserved. However, this is beyond the scope of this thesis. This study does hint towards 
these drugs having evolutionarily conserved mechanisms as the gene expression profile used as the 
input for the Connectivity Map was obtained from rodent cells exposed to sera from animals (rhesus 
monkeys or rats) undergoing caloric restriction. This was then compared with drug-induced gene 
expression profiles in various human cells. These drugs induced an extended longevity phenotype in 
worms, suggesting that their caloric restriction mimetic mechanism is evolutionary conserved. 
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This work supports the idea that these compounds are acting as caloric restriction mimetics. 
Due to large variations in gene expression in control wild-type worms, we cannot accurately detect 
how these compounds act on wild-type worms to increase lifespan. However, a number of candidate 
genes known to be important for caloric restriction and/or lifespan extension have been identified.  
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Chapter 3: Response to DNA damage in Heterocephalus glaber and Mus musculus skin 
fibroblasts 
3.1 Introduction 
In order to further our understanding of successful ageing, a microarray analysis of the 
nematode worm C. elegans undergoing caloric restriction or treatment with a caloric restriction 
mimetic was performed in the previous chapter. It was found that both caloric restriction and the 
mimetic compounds acted similarly but showed a large amount of differential gene expression 
between them. It was also observed that genes involved in the cell cycle and the surface chemistry of 
the cell were enriched within the differentially expressed genes suggesting a role in successful ageing 
for these cellular aspects. 
 In the present chapter, I will examine an alternative model of successful ageing, the naked 
mole rat (NMR), at the cellular level. The response of these cells to DNA damaging agents will be 
assessed and compared to cells derived from the short-lived mouse. As DNA damage is thought to be 
a major contributor to ageing we hypothesise that the NMR’s previously reported high DNA damage 
resistance is integral to its long lifespan. By assessing how the cells respond to genotoxic stimuli we 
can infer broad mechanisms of DNA damage responses which may play into successful ageing. 
Additionally, evaluating how cells respond provides us with a context in which we can evaluate further 
experiments of cells responding to genotoxic stress. The study of differences in lifespan and health-
span between these species is complementary to the previous chapter that studied these changes 
within a single species.   
Firstly, a survival assay of NMR and mouse cells treated with two DNA-damaging compounds, 
camptothecin and chromium (vi) oxide was performed. These compounds were chosen as they will 
allow us to assess the response of these cells to both specific and broad-spectrum DNA damaging 
agents as camptothecin induces single-strand breaks specifically, whereas chromium (vi) oxide 
induces a broad spectrum of DNA lesions. From this assay, an LD50 or lethal dose 50 value, the dose 
at which half the cells die as a result of the treatment, was calculated for each species and compound. 
These values are used to evaluate the levels of resistance of the compounds in both species. A beta 
galactosidase assay was then performed to evaluate the number of cells that undergo irreversible 
senescence as a result of the genotoxic insult.   
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3.1.1 Cell culture 
 Maintaining live rodents for experiments is financially expensive, time-consuming and 
ethically challenging. A much more favourable approach is to take cells from the animal of study and 
grow them outside the body. These cells can then be experimented on quickly and cheaply without 
ethical concern.  
 Cells are grown in culture media such as minimum essential media (MEM) that contains amino 
acids, glucose, salts, vitamins and other nutrients the cells need to live. This alone is often not enough 
as cells also require survival signals. In the body, a cell receives constant signals from its local 
environment that allow it to detect where it is (360). In a culture flask without these signals, many 
cells will not grow or will undergo apoptosis. Growth factors and hormones can be added to the 
culture media to provide these signals and promote proliferation. This is typically done by the addition 
of foetal bovine serum (FBS) or similar animal derived sera. FBS is, as the name suggests, sera derived 
from bovine foetuses and is collected after the mother is slaughtered for meat. In addition to providing 
growth factors and hormones to promote growth, FBS also provides attachment and spreading 
factors, additional nutrients such as lipids and amino acids and protease inhibitors (361). 
 In addition to appropriate culture media, an appropriate culture surface is required for 
anchorage-dependent cells such as fibroblasts (362). Without such anchorage, the cell would not 
proliferate. In cell culture, this anchorage is to the culture vessel’s surface. Culture vessels are typically 
made of polystyrene which is usually hydrophobic, so cells struggle to adhere to it. However, specialist 
treatment of the surface renders the surface hydrophilic allowing adhesion (363-365). Alternatively, 
coatings can be added to the culture surface, typically extracellular matrix components to increase 
cellular adhesion. Cells can only grow in a culture flask for a finite length of time. As the cell density 
increases toward 100% confluence (meaning 100% of the culture vessel surface is covered with cells), 
the rate of proliferation sharply decreases (186). This is due to contact between the cells allowing E-
cadherin and α-catenin binding that results in inhibition of the pro-proliferation transcription factor 
Yes-associated protein (YAP)-1 via the hippo signalling pathway in a process known as contact 
inhibition (366-368). To continue proliferation, the cells must be passaged, which involves the 
detachment of the cells, typically by using trypsin to cleave the protein connections to the culture 
vessel surface, and then diluting the cell solution and transferring to a fresh culture vessel. 
 Cells can only proliferate for so long in cell culture. As the total number of cell divisions a cell 
has undergone increases, its proliferative potential decreases and eventually the cell will no longer 
proliferate (142). This limited number of divisions is known as the Hayflick limit. This limit is due to the 
repetitive sections of DNA at the end of chromosomes, called telomeres, shortening. Each round of 
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division fails to copy all of the telomere, and as a result, the telomeres become shorter. Eventually, 
this loss of material extends beyond the telomere into the rest of the chromosome, at which point the 
cell will stop proliferating and may undergo apoptosis (143, 369, 370). Cells that do continue to 
proliferate undergo crisis, a period of genomic instability during which most cells will die. In 
immortalised cell lines and cancer cells, telomerase, an enzyme that replaces the lost telomeres is 
thought to prevent this shortening (143). Cells taken directly from the organism of study, such as those 
used in this study, are called primary cells.  
 Such cell culture techniques have been successfully applied to the NMR and allowed the 
identification of a number of toxic compounds that NMR cells are more resistant to then mouse cells 
(175). As NMRs have a lower body temperature than mice, a lower incubation temperature was used 
(170, 175).  Typically, mammalian cells are cultured at 37ᵒC as this is the typical internal body 
temperature of mammals. However, NMR cells show poor replicative ability at 37ᵒC because they have 
a lower body temperature and hence a lower temperature is used, typically ~33ᵒC (371). 
Typically, cells are cultured at atmospheric oxygen (~21% oxygen), however by using nitrogen 
to displace oxygen, cells can be maintained at lower concentrations (3% in this study) in part to mimic 
the low-oxygen environment of the NMR. The NMR lives in large colonies in subterranean burrows 
that have poor ventilation and hence result in low levels of oxygen (372). Additionally, cells are not 
exposed to atmospheric oxygen; they typically exist in 2-5% oxygen depending on the distance to the 
vasculature which contains a maximum of ~12% oxygen in arterial blood (373, 374). It has been shown 
that growing cells at lower oxygen concentrations improves growth, increases cellular lifespan and 
decreases the amount of cellular stress (375, 376). Hence the use of lower oxygen provides a more 
biologically relevant environment.  
 
3.1.2 Naked mole rat cells 
 NMR skin fibroblasts have been shown previously to be more resistant to chromium (vi) oxide 
(5 fold increase in LD50) and camptothecin (15 fold increase in LD50) treatment than skin fibroblasts 
derived from mice (175). Additionally NMR fibroblasts were shown to have decreased proliferation 
post genotoxic stimuli than mouse fibroblasts, and this decreased proliferation lasted longer (179). 
This suggests these cells are less prone to proliferate while DNA damage is present and that more time 
is spent repairing this damage. Furthermore, NMR cells were less likely to become irreversibly 
senescent as a result of the treatment (179). 
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 Skin fibroblast derived from NMR showed higher levels of the protein p53 compared to 
fibroblasts from mice (~50 fold higher) (179). Similarly, Nrf2 has a 3-fold greater expression in NMR 
fibroblasts as compared to those from mice (179). Increased p53 and Nrf2 expression may mean NMR 
cells are primed to stop proliferating in response to DNA damage.  
 
3.1.3 Hexavalent chromium 
 Chromium is a naturally occurring transition metal typically found in one of two oxidative 
states, trivalent chromium or hexavalent chromium. Hexavalent chromium is classed as a group 1 
carcinogen by the International Agency for Research on Cancer (IARC) (377), and professions with high 
exposure to chromium such as chromate pigment manufacture and chromium plating of metals have 
been associated with cancer (378). Hexavalent chromium enters the cell through non-specific 
sulphate/phosphate anionic transporters (379, 380). Once inside the cell hexavalent chromium 
undergoes metabolic reduction by a large number of potential cellular components but primarily 
ascorbic acid, glutathione and cysteine (381). If the amount of reductant in the cell is relatively low 
compared to the amount of chromium, then multiple one-electron reductions occur. However, if there 
is an abundance of reductant, then a two-electron reduction occurs followed by a one-electron 
reduction to create trivalent chromium (Figure 3.1). This reduction creates free radicals that may go 
on to damage DNA and other biological molecules (382).  
 
 
 
Figure 3.1. The reduction of hexavalent chromium (Cr6+) in the cell. If there is a relative abundance of 
reductant, then a 2 electron reduction may take place. If there is relatively low reductant, then a 
series of one electron reductions will occur. 
 
Hexavalent chromium does not interact with DNA but its reduction products can. Trivalent 
chromium is not considered toxic as it is unable to cross the cell membrane however it can accumulate 
when formed inside the cell as it is unable to leave (383). Trivalent chromium can form complexes 
with amino acids, proteins and nucleic acids (384-387). These interactions can result in DNA crosslinks 
to either proteins or other DNA strands (386-388). Additional types of DNA damage induced by the 
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reduction products of hexavalent chromium include DNA adducts, DNA single-strand break, oxidised 
bases, and abasic sites (389-392).  
3.1.4 Camptothecin 
 Camptothecin is a prescribed anti-cancer drug. It acts by inducing single and double-strand 
breaks. Camptothecin does not interact with DNA specifically but binds the DNA - topoisomerase 1 
complex (393, 394). Topoisomerase 1 is an enzyme that relaxes the tension of DNA by binding to 
double-stranded DNA and cleaving one of the strands. This allows the intact strand to pass through 
the cut strand. Topoisomerase 1 then promotes the religation of the cut strand and is released from 
the DNA (395). This reduction in DNA tension is essential for transcription and DNA replication. Binding 
of camptothecin prevents the religation step, thereby inducing a single-strand break (394, 396). During 
DNA replication the DNA and camptothecin-bound topoisomerase 1 causes arrest at the replication 
fork. If the single-strand break is on the leading strand of DNA synthesis, then a double-strand break 
can form. As the replication fork reaches the break the newly synthesised double-strand DNA will no 
longer be connected to the rest of the DNA beyond the single-strand break and hence becomes a 
double-strand break (Figure 3.2) (397, 398). This can result in cell death or G2 arrest (399). These 
double-strand breaks are considered the primary cause of camptothecin-induced cytotoxicity (400). 
As these double-strand breaks form during cell DNA synthesis, cells that are proliferating more are 
more susceptible to camptothecin cytotoxicity. This is why camptothecin is used to treat cancer, as 
the rapidly dividing tumour cells will be more likely to divide and form a double-strand break before 
the single-strand break is repaired.  
 
 
 
 
 
 
 
 
 
 
80 
 
 
 
 
 
 
 
 
 
Figure 3.2. The collision model of topoisomerase 1 (TOPO-1) when bound to DNA and camptothecin 
(cam) at the replication fork. This will result in a double-strand break if the topo-1 induced cleavage 
occurs on the leading strand. As the replication fork reaches the break, the newly synthesised double-
strand DNA will no longer be connected to the rest of the DNA beyond the single-strand break and 
hence becomes a double-strand break (397). The collision at the replication fork results in signalling 
via p53, NF-kB, Chk1 and RPA. 
3.2 Aims 
The naked mole rat is becoming increasingly popular as a model organism. However, it is still 
new and relatively poorly studied. For example, searching the term ‘naked mole rat’ in PubMed 
returns 299 items as opposed to the term ‘mouse’, which returns over 1.4 million results (as of October 
2016). As such it is important to check that results seen in other labs can be reproduced both to ensure 
the validity of the data and the capability of the researcher repeating the experiment.  
The dose of a drug that kills half the treated cells, known as the LD50, can be used as an 
indicator of how resistant a cell is to a drug; the higher the dose required, the more resistant the cell. 
Finding the LD50 in mouse and NMR cells will allow us to confirm previously reported genotoxin 
resistance in the NMR (175). Identifying these values will also facilitate further experiments by 
providing doses that elicit similar levels of stress between the two species. In addition to cell death, 
another key indicator of cellular stress is cellular senescence. Identifying levels of cellular senescence 
in mouse and NMR cells exposed to genotoxic stressors helps evaluate their tolerance to such 
treatment and provides further biological context by which to evaluate further experiments in these 
cells. 
TOPO‐1 
cam 
NF‐kB, p53 
Chk1, RPA 
Cell death/ G2 arrest 
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3.3 Materials and methods 
3.3.1 Cell stock and cell culture 
All primary cell cultures were grown on minimum essential medium (ThermoFisher 11095080) 
supplemented with 15% foetal bovine serum (ThermoFisher 10500064), 1% Penicillin Streptomycin 
(Lifetechnologies 15070-063), and 0.1% fungizone (ThermoFisher 15290026). Cells were grown in 
75cm2 culture flasks with 10ml of growth media unless otherwise stated, and were grown at 35ᵒC with 
3% oxygen and 5% carbon dioxide.  
Initial primary skin fibroblasts from 3 naked mole rats and 3 C57BL/6 mice were kindly 
provided by Vera Gorbunova (referred to as alpha stocks). Due to contamination, these were replaced 
by C57BL/6 primary skin fibroblasts derived from 3 different specimens which were purchased from 
Caltag Medsystems Ltd and NMR primary skin fibroblasts derived from 3 NMRs provided by Vera 
Gorbunova (referred to as beta stock). Cells derived from Vera Gorbonova’s group were taken from 
underarm skin and isolated as described by Seluanov et al. (401). Mice used were 4-6 months old, and 
NMRs were 2-5 months old. Skin was shaved and cleaned with 70% ethanol before harvesting. The 
tissue was minced and incubated in DMEM (Dulbecco's Modified Eagle's medium) F12 with 0.14 
Wunsch U/mL collagenase at 37ᵒC for 30-90 minutes with agitation. Disassociated cells were washed 
and added to culture dishes with DMEM F12 supplemented with 15% FBS and 
antibiotics/antimycotics. Cells were cultured at 5% CO2 and 3% O2. Mouse cells were cultured at 37ᵒC, 
and NMR cells were cultured at 32ᵒC. Cells were grown to confluency before passaging with trypsin 
and frozen using liquid nitrogen. Cells were not tested for identity as fibroblasts are more proliferative 
than other cell types and hence dominate the cell culture under the described conditions. Cells derived 
from Caltag Medsystems were extracted from underarm skin as described above from 6-week-old 
mice except only CO2 was controlled (5%) and ‘Cell Biologics Culture Complete Growth Medium’ was 
used in place of DMEM F12. These cells were tested through immunofluorescent staining with anti-
FSP1 (fibroblast specific protein1) (Millipore USA) a marker of fibroblast identify (402). Upon receipt, 
all cells were visually inspected and found to have a fibroblast morphology. 
To passage cells, the growth media was aspirated, and the cells were rinsed with PBS. This was 
replaced with 5ml phenol red free trypsin (Lifetechnologies, 15090-046) and incubated at 37ᵒC, 5% 
CO2 for 5 minutes. The cells were checked under a microscope to confirm detachment and 5ml of 
growth media was added to quench the trypsin reaction. This was spun down at 1,000rpm for ten 
minutes and resuspended in the required volume of growth media.  
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 Cells were periodically frozen to maintain cell stocks for later use. Confluent plates were 
trypsinised and spun down at 1,000rpm for ten minutes and resuspended in 1ml growth media 
(minimum essential medium, 15% FBS, 1% Penicillin Streptomycin 0.1% fungizone) with 10% DMSO. 
This was frozen in a cryovial stored in a polystyrene 15ml falcon tube holder at -80ᵒC to facilitate slow 
freezing. To thaw, cryovials were placed in a 37ᵒC water bath to defrost quickly. As soon as the vial 
had completely thawed, the contents were added to 10ml of growth media and mixed gently. This 
was spun down at 1,000rpm for ten minutes and resuspended in 10ml of fresh growth media to 
remove the DMSO. This was transferred to a fresh culture flask.  
 Cell images were taken of the alpha cell stock; however, due to a corrupted storage drive, 
these images were lost. All presented cell images are of the beta cell stock only. 
3.3.2 LD50 assay  
After 10 population doublings, cells were grown to near confluence and passaged using 
phenol red free trypsin (Lifetechnologies, 15090-046) and plated into T25 flasks ensuring an equal 
number of cells were transferred to each plate. Each was either treated with a serial dilution of 
chromium (vi) oxide (Sigma Aldrich 236470) (5, 10, 20, 40, 80, and 160µM) or camptothecin (Sigma 
Aldrich C9911) (3.75, 7.5, 15, 30, 60, 120µM) in 2% DMSO (Sigma Aldrich D4540) or 2% DMSO only in 
normal growth media for two hours. The plates were rinsed with PBS and media was replaced. After 
24 hours post-stimuli, cells were removed from the plate surface with trypsin and diluted 1:0.5 with 
trypan blue to mark dead cells and counted using one half of a haemocytometer. This was done four 
times per sample. Dead cells were not counted. This was repeated twice per cell line on separate 
occasions. Mouse cell line 1 was run alongside NMR cell line 1. The same applies to cell line 2 and 3 
for both species and cell stocks. One replicate of mouse cell line three from the beta stock treated 
with camptothecin was run alone. NMR cell line 2 samples were grown in twice the number of T25 
culture flasks due to cell availability in stock samples. LD50 values were calculated using the method 
of Miller and Tainter (403). LD50 values for each species were compared by independent sample T 
test. The total number of cells from the alpha cell line in control conditions are as follows mouse 1 – 
140,250, mouse 2 – 101,306, mouse 3 – 108,800, NMR 1 – 4,083, NMR 2 – 23,527 and NMR 3 4,888. 
The total number of cells from the beta cell line control conditions are as follows mouse 1 – 12,130, 
mouse 2 – 5,667, mouse 3 – 6,898 (chromium treatment) mouse 3 –21,556 (camptothecin treatment), 
NMR 1 – 678, NMR 2 – 9,630 and NMR 3 – 5,741. Mouse 3 cells treated with camptothecin and 
chromium were conducted at different times hence have a different number of cells. Comparisons 
between DMSO-treated controls and DMSO-free controls were conducted as described in Section 
3.3.3. 
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3.3.2.1 LD50 assay optimisation 
Initial chromium treatment was performed using sodium chromate. However, this proved 
ineffective at killing either mouse or NMR cells. This was only performed on the alpha cell stock. The 
following doses were administered to both species: 1.57, 3.13, 6.25, 12.5, 25, 50, 100, 200, 400 and 
800um. This was performed once per cell line, (3 cell lines per species). A higher dose of 3,200µM was 
tested once per NMR cell line to assess the killing ability of this compound at an extreme dose. 
Determining the LD50 proved technically challenging due to the high level of noise in the 
samples. Initial studies utilised a cell counter to speed up the assay and remove human error or bias 
from the analysis and used cells grown in a single well of a 24 well plate to allow large numbers of 
samples to be run simultaneously. However, the automated cell counter was communal and poorly 
maintained and was found to give irregular readings that persisted after replacing the inlet nozzle 
(which was found to contain mould) and flushing the system with water prior to analysis. As such, a 
haemocytometer was used instead and found to give more consistent readings. However, the cell 
counts were very low with control samples for NMR cells often including no cells at all. This was due 
to the low surface area in the 24 well plates combined with the volume of trypsin (0.5ml) required to 
coat the plate (lower volumes resulted in the centre of the plate often not being coated due to the 
meniscus of the liquid) and subsequent addition of culture media to neutralise the trypsin (0.5ml). To 
combat this the samples were spun down at 1,000rpm for 10 minutes and resuspended in 400µl 
however consistent removal of the supernatant without disturbing the pellet proved difficult and it 
was a concern that this would introduce variation within the samples. This was reflected in variation 
between technical replicates. Next, the level of starting material was increased instead using one well 
per 6-well plate for each sample, but these counts were still too low for NMRs that have a lower cell 
density due to early contact inhibition. Finally, the method described above was decided and provided 
sufficient cells to work with. However, due to the limited size of the incubator used and the slow-
growing nature of the NMR cells, this proved very time-consuming.  
Additionally, quantification of cell counts was also performed through the use of the abcam’s 
WST-1 staining kit. WST-1 (Water-soluble Tetrazolium salt 1) is broken down by mitochondrial 
dehydrogenases into a formazan dye that can be detected by monitoring absorbance at 440nm. This 
level of absorbance indicates the number of cells in the well. This was run according to the 
manufacturer’s specification. In short, ~1,000 cells were plated per well of a 96-well plate and allowed 
to attach overnight. These were then treated with genotoxic compounds as described in 3.3.2 for 2 
hours and allowed to recover overnight. WST-1 was added and incubated for 4 hours. The plate was 
shaken to mix the contents and loaded onto a 96-well plate reader to monitor absorbance at 440nm. 
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This approach has been used successfully in NMR fibroblasts previously (175). This method had two 
major setbacks in that the available plate reader was very old and had high background noise, but also 
this was unavailable for use halfway through the initial experiments due to its use in the teaching 
laboratories. Due to the unreliability of this equipment and concerns regarding its reproducibility this 
assay was dropped in favour of the haemocytometer counting approach that was trialled at the same 
time.  
3.3.3 Senescence assay 
Beta galactosidase staining kit (9860S) was purchased from New England Biolabs and was used as 
specified by the manufacturer’s instruction. In brief, cells that had undergone approximately 10 
population doublings were plated into two 24-well plates (5,000 cells per well) per condition and time 
point. This cell density was chosen because higher cell densities resulted in high levels of overlap 
between cells reducing the accuracy of cell counts. Cells were either treated at LD50 (Mouse: 
camptothecin: 5.24μM, chromium (vi) oxide: 6.88μM, NMR: camptothecin: 30.93μM, chromium (vi) 
oxide: NMR1 24.68μM, NMR2 28.28μM, and NMR3 27.3μM) for alpha stocks or a logarithmic range 
of doses (camptothecin: 3.75-120μM, chromium (vi) oxide: 5-160μM) for beta stocks for each 
compound in 2% DMSO. Treatment lasted 2 hours; then wells were rinsed with PBS before replacing 
with fresh media. Additionally, alpha stocks were tested as above for control conditions with or 
without DMSO, 2 counts were made per well, and 2 wells were used per cell line however only NMR 
cell lines 2 and 3 were used in the analysis due to contamination of cell line 1. Alpha cells were analysed 
after 8 or 48 hours; beta cells were analysed after 24-hour post-treatment. Cells were fixed and 
incubated in beta galactosidase staining solution at pH6 for 3 days at 37°C at atmospheric CO2 to 
ensure clear staining. This incubation time was selected because staining after the recommended 24 
hours was too faint for accurate counting. The staining solution contains X-gal that is broken down by 
beta galactosidase and subsequently oxidised into 5,5'-dibromo-4,4'-dichloro-indigo, an insoluble blue 
compound. This reaction occurring at ph6 indicates senescence, and hence cells containing blue 
staining are presumed to be senescent. A random field of view was selected under the light 
microscope, and the percentage of stained cells was calculated twice per well resulting in six random 
fields of view per species per condition. 
3.3.4 Population doubling time 
 Approximately 5,000 cells were plated into four wells of a six-well plate. These were allowed 
to grow for 24 hours or 48 hours. At these time points, half of the wells were trypsinised with 3ml of 
trypsin and the cells counted with a haemocytometer. Two counts were made per well. This was only 
performed on mouse cell lines one and two and NMR cell line two and three from the alpha cell stock.  
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3.4 Results 
 Initially primary skin fibroblast cell stocks derived from either 3 NMRs or mice were used in 
this project (referred to as the alpha cell stocks), however, due to a major contamination of cell stocks 
halfway through the project, these were replaced with new cell stocks (referred to as the beta cell 
stocks). Morphologically, untreated cells of each species appeared to look the same (Appendix Figure 
1). The population doubling times for the alpha mouse 1 and 2 were calculated as 13.8 and 14.7 hours, 
respectively. NMR cell line 2 and 3 of the alpha cell stock was found to have a population doubling 
time of 33.5 and 31.3 hours, and hence these cells grow more than twice as slowly as the mouse cells. 
 Initial chromium treatment was performed using sodium chromate. However, this proved 
ineffective at killing either mouse or NMR cells (Appendix Figure 2) and treating NMR cells with an 
extreme dose of 3,200uM resulted in 20% survival. There was no significant difference between 
species or cell lines. Correspondence with the Buffenstein lab later indicated that these salts had been 
tested (unpublished data) and that a poor response was observed as these salts were taken up ‘poorly’ 
by the cells. Hence all further work was conducted using chromium (vi) oxide. 
3.4.1 NMR cells show greater DNA damage resistance than cells derived from mice 
We identified the LD50 of the two DNA damaging agents, chromium (vi) oxide (Figure 3.3-3.5, 
and 3.9-3.11) and camptothecin (Figure 3.6-3.8 and 3.12-3.14) for both primary NMR and mouse skin 
fibroblasts. In the alpha stocks, the cell survival of mouse cells (median 45%) was significantly lower 
than that in NMR cells (median 57%) when treated with 20µM chromium (vi) oxide (U25=49, p=0.045).  
The mean LD50 was calculated in NMR as 25µM (+/- 14.65) and in mice as 6.88µM (+/- 0.06µM). The 
LD50 values for mice (Standard deviation (SD)=1.32) and NMR (SD=1.86) were significantly different 
(t(4)=-15.09 p>0.05). There was an approximate 4-fold increase of LD50 in NMR, which is similar to 
the previously reported 5-fold increase (175). There was a large standard error of the mean associated 
with the LD50 in NMR. This is due to variation seen in the three primary cell cultures, as such in future 
experiments the LD50 calculated for each primary cell culture would be used. These are as follows, 
NMR1 24.68μM (+/- 0.93μM), NMR2 28.28μM (+/- 3.09μM), and NMR3 27.3μM (+/- 12.42μM). 
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Figure 3.3. Percentage survival of primary skin fibroblasts from either mouse (blue) or NMR (red) 
from the alpha cell stocks after treatment with chromium (vi) oxide for 2 hours in media with 2% 
DMSO. A clear increase in resistance to chromium (vi) oxide is seen in the NMR with an LD50 in NMR 
at 25µM (+/- 14.65) and in mice at 6.88µM (+/- 0.06µM). Error bars indicate +/- one standard error 
of the mean between each cell line (3 cell lines per species, each cell line value is the average of two 
independent experiments which each consist of four individual counts). Star (*) indicates significance 
at the p<0.05 level between the percentage of cells alive in mouse and NMR cell cultures by Mann 
Whitney U test. The total number of cells under control conditions for each species is 350,356 cells for 
mice and 32,498 cells for NMR. The total number of cells counted in control conditions was greater 
than or equal to 300 cells. In the treated samples this was greater than or equal to 150 cells. 
To assess the variability between alpha cell lines treated with chromium (vi) oxide within 
each species an ANOVA (analysis of variants) was performed. There was no statistical difference 
observed between mouse cells treated with chromium (vi) oxide (F(2, 18)= 1.201, p=0.324). NMR 
cells, however, were significantly different (F(2, 18)= 9.116, p=0.002). A post hoc Turkey test showed 
that NMR cell line 1 was significantly lower than the other cell lines (p>0.05), but that there was no 
significant difference between the other two cell lines (Figure 3.4). 
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Figure 3.4 Percentage survival of primary skin fibroblasts in each of the primary skin fibroblast cell 
lines from 3 mice and NMRs that form the alpha cell stocks after treatment with chromium (vi) oxide 
for 2 hours in media with 2% DMSO. Error bars indicate ± one standard error of the mean between 
two independent experiments which each consist of four individual counts. The total number of cells 
under control conditions for each cell line is as follows mouse 1 – 140,250, mouse 2 –101,306, mouse 
3 – 108,800, NMR 1– 4,083, NMR 2 – 23,527 and NMR 3 4,888. Each cell line was analysed twice. The 
total number of cells counted in control conditions was greater than or equal to 100 cells. In the 
treated samples this was greater than or equal to 50 cells. 
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Figure 3.5. Percentage survival of primary skin fibroblasts from either mouse (blue) or NMR (red) 
from the alpha cell stocks after treatment with chromium (vi) oxide for 2 hours in media with 2% 
DMSO. A clear increase in resistance to chromium (vi) oxide is seen in the NMR with an LD50 in NMR 
at 25µM (+/- 14.65µM) and in mice at 6.88µM (+/- 0.06µM). Error bars indicate +/- one standard 
error of the mean between each cell line (3 cell lines per species, each cell line value is the average of 
two independent experiments which each consist of four individual counts). Star (*) indicates 
significance at the p<0.05 level between the percentage of cells alive in mouse and NMR cell cultures 
by Mann Whitney U test. The total number of cells under control conditions for mice was 350,356 
and NMRs was 32,498. The total number of cells counted in control conditions was greater than or 
equal to 300 cells. In the treated samples this was greater than or equal to 150 cells. 
 
 When treated with 3.75uM, 7.5uM, 15µM or 30µM of camptothecin, cell survival of mouse 
cells (median 83%, 54%, 49% and 48%, respectively) was significantly lower than that in NMR cells 
(median 90%, 74%, 59% and 57%, respectively) (U28=11, p=0; U22=4, p=0; U22=32, p=0.021; U22=24, 
p=0.006, respectively) in alpha cell stocks. The LD50 was calculated in NMR as 30.93µM (+/- 5.3µM) 
and in mice as 5.24µM (+/- 0.03µM). The LD50 values for mice (SD=0.43) and NMR (SD=1.28) were 
significantly different (t(4)=-32.82 p>0.05). This is an approximate 6-fold increase of LD50 in NMR, 
which is lower than the 15-fold increase that has been previously reported (175). 
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Figure 3.6. Percentage survival of primary skin fibroblasts from either mice (blue) or NMR (red) from 
the alpha cell stocks after treatment with camptothecin for 2 hours in media with 2% DMSO. A clear 
increase in resistance to camptothecin was seen with an LD50 in NMR at 30.93µM (+/- 5.3µM) and in 
mice at 5.24µM (+/- 0.03µM). Error bars indicate +/- one standard error of the mean between each 
cell line (3 cell lines per species, each cell line value is the average of two independent experiments 
which each consist of four individual counts). Star (*) indicates significance at the p<0.05 level 
between the percentage of cells alive in mouse and NMR cell cultures by Mann Whitney U test. The 
total number of cells under control conditions for mice was 350,356 and NMRs was 32,498. The total 
number of cells counted in control conditions was greater than or equal to 300 cells. In the treated 
samples this was greater than or equal to 150 cells. 
 
  
To assess the variability between alpha cell lines treated with camptothecin within each 
species an ANOVA was performed. There was no statistical difference observed between mouse or 
NMR cell lines treated with camptothecin (mouse: F(2, 18)=0.595, p=0.562, NMR: F(2, 18)= 0.023, 
p=0.977) (Figure 3.7). 
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Figure 3.7 Percentage survival of primary skin fibroblasts in each of the primary skin fibroblast cell 
lines from 3 mice and NMRs that form the alpha cell stocks after treatment with camptothecin for 2 
hours in media with 2% DMSO. Error bars equal ± one standard error of the mean between two 
independent experiments which each consist of four individual counts. The total number of cells 
under control conditions for mice was 350,356 and NMRs was 32,498. The total number of cells 
under control conditions for each cell line was as follows mouse 1 – 140,250, mouse 2 – 101,306, 
mouse 3 – 108,800, NMR 1 – 4,083, NMR 2 – 23,527 and NMR 3 4,888. Each cell line was analysed 
twice. The total number of cells counted in control conditions was greater than or equal to 100 cells. 
In the treated samples this was greater than or equal to 50 cells. 
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Figure 3.8. Percentage survival of primary skin fibroblasts from either mice (blue) or NMR (red) from 
the alpha cell stocks after treatment with camptothecin for 2 hours in media with 2% DMSO. A clear 
increase in resistance to camptothecin is seen with an LD50 in NMR at 30.93µM (+/- 5.3µM) and in 
mice at 5.24µM (+/- 0.03µM). Error bars equal ± one standard error of the mean between each cell 
line (3 cell lines per species, each cell line value is the average of two independent experiments which 
each consist of four individual counts). Star (*) indicates significance at the p<0.05 level between the 
percentage of cells alive in mouse and NMR cell cultures by Mann Whitney U test. The total number 
of cells under control conditions for mice was 350,356 and NMRs was 32,498. The total number of 
cells counted in control conditions was greater than or equal to 300 cells. In the treated samples this 
was greater than or equal to 150 cells. 
 
 When this analysis was repeated on the beta primary cell cultures, the difference between 
NMR and mouse resistance was less pronounced. In chromium treatment, there were no individual 
doses that are significantly different though 40µM shows near significance (t(4)=-2.73, p=0.052) 
between NMR (68%) and mouse (52%) (Figure 3.9). The average LD50 was calculated as 48.4µM (±1.2) 
for mouse cells and 92.2µM (±18.1) and was significantly different (U4=0, p=0.05). These values are 
much higher than were found in the alpha primary cell cultures which may be due to variation 
between the cells or variations in the equipment used to weigh the compounds out. There was ~2 fold 
greater LD50 in NMR than mice; this is lower than the 4 fold seen previously. 
 
* 
* 
* 
* 
Log Camptothecin (µM) 
0.6            0.9             1.2           1.5            1.8            2.1         
92 
 
 
Figure 3.9. Percentage survival of primary skin fibroblasts from either mice (blue) or NMR (red) from 
the beta cell stocks after treatment with chromium (vi) oxide for 2 hours in media with 2% DMSO. 
Error bars equal ± one standard error of the mean between each cell line (3 cell lines per species, 
each cell line value is the average of two independent experiments which each consist of four 
individual counts). The total number of cells under control conditions for mice was 24,695 and NMRs 
was 2,469. The total number of cells counted in control conditions was greater than or equal to 300 
cells. In the treated samples this was greater than or equal to 150 cells. 
 
To assess the variability between beta cell lines treated with chromium (vi) oxide within each 
species an ANOVA was performed. There was no statistical difference observed between mouse or 
NMR cell lines treated with chromium (vi) oxide (mouse: F(2, 18)= 0.096, p=0.909, NMR: F(2, 18)= 
0.24, p=0.789) (Figure 3.10). 
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Figure 3.10 Percentage survival of primary skin fibroblasts in each of the primary skin fibroblast cell 
lines from 3 mice and NMRs that form the beta cell stocks after treatment with chromium (vi) oxide 
for 2 hours in media with 2% DMSO. Error bars equal ± one standard error of the mean between two 
independent experiments which each consist of four individual counts. The total number of cells 
under control conditions for each cell line was as follows mouse 1 – 12,130, mouse 2 –5,667, mouse 3 
– 6,898, NMR 1 –678, NMR 2 –9,630 and NMR 3 – 5,741. Each cell line was analysed twice. The total 
number of cells counted in control conditions was greater than or equal to 100 cells. In the treated 
samples this was greater than or equal to 50 cells. 
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Figure 3.11 Percentage survival of primary skin fibroblasts from either mice (blue) or NMR (red) from 
the beta cell stocks after treatment with camptothecin for 2 hours in media with 2% DMSO. Error 
bars equal ± one standard error of the mean between each cell line (3 cell lines per species, each cell 
line value is the average of two independent experiments which each consist of four individual 
counts). The total number of cells under control conditions for mice was 24,695 and NMRs was 
15,648. The total number of cells counted in control conditions was greater than or equal to 300 cells. 
In the treated samples this was greater than or equal to 150 cells. 
 
 As seen in the alpha primary cell culture, camptothecin treatment showed a greater difference 
between species in terms of survival. However only one dose (30µM) was significantly different 
between mouse (53%) and NMR (73%) (t(4)= -10.7, p=0.00). The average LD50 was calculated as 
44.4µM (5.9±) for mouse and 128.1µM (21.0±) for NMR which was significantly different (U4=0, 
p=0.05). Again, these values are greater than those seen in the alpha primary cell cultures. This was a 
~3 fold increase in NMR relative to mouse cells, which is half of what was seen in the alpha primary 
cell cultures. 
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Figure 3.12. Percentage survival of primary skin fibroblasts from either mice (blue) or NMR (red) from 
the beta cell stocks after treatment with camptothecin for 2 hours in media with 2% DMSO. Star (*) 
indicates significance at the p<0.05 level between the percentage of cells alive in mouse and NMR 
cell cultures by student T test. Error bars equal ± one standard error of the mean between each cell 
line (3 cell lines per species, each cell line value is the average of two independent experiments which 
each consist of four individual counts). The total number of cells under control conditions for mice 
was 39,353 and NMRs was 15,648. The total number of cells counted in control conditions was 
greater than or equal to 300 cells. In the treated samples this was greater than or equal to 150 cells. 
 
To assess the variability between beta cell lines treated with camptothecin within each 
species an ANOVA was performed. There was no statistical difference observed between mouse or 
NMR cell lines treated with camptothecin (mouse: F(2, 18)= 0.192, p=0.827, NMR: F(2, 18)= 0.942, 
p=0.412) (Figure 3.13). 
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Figure 3.13. Percentage survival of primary skin fibroblasts in each of the primary skin fibroblast cell 
lines from 3 mice and NMRs that form the beta cell stocks after treatment with camptothecin for 2 
hours in media with 2% DMSO. Error bars equal ± one standard error of the mean between two 
independent experiments which each consist of four individual counts. The total number of cells 
under control conditions for each cell line was as follows mouse 1 – 12,130, mouse 2 – 5,667, mouse 
3 – 21,556, NMR 1 – 678, NMR 2 – 9,630 and NMR 3 – 5,741. Each cell line was analysed twice. The 
total number of cells counted in control conditions was greater than or equal to 100 cells. In the 
treated samples this was greater than or equal to 50 cells. 
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Figure 3.14. Percentage survival of primary skin fibroblasts from either mice (blue) or NMR (red) from 
the beta cell stocks after treatment with camptothecin for 2 hours in media with 2% DMSO. Star (*) 
indicates significance at the p<0.05 level between the percentage of cells alive in mouse and NMR 
cell cultures by student T test. Error bars equal ± one standard error of the mean between each cell 
line (3 cell lines per species, each cell line value is the average of two independent experiments which 
each consist of four individual counts). The total number of cells under control conditions for mice 
was 39,353 and NMRs was 15,648. The total number of cells counted in control conditions was 
greater than or equal to 300 cells. In the treated samples this was greater than or equal to 150 cells. 
 
 To assess the effect of DMSO on cell mortality, cell counts from an assay looking at how 
DMSO affects senescence was analysed. This count data is less accurate than the above analyses as 
the cells were counted while still attached to the plate, and cell densities vary across the plate. No 
significant difference was observed between the DMSO treated and untreated samples. There was 
found to be no significant difference between the number of cells in counts from samples treated 
(mouse: 67 SD: 57, NMR: 71 SD: 50) or untreated (mouse: 80 SD: 66, NMR: 69.3 SD: 66) with DMSO 
(mouse: t(22):0.50, p=0.623, NMR: t(14): -0.07, p=0.943) (Figure 3.16).   
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Figure 3.15. Cell counts of samples treated or untreated with 2% DMSO for 2 hours. There was found 
to be no significant difference between the number of cells in counts from samples treated (mouse: 
67 SD: 57, NMR: 71 SD: 50) or untreated (mouse: 80 SD: 66, NMR: 69.3 SD: 66) with DMSO (mouse: 
t(22): 0.50, p=0.623, NMR: t(14): -0.07, p=0.943).  Error bars indicate +/- one standard error of the 
mean between three cell lines in mouse and two cell lines in NMR (cell line 1 was not included) each 
cell line value is the average of two replicates performed as part of one experiment. 
 
3.4.2 Naked mole rat cells are less prone to enter senescence in response to genotoxic 
stressors than mouse cells 
To better characterise the cellular response to genotoxic stimuli in mouse and NMR a 
preliminary beta galactosidase staining assay was performed on the alpha stocks to visualise the levels 
of senescence in these cells after treatment with the DNA damaging agents; camptothecin and 
chromium (vi) oxide (Figure 3.16-3.17). The proportion of senescent cells in the NMR cell cultures did 
not significantly increase between control treated or DNA damaging agent treated samples after 8 
hours or 48 hours. However, mouse cells showed a significantly higher level of senescence both in 
response to the DNA damage stimuli at both 8 and 48-hour time points compared to controls, and 
also showed increased senescence over time with all treatments showing greater levels of senescence 
at 48 hours compared to 8-hour time points. The increase in senescence was greatest in the DNA 
damaged samples indicating that this increase was in part in response to the received DNA damage. 
After 48 hours mouse cells showed significantly more senescence in all treatments than the NMR cells. 
At 8 hours control treated NMR cells showed greater senescence then control treated mouse cells.   
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Figure 3.16. Beta Galactosidase assay of mouse and NMR cells treated with chromium (vi) oxide 
(green), camptothecin (red) or control media (blue) with 2% DMSO at LD50 for each species. Star (*) 
indicates a significance between NMR and mouse at the p<0.05 level between the percentage of 
senescent cells in mouse and NMR cell cultures by one way ANOVA. Treated mouse cells upon either 
8 or 48 hours had significantly greater senescence than comparative controls. At 48hours mouse cells 
showed significantly more senescence than NMR cells and this difference was greatest in the treated 
cells. Error bars indicate +/- one standard error of the mean between the three cell lines within each 
species; each cell line value is the average of two replicates performed as part of one experiment. The 
number of cells counted for each sample were >600 cells per sample.  
To assess the variability between alpha cell lines treated with camptothecin or chromium 
within each species an ANOVA was performed. There was no statistical difference observed between 
mouse cell lines on control, camptothecin or chromium (vi) oxide treatment after 8 or 48-hour 
treatment (F(2, 9)<1.5, p>0.05). All NMR samples showed a significant difference (F(2,9)>8, p<0.05). 
Post hoc turkey analysis of 48-hour samples showed this is due to NMR cell line 2 being significantly 
higher than both other samples. Post hoc turkey analysis of 8-hour samples indicated that each of 
the cell lines showed significantly different levels of senescence in control samples, NMR cell line 2 
was significantly greater than cell line 3 in camptothecin-treated samples and NMR cell line 2 is 
significantly greater than the other cell lines in chromium treatment (Figure 3.17). 
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Figure 3.17. Percentage senescent cells in each of the primary skin fibroblast cell lines from 3 mice 
and NMRs that form the alpha cell stocks after treatment with camptothecin, chromium, or control 
conditions for 2 hours in media with 2% DMSO. Error bars equal ± one standard error of the mean 
between two replicates performed as part of one experiment. The number of cells counted for each 
sample were >200 cells per sample.    
 
 This analysis was repeated in the beta stocks (Appendix Figure 3). Due to limited time only 
one time point was studied, 24 hours post stimuli as a compromise between 8 and 48 hours. 
Additionally, instead of looking at LD50 which is limiting, a logarithmic range of doses for both 
compounds was analysed (Figure 3.18-3.20). Control treated NMR cells showed significantly more 
senescent cells (46%) than mouse cells (17%) under the same treatment (t(4)=-12.2, p<0.01). 
However, as the dose of either compound was increased the percentage of senescent cells increased 
in mouse cells, but only increased in the highest doses in NMR (Figure 3.7-3.8). This can be seen clearly 
from the maximum increase in senescence observed; only a total increase of 7% in NMR cells after 
either treatment, however camptothecin and chromium treatment resulted in a maximum increase 
of 44% and 46%, respectively in mouse cells. For camptothecin treatment the only doses that differed 
significantly were 60μM (NMR: 42%, Mouse: 54%) and 120μM (NMR: 53%, Mouse: 61%) with mice 
showing significantly more senescence (60μM: t(4)= 2.9, p=0.043, 120μM: t(4)= 3.3, p=0.029) (Figure 
3.7). For chromium treatment, the only significantly different dose was 10μM (NMR: 44%±11, Mouse: 
34%±3) with mouse showing significantly less senescence (t(4)=-4.7, p=0.01). Two-way ANOVAs of the 
data set and the data set minus control data showed a statistically significant interaction between 
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dose and species indicating the two species were responding differently to the stimuli (camptothecin: 
F(5,24)= 2.9, p=0.035, chromium: F(5,24)= 4.7, p<0.01).   
 
 
Figure 3.18. The percentage of senescent cells 24 hours after treatment with camptothecin at various 
doses. NMR cells show higher senescence in control samples than mice however there is very little 
increase in senescence at higher doses in NMR. Mouse cells show a large increase in senescence with 
increased dose. Large doses (30-120μM) show more senescence in mice than in NMR cells. Error bars 
represent +/- one standard error of the mean between 3 cell lines each cell line value was the 
average of two replicates performed as part of one experiment. Star (*) indicates significance at the 
0.05 level between the percentage of senescent cells in mouse and NMR cell cultures by student T 
test. Each count consists of over 300 cells per point.  
To assess the variability between beta cell lines treated with camptothecin within each 
species an ANOVA was performed. There was no statistical difference observed between mouse or 
NMR cells treated with camptothecin (mouse: F(2, 18)= 0.27, p=0.766, NMR: F(2, 18)= 1.137, 
p=0.343) (Figure 3.19). 
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Figure 3.19. Percentage senescent cells in each of the primary skin fibroblast cell lines from 3 mice 
and NMRs that form the alpha cell stocks after treatment with camptothecin, or control conditions 
for 2 hours in media with 2% DMSO. Each data point is the mean between 3 cell lines each cell line 
value was the average of two replicates performed as part of one experiment. Each count consists of 
over 100 cells per point. Error bars represent +/- one standard error of the mean between two 
replicates performed as part of one experiment. 
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Figure 3.20. The percentage of senescent cells 24 hours after treatment with chromium (vi) oxide at 
various doses. NMR cells show higher senescence in control and low dose samples than mice, 
however, there is very little increase in senescence at higher doses in NMR. Mouse cells show a large 
increase in senescence with increased dose. Large doses (40-160μM) show more senescence mice in 
than NMR cells. Error bars represent +/- one standard error of the mean between 3 cell lines each cell 
line value was the average of two replicates performed as part of one experiment. Star (*) indicates 
significance at the 0.05 level between the percentage of senescent cells in mouse and NMR cell 
cultures by student T test. Each count consists of over 300 cells per point. 
To assess the variability between beta cell lines treated with chromium (vi) oxide within each 
species an ANOVA was performed. There was no statistical difference observed between mouse or 
NMR cell lines treated with chromium (vi) oxide (mouse: F(2, 18)= 0.075, p=0.928, NMR: F(2, 18)= 
1.422, p=0.267) (Figure 3.21).  
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Figure 3.21. Percentage senescent cells in each of the primary skin fibroblast cell lines from 3 mice 
and NMRs that form the alpha cell stocks after treatment with chromium (vi) oxide, or control 
conditions for 2 hours in media with 2% DMSO. Error bars have not been included due to large 
overlap. Each data point is the mean between 3 cell lines each cell line value was the average of two 
replicates performed as part of one experiment. Each count consists of over 100 cells per point. Error 
bars represent +/- one standard error of the mean between two replicates performed as part of one 
experiment. 
 
 In order to conduct accurate comparisons between control and treated cells, the control 
samples were treated with 2% DMSO for 2 hours, removing this as a source of variation between the 
treatments. However, this exposure to DMSO was suspected of being the cause of the high level of 
senescence seen in control cells. Hence this analysis was repeated for control conditions with and 
without DMSO. There was found to be no significant difference between the number of senescent 
cells in samples treated (mouse: 1.9% SD: 0.02, NMR: 2.8% SD: 0.03) or untreated (mouse: 2.5% SD: 
0.02, NMR: 2.9% SD: 0.05) with DMSO (mouse: t(22): 0.644, p=0.526, NMR: t(14): 0.003, p=0.998) 
(Figure 3.22).  
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Figure 3.22. The percentage of senescent skin fibroblasts from mouse and NMR that were either 
untreated or treated with 2% DMSO for 2 hours. There was found to be no significant difference 
between the number of senescent cells in samples treated after 24 hours (mouse: 1.9% SD: 0.02, 
NMR: 2.8% SD: 0.03) or untreated (mouse: 2.5% SD: 0.02, NMR: 2.9% SD: 0.05) with DMSO (mouse: 
t(22): 0.644, p=0.526, NMR: t(14): 0.003, p=0.998). Error bars indicate +/- one standard error of the 
mean between the 3 mouse cell lines and NMR cell line 2 and 3. Each cell line value was the average 
of two replicates performed as part of one experiment. Total number of cells counted are as follows: 
mouse control – 975 cells, mouse DMSO treated – 791 cells, NMR control – 480 cells and NMR DMSO 
treated – 594 cells. 
 
3.5 Discussion 
The NMR has a lower resting body temperature (~32ᵒC) than mice (37ᵒC) (170). NMR cells 
grow poorly at 37ᵒC (175, 371) and hence a lower temperature than standard is required. NMR cells 
have been successfully grown at 33ᵒC (175), but this is several degrees lower than the optimal mouse 
growing conditions. As only one incubator is available and consistency between primary cell cultures 
is essential for reliable and comparable results a compromise of 35ᵒC was selected. Both primary cell 
cultures appear to grow under these conditions. As has been discussed previously, low oxygen (3%) 
was used in this study to represent the native environment of a cell. Conditions for cell culture were 
optimised by Vera Gorbunova’s lab at 3% oxygen (176). 
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3.5.1 Resistance of NMR to DNA damage stimuli 
NMR skin fibroblasts show greater resistance to DNA damaging stimuli than those derived 
from mice. This is seen in the approximately 3-6 fold and 2-4 fold increases in LD50 of the cells for 
camptothecin and chromium (vi) oxide, respectively. This is a small difference in resistance and less 
than the previously reported 15 and 5 fold resistances (175) and is likely due to the difference in 
growth conditions and variation between cells. When looking at each dose in the survival assay, we 
see more doses of camptothecin that result in a significant difference between the mouse and NMR 
survival than with chromium (vi) oxide. These differences are relatively small. Still, this indicates that 
the sensitivity of these primary cell cultures to chromium is more similar than with camptothecin. 
These compounds cause different kinds of DNA damage with chromium inducing a broad array of 
damage types and camptothecin specifically inducing single and double-strand breaks. This suggests 
NMR cells may have mechanisms to enhance their ability to prevent and repair DNA strand breaks 
specifically. The increased resistance to camptothecin observed in this assay may be down to 
camptothecin’s mode of action. Camptothecin acts by binding topoisomerase 1 and preventing the 
religation of DNA after topoisomerase 1 induced single-strand cleavage. However, if the level of 
topoisomerase was lower in the NMR, then less single-strand breaks would occur as a result of 
camptothecin treatment. Additionally, single-strand breaks become more hazardous double-strand 
breaks if unrepaired before DNA replication. As NMR cells divide more slowly than mouse cells (175, 
187, 188) they may be less likely to have unrepaired single-strand breaks during DNA replication. Were 
more time available we would assess if this is the case by analysing a compound that induces single-
strand breaks independently of topoisomerases such as bleomycin in place of camptothecin.    
There was a large amount of variation in the NMR alpha cell line between NMR cell line 1 and 
the others. Cell line 1 was significantly lower and if considered an outlier would not affect our 
conclusion, however, if this cell line was representative, then we would have to conclude that there 
was little difference between NMR and mouse cells in terms of survival. It is not clear why such 
variation is observed. This could be due to intrinsic variations within the cell or variations in the 
environment that the cells were maintained.  
An unknown factor in this experiment is the effect of DMSO on the cells as this was never 
tested directly in our lab. The preliminary data utilised from the senescence assay indicates no 
difference in cell mortality between cells treated or untreated with 2% DMSO for 2 hours. This data 
shows a large amount of variability likely due to variability in cell density on the culture plate surface 
in the area of the count. Studies using transformed mouse cells have indicated that treatment with 
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2% DMSO can result in ~50-70% cell viability (404, 405). However, both analyses use a 24-hour 
treatment which will likely have a much more amplified effect than the 2 hours used in this study. As 
both control and treatments contain DMSO, the effects seen in this study will be down to the 
compounds under study. However, it is possible that DMSO may act synergistically or antagonistically 
with these compounds enhancing the damaging effects or protecting against it which would impair 
our ability to assess the compounds of study. This would not affect our analysis of the species of study 
unless one organism reacted differently to DMSO treatment than the other which our preliminary 
data indicates is not the case.  
 3.5.2 Reduced senescence in response to DNA damage in the NMR 
When treated with the LD50 of either compound under study NMR skin fibroblasts showed 
lower beta galactosidase staining in response to DNA damage than cells derived from mice. At 8 hours 
post initial DNA damage stimuli, there is a significantly greater level of senescent mouse cells in the 
treated condition than the untreated control. This increase is not seen between NMR treatments 
indicating that these cells do not enter senescence in response to this DNA damage. However, NMR 
cells under control conditions have a significantly higher proportion of senescent cells than control 
mouse cells. This may be a caveat of NMR cells’ slower growth rate as the less frequent passaging 
would allow the accumulation of such cells that would otherwise be diluted out of the population in 
faster-growing cell lines. Alternatively, this could indicate suboptimal growth conditions for the NMR 
cells. Were this project to continue, these growth conditions would be optimised for these cells. This 
could easily be done by taking a design of experiments (DoE) approach that uses statistical modelling 
to predict responses under study from fewer experiments (discussed in more detail in Chapter 6). A 
design could be implemented varying the oxygen content, temperature and FBS media content. The 
level of senescence and growth rates would be used to assess how well the cells grow. After 48 hours 
the level of senescence-associated staining increased in mouse cells under all treatments. The increase 
was larger for the cells treated with the DNA damaging agent, and these cells showed significantly 
more staining than the 48-hour mouse control cells. This increase over time for treated cells could 
mean that these cells take longer than 8 hours to undergo senescence or that the increased level of 
senescent cells is having a negative effect and creating unfavourable conditions that further promote 
senescence in these cells that only appear senescent at the later time point (as discussed in Section 
5.1.2). For untreated cells, this increase could again be caused by senescent cells already present in 
the sample or could indicate an effect of the DMSO in the control treatment, however as discussed 
below this is unlikely as DMSO treatment did not increase levels of senescence relative to untreated 
cells. NMR cells did not increase in levels of senescence from 8 to 48 hours. When treated with a 
logarithmic range of doses, the same trend is observed. NMR cells have a higher starting senescence 
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level which only increases a little at high doses of the compounds and mouse cells have very little 
starting senescence that dramatically increases as the dose increases. Camptothecin-treated mouse 
cells showed similar or significantly more senescence than NMR cells, however, statistically, the 
opposite was true for chromium treatment. This may be because the difference in perceived 
resistance to chromium is smaller between these two species. The alpha and beta cell lines responded 
similarly with NMR having large levels of starting senescence that did not increase with treatment and 
mice having a lower starting level of senescence that increased with increased treatment. The beta 
cell stocks showed consistently higher levels of senescence than the alpha cell stock. This was much 
greater in NMR (40-50% vs. 10-20%) than in mice (20-60% vs. 20-50%). This could in part be explained 
by the fact the beta cell line experiments were carried out at 24 hours post stimuli as opposed to 8 
and 48 hours. Differences in the cells themselves may explain this difference as well with the alpha 
cell line simply being more resistant to senescence induction than the beta cell lines. 
Interestingly the levels of senescence in NMR cells vary dramatically between the two 
experiments. This will likely be in part due to differences between primary cell cultures, but may also 
be due to experimental variation or variation in the assay kit as a new kit was used for the later assay.  
It was found that exposure to DMSO has no significant effect on levels of senescence. Hence 
this data indicates that DMSO has no effect on the incidence of senescence in these cell lines; however, 
it is possible that DMSO can act synergistically and or antagonistically to alter the levels of senescence 
induced by the compounds of study. In this experiment similar levels of senescence between mice and 
NMR cells was observed with only a ~1% difference between the samples, which is in contrast to 
previous results; additionally, lower levels were observed in this experiment (~2.5% vs. 10% in NMR). 
Again, this could be due to variation in the assay kit used or because this experiment was carried out 
after 24 hours as opposed to 8 and 48 hours. 
The alpha cell line showed a large level of variation between the cell lines for NMR cells, 
particularly NMR cell line 2 which frequently had more senescent cells than the other cell lines. If this 
cell line was taken as an outlier, it would not affect our present conclusion that NMR cells show lower 
incidence of senescence in response to the toxic stimuli studied.  However, it could be that this cell 
line is representative of NMR skin fibroblasts and the other cell lines are unusual in which case we 
would conclude that there is no difference between mouse and NMR cells. It is not clear why such 
variation is present but may indicate some intrinsic difference in these cells, such as a genetic 
variation, or differences in the treatment such as variation in temperature or culture media. 
Taken together these results show that in response to DNA damaging agents the NMR cells 
are less prone to enter senescence than those from mice which show an immediate increase in 
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senescence which increases over time. The reduced tendency to enter senescence in response to 
genotoxic insults in the NMR would result in such exposed tissues being healthier as senescent cells 
have been associated with accelerated ageing and age-related pathologies (406). As such the NMR’s 
tendency to avoid induced senescence may contribute to its long-lived status but may also be a 
consequence of this status. 
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Chapter 4: RNAseq analysis of H. glaber and M. musculus skin fibroblasts 
4.1 Introduction 
In the previous chapter, it was shown that NMR skin fibroblasts appear more resistant than 
mouse cells to the DNA damaging agents, camptothecin and chromium (vi) oxide. This confirms what 
was previously shown in other studies (175). Additionally, we indicated that the NMR cells responded 
differently to these genotoxic compounds showing less induced senescence than mouse cells.  
In this chapter, the ways by which these skin fibroblasts differ in their response to DNA 
damaging agents will be examined at the molecular level. How gene expression changes in response 
to treatment with DNA damaging compounds indicates how the cells deal with this genotoxic insult. 
By looking at how these responses differ between the NMR and mouse cells, genetic explanations for 
the variation in lifespan, cancer susceptibility and DNA damage resistance between these two species 
can be inferred.  
To this end, an RNAseq experiment was run to identify the levels of gene expression in mouse 
and NMR cells responding to DNA damaging agents in the short term (8 hours after initial exposure) 
or long term (48 hours after initial exposure). A functional enrichment was performed on the data to 
identify if differentially expressed genes were enriched for particular pathways or processes. Genes 
involved in DNA damage repair and cellular adhesion were specifically studied to determine if these 
cancer-associated components vary between the two species.  
4.1.1 RNAseq analysis 
Cells respond to stimuli such as genotoxic insults through either changes in protein activity 
directly or changes in gene expression that ultimately affect protein activity.  The purpose of RNAseq 
analysis is to detect these changes in gene expression at the mRNA level. The process (detailed in 
Chapter 1.4) essentially quantifies the amount of mRNA from each sample. The read count is the 
number of sequenced pieces of cDNA (derived from the sample mRNA) that correspond to a given 
gene. These read counts have been shown to be linearly related to the amount of the target transcript 
(298). However, these counts need to be normalised to remove technical bias between samples. A 
number of methods can be employed to normalise RNAseq data, but for our analysis, we used the 
statistical program, DEseq’s, inbuilt method (407). In short, the normalised value is calculated by 
dividing the read count of a given gene in a given sample by the geometric mean of these values across 
the samples (407). Whether a gene is significantly differentially expressed is determined by a test that 
is initially analogous to Fisher's exact test but is based on the assumption that the number of reads in 
a sample assigned to a given gene fits a modified negative binomial distribution as detailed in (407). 
111 
 
The final output of an RNAseq analysis is essentially a list of genes with expression values of 
each gene in the compared samples, the fold change between these values and a p-value. This p-value 
tells us the probability of these expression values being as they are by chance if the null hypothesis of 
equality between the expression values was correct. These lists of genes are often too large to yield 
useful information on their own and as such further analysis must be conducted. Typically, this is done 
by grouping genes by function by either selecting for certain types of gene and seeing if collectively 
these are more expressed in one sample. 
Functional enrichment is a statistical method to identify types of genes (classified by GO (gene 
ontology) terms for example) that are over represented in a dataset. By looking at the total number 
of genes that fall into a particular group in the entire sample and comparing that to the number genes 
differentially expressed through a modified Fisher's exact test we can determine the probability of 
observing these values and hence whether a particular type of gene is significantly enriched in the 
sample (330). This analysis essentially takes a list of genes and outputs a list of enriched biological 
terms which is often easier to interpret.  
4.1.2 Quantitative polymerase chain reaction 
Polymerase chain reaction (PCR) is a commonly used technique for amplifying DNA. The 
reaction requires the following ingredients: the target DNA that the reaction is aiming to amplify, an 
abundant supply of nucleotides that the newly synthesised DNA will be made of, a DNA polymerase 
to synthesise the new DNA and a pair of primers specifically designed to match the target gene. These 
primers are short nucleotide sequences (~ 20 nucleotides long in this assay) that are complementary 
to the DNA that flanks the region of the target DNA to be amplified. The reaction is controlled by 
changes in temperature; hence a thermocycler that repeatedly induces the required temperatures is 
required. To begin the reaction, the solution of the above ingredients is heated to 95ᵒC. This results in 
the double-strand DNA melting into single-strand DNA. Additionally, hot start polymerase (as used in 
this assay) are activated as the high temperature denatures the attached antibodies that otherwise 
block their activity. The mixture is then cooled to 60ᵒC. At this temperature, the primers anneal to the 
target DNA sequence. The DNA polymerase binds to this primer and begins synthesising new DNA on 
the end of the primer using the target DNA as a template. This can happen at 60ᵒC in a two-step 
process as used in this assay. Alternatively, a three-step process can be used in which the sample is 
heated to ~72ᵒC to facilitate the synthesis of DNA. This synthesis continues until the DNA polymerase 
falls off the chain. The mixture is then heated to 95ᵒC again to melt the newly formed double-stranded 
DNA. When the sample is cooled to 60ᵒC, both the original sample DNA and the newly synthesised 
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DNA strands can be used as templates for synthesising new DNA. As such, the amount of the target 
DNA increases exponentially.  
Quantitative PCR (qPCR) is a version of PCR that allows quantification of the DNA that is 
amplified. It works as described above except that the amount of DNA in the sample is recorded at 
each thermal cycle. This is done by the use of specialist fluorescent dyes such as SYBR Green that, 
when bound to double-stranded DNA has a >1,000 fold increase in fluorescence (408). The 
fluorescence emitted is measured, and hence the relative amount of DNA can be determined. To 
calculate the fold change of the target DNA between samples, the number of cycles required for the 
level of fluorescence in the sample to hit a pre-determined threshold, known as a cycle threshold (ct) 
value, must be obtained. The threshold used is largely arbitrary but must fall within the linear phase 
of the amplification plots to allow for accurate comparison. This method can be used to validate 
RNAseq data, by checking a small selection of genes to ensure that the fold change observed for these 
genes in the RNAseq data can also be observed through qPCR. 
A major source of error in qPCR is the amplification of contaminating genomic DNA in the 
sample instead of cDNA. To minimise this DNase can be used to digest the genomic DNA during RNA 
extraction as has been performed in this analysis. Another measure that can be taken is to use primers 
that span exons either directly (the primer encodes the ends of two exons) or indirectly (the amplified 
region between primers span over multiple exons). As genomic DNA will contain introns, it will not be 
amplified. Exon spanning was not factored into the primer design in this analysis.  
Another source of error is due to sample and run variation. Ideally, we would extract the same amount 
of mRNA from the same number of cells for each sample and the level of degradation and/or 
contamination of these samples would be the same and minimal. However, variation in these factors 
may result in differences in the observed ct values obtained. Similarly, each run will likely vary due to 
variations in the running of the machine, and sample preparation between days among other possible 
factors. To account for this reference or housekeeping genes are used. These are genes that are 
presumed to have consistent expression over all conditions, i.e. that they are unaffected by the 
treatment. As their expression should be consistent, the ct values observed for this gene, if amplified 
with appropriate primers, should be the same for both control and treated samples. Variation in these 
ct values indicates other sources of variation during the harvesting, purification, reverse transcription 
and qPCR of the mRNA. We can use the ct values of the housekeeping genes to normalise the ct values 
of our genes of interest to remove this source of error. There are many commonly used reference 
genes, including the two used in this study, Tbp (TATA-Box Binding Protein) and Hprt1 (Hypoxanthine 
Phosphoribosyltransferase 1). The TATA-box binding protein Tbp is a general transcription factor that 
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binds specifically to TATA-box DNA sequence. It is involved in the transcriptional initiation of RNA 
polymerase 1, 2 and 3 (409). This gene has been found to have stable expression in various treatments, 
particularly Tbp has been shown to be one of the most stably expressed genes in skin fibroblasts in 
mice as part of studies into skin wound healing (410). Hprt1 is a transferase that plays a key role in the 
generation of purine nucleotides. Its expression has been shown to be stable in skin fibroblasts in 
humans (411). 
4.2 Aims 
RNAseq analysis identifies the level of expression of all genes in an organism. As discussed in 
Chapter 1.4, RNAseq is a powerful technique that has been employed successfully in the NMR to help 
elucidate the mechanisms behind their remarkable cancer resistant and long-lived phenotype. 
However, no RNAseq studies have been performed on cells responding to genotoxic stress to date. By 
performing RNAseq on mouse and NMR cells exposed to DNA damaging agents, we can identify how 
changes in gene expression in response to DNA damage differ between the two organisms. A dose 
predicted to be sufficient to kill half the cells was used to ensure similar levels of stress in the surviving 
cells of both species. This LD50 was calculated in Section 3. In NMR cells senescence does not appear 
to increase at these doses, and hence we can be sure the reduction in cell numbers is due to half the 
cells being killed and not by the induction of senescence. The mouse cells used in this assay (alpha 
stock) showed up to 8% and 22% more senescent cells at 8 and 48 hours post-treatment with the 
designated LD50 dose, respectively. An intermediate value is likely to represent the level of 
senescence at 24 hours (the time the LD50 value was derived from). As such the majority of the 
decrease in cell count will be due to cells dying however such senescence may result in 
underestimation of the LD50 in mice. By identifying differences between the NMR and mouse, it may 
be possible to identify mechanisms by which the NMR cells elicit their apparent DNA damage 
resistance and potentially why they are more resistant to cancer and are longer lived than mice.  
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4.3 Materials and methods 
4.3.1 RNA sequencing 
Cells from mouse and naked mole rat (NMR) were grown to near confluence in 100mm culture 
dishes with media and under the conditions described in Section 3.3.1. These were treated with 
camptothecin or chromium (vi) oxide (Sigma Alderich) at LD50 (found in this study to be 5.24 µM 
camptothecin and 6.88µM chromium (vi) oxide for all mouse primary cell cultures, 26.93µM 
camptothecin for all NMR primary cell cultures and 24.68uM, 28.28µM and 27.3µM chromium (vi) 
oxide for NMR primary cell cultures 1, 2 and 3, respectively). The compounds were dissolved in media 
with 2% DMSO that was also present in control treatments. Treatment lasted 2 hours, and RNA was 
collected using RNeasy RNA extraction kit as per manufacturer’s instructions, 8 or 48 hours after the 
start of the treatment. Only cells from the alpha cell stock were used in this assay. Prior to RNA 
extraction, the cells were examined, and no change in morphology was observed. The cells in 48-hour 
post-treatment samples were counted prior to RNA extraction to check that the treatment had killed 
approximately 50% of the cells. Only the 48-hour samples were counted as the 8-hour time point was 
deemed not long enough to see differences in cell count. Only one count per sample was performed 
as a ‘quick check’. 
RNA samples were sent to the Centre for Genomic research at the University of Liverpool to 
run the RNAseq experiment as follows. The total RNA was depleted with the Ribo-Zero Low Input Gold 
Kit (Human/Mouse/Rat) from Epicentre using 500-1,000ng of starting material. The success of the 
depletions was assessed using Qubit and Bioanalyzer for each sample.  RNA–Seq libraries were 
prepared from the enriched material using the Epicentre ScriptSeq v2 RNA-Seq Library Preparation 
Kit.  The rRNA depleted RNA was used as input, and following 15 cycles of amplification, libraries were 
purified using AMPure XP beads. Each library was quantified using Qubit and the size distribution 
assessed using the Agilent 2100 Bioanalyzer. These final libraries were pooled in equimolar amounts 
into 6 pools using the Qubit and Bioanalyzer data. The quantity and quality of each pool was assessed 
by Bioanalyzer and subsequently by qPCR using the Illumina Library Quantification Kit from Kapa on a 
Roche Light Cycler LC480II according to manufacturer's instructions. The average read length over all 
the pools was 386bp with an average concentration of 26.9ng/µl. Each pool of libraries was sequenced 
on one lane of the HiSeq 2,500 at 2x50bp paired-end sequencing in the rapid run mode. 
 
The data received from the Centre for Genomic research was analysed through our lab's 
pipeline that consists of STAR (412) and readcounter (413). The mouse genome used to map mouse 
data was the GRCm38 from Ensembl release 76. The NMR genome used to map NMR samples was the 
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NCBI (National Centre for Biotechnology Information) annotation of HetGla_female_1.0 NMR 
assembly. A combination of the NMR database (414), NCBI gene database 
(http://www.ncbi.nlm.nih.gov/gene) and Ensembl (415) were used to name each gene. 
 
The genes Cdkn2a (Cyclin-Dependent Kinase Inhibitor 2A) and Cdkn2b (Cyclin-Dependent 
Kinase Inhibitor 2B) do not appear in the current NMR annotation, for Cdkn2a this is likely due to a 
premature stop codon in the NMR (described in Section 1.2.2) (175, 414). To make sure these genes 
were included in our analysis we BLAST the known NMR Cdkn2a sequence from the NMR database 
(414) and the mouse sequence of Cdkn2b (GI:3075496) against the nr database from NCBI. The top 
matches in NMR were taken as the homologues. These were LOC101701430 and LOC101701062, 
respectively. 
 
Deseq (407) was used to analyse the RNAseq data using default settings. Deseq2 (416) was 
also used with default settings as this is thought to be less stringent and hence have a reduced type 
two error. Deseq was also used to normalise the data as described in 4.1.1. and to calculate fold 
change values as the normalised value of one condition divided by the normalised value for the other 
condition.  
4.3.2 Quantitative PCR 
RNA was extracted using an RNAeasy mini kit as per the manufacturer’s specification including 
the use of DNase to remove DNA contaminant (which could otherwise be amplified instead of our 
target cDNA) and hence remove the need for exon spanning primers. The tetro cDNA synthesis kit by 
Bioline was used to generate cDNA as per the manufacturer’s instructions for Oligo (dT)18 and 
incubated for an additional 30 minutes to ensure a complete reaction. Primers (Table 4.1) were 
designed using OligoPerfect™ Designer (Invitrogen Corp. Carlsbad, CA) using the following 
parameters: Primer size: Min 18, Opt 20, Max 27, Primer Tm: Min 57, Opt, 60, Max 63, Primer GC 
percentage: Min 40, Opt, 50, Max 60, Product size: Min 100, Max 150, Salt Conc: 50 and Primer Conc: 
50. The output primers were checked for specificity using the NCBI’s primer blast tool (417). Primers 
for Hprt1 and Tbp in NMR were taken from (192), and primers for Hprt1 in mice were taken from (418) 
as these have been extensively tested. No product length for the NMR Tbp primers was provided as 
this primer was designed to the mouse ortholog and hence the product length provided here was 
predicted from gels run on control RNA (Figure 4.20). 
To test the specificity of the primers control sample cDNA was diluted 1 in 50 and 5µl of this 
was added per required well with 10µl Maxima SYBR Green/ROX qPCR master mix (x2) (Invitrogen 
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Corp. Carlsbad, CA), 4µl nuclease-free water and 0.5µl of 10µM forward and reverse to give a final 
volume of 20ul. This was done for each primer pair in triplicate. The plate was immediately placed in 
a StepOnePlus Real-Time PCR System by Applied Biosystems. Each cycle consisted of 15 seconds at 
95ᵒC and 60 seconds 60ᵒC period and was repeated 40 times. To assess the specificity of the primers 
the PCR product was mixed with 5µl loading buffer and 10µl of this solution was run on a 3% agarose 
gel. The gel was prepared by mixing 6µl of Midori Green to 100ml of molten 3% agarose before pouring 
the gel. The gel was run at 110 volts for 1.5 hours. This was then imaged using UV light.  
Due to limited amounts of RNA remaining after the RNAseq analysis only the following mouse 
samples could be analysed, mouse primary cell culture 1, (8 hours post stimuli all samples, and 48-
hour post stimuli control, and camptothecin samples) and mouse primary cell culture 2 (8-hour post 
stimuli control and camptothecin-treated samples and 48-hour post stimuli control and chromium 
treated samples). Each sample was run in triplicate. For each sample, a standard curve was created 
using a five-fold serial dilution of the control cDNA with each sample being amplified and analysed in 
triplicate (Appendix Figure 4 to 7). Only samples with an efficiency of 95-105% (efficiency calculated 
as: 10(-1/slope) -1 where ‘slope’ refers to the slope of the standard curve (Appendix Table 1)) and an R2 
value of ≥0.98 were used for the quantification analysis initially. For mouse cell line 1, Foxo1 in 8-hour 
post-treatment samples, R3hcc1 (R3H Domain And Coiled-Coil Containing 1) in 48-hour post-
treatment sample and p21 from both 8 and 48-hour post-treatment samples was included in this assay 
despite high efficiency (106-113%) and hence care should be taken when interpreting data from these 
samples. Due to limited starting volumes of RNA, only a subset of the target genes could be tested, 
and those that failed to meet the required efficiency and R2 could not be re-tested. To assess that DNA 
contamination was not being amplified in the PCR reaction, RNA samples that had not undergone 
reverse transcription were used as the input to the qPCR reaction. However, due to limited remaining 
RNA, this was only performed on primary mouse cell culture 2 8-hour and 48-hour control samples 
using the primer pair designed for p21. No amplification was observed suggesting nuclear DNA 
contamination is not an issue in these samples.  
Fold change was calculated by taking the ct value of Tbp from the target gene ct value to give 
delta ct (Δct). As Tbp expression should remain consistent between treatment, this normalises for 
differences in starting RNA and cDNA concentrations. Fold change in a sample was then calculated by 
the following: 2-(Δct control (untreated)  – Δct treatment). Upon analysis of ct values for the housekeeping genes Tbp 
and Hprt1 (Appendix Table2) it was found that there was little variation between them with the 
coefficient of variation (calculated as the standard deviation of the ct divided by the average ct within 
a run (control and treated cells) multiplied by 100 to be expressed as a percentage) between control 
and treated samples in each qPCR run being less than 4%. The coefficient of variation is a statistic for 
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assessing the variation in expression of a gene that allows for comparisons between genes with large 
differences in base expression. There is no agreed value that the coefficient of variation needs to be, 
but the lower, the better. The ct values were input into a one way ANOVA using the statistical package 
SPSS to assess if there was significant variation between samples. 
 
Table 4.1. All primers created for this experiment. With the exception of Hprt1 and Tbp targeting 
primers, all primers were designed especially for this study. Star (*) value derived from the gel image 
as no predicted size was available.  
Gene Forward 5’ – 4’ Reverse 5’ – 4’ Product 
Size 
P21 nmr p1     ATAGTGGCTCAGGAGGACCA TTTTCGGCTCTGAGAGGTTC 114 
P21 nmr p2 ACCTCTCAGAGCCGAAAACG TAGGCCGTGGATTCTGTGGG 101 
P21 mouse p1 TTGCACTCTGGTGTCTGAGC TCTGCGCTTGGAGTGATAGA 112 
P21 mouse p2 ACCACCAAGCCATTCCATAG ACACTATCCTGGGCATTTCG 111 
Sox5 NMR p1 GGAAGGTGGCTGTTGTGAAT TCCATCATTGCATGGCTAAA 136 
Sox5 NMR p2 TGACCCTTACCCTGTTCAGC GCTTCCCTCCTGGAGATACC 137 
Sox5 Mouse p1 CCGTGTCTCCTACCAGCATT GGTGATTTGCCATCAGAGGT 124 
Sox5 Mouse p2 AACTGTGCCCAGACAAAACC CCCCTAGGGAAAACTCTTGG 113 
Grik2 NMR p1 CATCAAGGCTCCATCAAGGT TTGCCTCGCTTCATTTCTTT 102 
Grik2 NMR p2 CTCATGCAGCAAGGTTCTGA ACTGTCAGAAAGGCGGCTAA 128 
Grik2 Mouse p1 GCAATGAGGAAGGGATTCAA GTGCCAACACCATAGCCTTT 145 
Grik2 Mouse p2 TCGACTTTTCAAAGCCGTTT GCAAGCCAGCAGAACATACA 134 
R3hcc1 NMR p1 CTGGCCACGTTCTCTGAGTT TTGGTCAGAGCCTCAGTAGC 113 
R3hcc1 NMR p2 GGCTCAAGATCCAGTGGGTA GCTCTGAGCTTCGACTGCTT 145 
R3hcc1 Mouse p1 AAGGATTTCTCCGTGCTCAA CCTTCGATAGTCGCAGGAAC 100 
R3hcc1 Mouse p2 TACTCCCCCAAGTGTTCTGC AAGGGGCTGTCCTGGTATCT 103 
Serpinb2 NMR p1 ATGAGGCAACCAAGATGGTC CCTGTTCACACGGAAAGGAT 107 
Serpinb2 NMR p2 TGTTGATGAGGCAACCAAGA CCTGTTCACACGGAAAGGAT 112 
Serpinb2 Mouse p1 ACCTGCTACCCGAAGGTTCT CGAGTTCACACGGAAAGGAT 131 
Serpinb2 Mouse p2 AAATCCCAAACCTGCTACCC CGAGTTCACACGGAAAGGAT 140 
Dpp10 NMR p1 CCCAAAGCAAAGCAGTATCC GGTGGCATGAGTTCCAAAGT 110 
Dpp10 NMR p2 TACCGTGCGTCATCTGACAT TGGGAGATAACTCGGTGCTC 104 
Dpp10 Mouse p1 GCGAACCCATCAGTGAAGTT ACCACCTGACCACTGTCCTC 148 
Dpp10 Mouse p2 TGGCATACGACGTTAAGCAG CTCAACTTCTGGGGGATTCA 107 
FOXO NMR p1 GGCTATTCTTCCGTGAGCAG GTCACAGTCCAAACGCTCAA 111 
FOXO NMR p2 TGCCTCTTTCCCATCCTATG GTCACAGTCCAAACGCTCAA 146 
FOXO Mouse p1 CCGGAGTTTAACCAGTCCAA TGCTCATAAAGTCGGTGCTG 124 
FOXO Mouse p2 ACATTTCGTCCTCGAACCAG GGTGGATACACCAGGGAATG 116 
P57 NMR p1 GTGGAAACGTCCCTGTGATG AGTTGAAGTCCCAGCGGTTC 141 
P57 NMR p2 TGGAAACGTCCCTGTGATGG AAGTTGAAGTCCCAGCGGTT 141 
P57 Mouse p1 AGAGAACTGCGCAGGAGAAC TCTGGCCGTTAGCCTCTAAA 141 
P57 Mouse p2 GGAGCAGGACGAGAATCAAG GTTCTCCTGCGCAGTTCTCT 145 
Hprt1NMR p1 GCTTCCTTCTCCGCAGACT CTTCATCACGTCTCGAGCAA 215 
Hprt1 Mouse p1 GGACTAATTATGGACAGGACTG GCTCTTCAGTCTGATAAAATCTAC 195 
Tbp NMR p1 GAGAGGAGCTGCTTCGGATT GCTCATGCCAGAGAATAGGC 208* 
Tbp Mouse p1 TGTCTGCCATGTTCTCTTGC TGCTGCCACCTGTAACTGAG 109 
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4.4 Results and discussion 
4.4.1 Quality control 
Prior to RNA extraction, the cells from the 48-hour post-treatment samples were counted to 
check that ~50% of the cells had been killed by the treatment (Figure 4.1). On average, there were 
almost exactly 50% fewer cells in treated samples compared to untreated controls for mouse cells 
(50.5% and 50.6% for camptothecin and chromium treatment, respectively) with very little variation 
between the cell lines (Appendix Figure 8). However, NMR cells varied more with camptothecin-
treated samples having an average of 45.7% the number of cells from untreated control samples and 
chromium (vi) oxide treated cells having 58.8% the number of cells in control samples. This chromium 
treated samples showed much more variation between cell lines (43.1-68.8%) (Appendix Figure 8). 
Despite the variation, these numbers suggest that the compounds of study are in fact killing or 
otherwise reducing the number of cells in the sample by approximately 50%. The deviations from this 
value may be due to the fact the cells had an extra 24 hours to grow and or die. Given the data 
previously collected that showed mouse cells had significantly more senescent cells in treated samples 
compared to control cells and that NMR cells showed no increase after 48 hours post-treatment 
(Figure 3.16), it is surprising that the deviation from 50% is not the reverse of what we observe. Mouse 
cells should deviate more due to the accumulation of non-dividing cells reducing the cell count relative 
to the dividing control cells. Perhaps the accumulation of senescent cells occurs slowly and so the 
number of senescent cells observed at 48 hours only recently arriving at such levels. Given the 
suggestion that senescent cells can promote further senescence (discussed in Section 5.1.2) we would 
expect a non-linear accumulation of senescent cells over time with the rate of accumulation of 
senescent cells increasing with time. This means that some of the senescent cells observed at 48 hours 
would not have been around long enough to affect the population growth. Alternatively, the dose 
provided may have not quite killed 50% of the cells so that the difference was made up by the 
senescent cells in the population.  
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Figure 4.1 Average proportion of mouse or NMR cells from the alpha cell stock alive after genotoxic 
treatment prior to RNA extraction for 48hour post-treatment samples. Error bar indicates ± one 
standard error of the mean between three cell lines; each cell line is a single sample (no replicates). 
Key, cam - camptothecin, chro - chromium (vi) oxide, con - control. Each cell line count consisted of 
~100 cells, hence the average displayed above consists of ~300 cells counted. 
 
In order to detect changes in gene expression in response to DNA damage, RNA was extracted 
from primary skin fibroblasts from both C57BL/6 mice, and NMRs treated with camptothecin, 
chromium (vi) oxide or control conditions after 8 and 48 hours. These time points were selected to 
allow detection of changes in the response over time.   
Due to low cell numbers (due to early contact inhibition and slow growth) lower amounts of 
RNA were obtained from NMR samples (Table 4.2). Additionally, variation was seen between different 
cell cultures and treatments. This may reflect variations between the cell lines, variations in conditions 
within the incubator or variations in the RNA extraction. Lower levels of starting material mean that 
genes with very low levels of expression may be lost and hence the assay becomes less sensitive. We 
proceeded with these lower amounts of RNA as we wished to use primary cells that had undergone 
as few cell passages as possible to ensure the cells represented their in vivo counterparts as best as 
possible. Dilution of the RNA to equal concentrations was performed prior to the analysis to minimise 
this as a source of variation within the data. In future work, this variation in RNA could be avoided by 
counting the number of cells before RNA extraction and using the same number for each extraction. 
Any differences in RNA yield observed under these conditions would indicate species variation in 
either RNA content of the cells or the cells’ ability to be purified by the method used. Furthermore, if 
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work were to be repeated the incubator used would be heat mapped when empty and at varying 
levels of full. This would assess possible sources of variation and a maximum safe-fill level in which air 
circulation is still possible to facilitate consistent temperatures. 
Table 4.2. The total RNA extracted from each primary cell culture and condition (ng).  
Key, cam-camptothecin, chro-chromium (vi) oxide, con-control. 
    Mouse     NMR     
    Culture 1 Culture 2 Culture 3 Culture 1 Culture 2 Culture 3 
8hr cam 5,314 2,898 1,385 1,361 1,666.8 493 
  chro 3,924 1,783 3,580 1,692 1,890 718 
  con 5,171 5,035 9,044 1,208 1,070 472 
48hr cam 9,698 10,639 2,040 1,741 1,828 276 
  chro 5,656 9,264 1,175 1,559 1,280 453 
  con 14,414 15,163 2,848 1,841 986 511 
 
To assess the quality of the RNA, samples were input into a 2100 Bioanalyzer (Agilent 
technologies). The Bioanalyzer assesses RNA quality by analysing the ratio of small to large RNA 
products as well as the ratio of ribosomal subunits RNA (28S:18S) and assigns an RNA integrity number 
(RIN score). A large proportion of small RNA molecules indicate sample degradation which is reflected 
by a lower RIN score. Sample degradation affects measurements of gene expression and can reduce 
library complexity (419). The RNA samples can be displayed graphically by plotting the size of the RNA 
in nucleotides (nt) against fluorescence units (FU); the greater the FU, the greater the volume present 
(Figure 4.2). By doing this, we can see that the samples are dominated by RNA fragments of a given 
length. This is the ribosomal RNA. This RNA is visibly different between NMR and mouse. In mouse, 
there were two clear peaks representing the 18s and 28s ribosomal subunits (Figure 4.2). However, in 
NMR we saw at least 3 peaks (Figure 4.3). In the NMR the 28s ribosomal subunit is divided into two 
unequal sized fragments reported to be 2,500nt and 3,000nt (177). The software incorrectly identifies 
the peaks in all NMR samples resulting in inaccurate RIN scores. As such RIN scores (Table 4.3) were 
only used as an indicator of RNA integrity for NMR samples and the Bioanalyzer traces were used to 
decide which samples were intact. The peak representing the 18s subunit was likely the peak to the 
left of the one mislabelled as 18s (labelled with #) (Figure 4.3). The peak labelled at 18s is likely a 
component of the 28s subunit as well as the peak to the right of this (labelled with *).  
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Figure 4.2. Fragment size plot by 2100 Bioanalyzer of mouse RNA samples. Fragment size in 
nucleotides (nt) plot against fluorescent units (FU). Representative graph of control samples of the 
Mouse 2 primary cell culture (alpha cell stock). 
 
 
Figure 4.3. Fragment size plot by 2100 Bioanalyzer of NMR RNA samples. Fragment size in 
nucleotides (nt) plot against fluorescent units (FU). Representative graph of control samples of the 
NMR 2 primary cell culture (alpha cell stock). The peaks are mislabelled in the graph; stars (*) 
indicates peaks representing the two 28s ribosomal subunits, hash (#) indicates the peak 
representing the 18s ribosomal subunit. 
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Table 4.3. RIN scores calculated by the 2100 Bioanalyzer. All NMR scores are inaccurate due to 
misidentification of the peaks representing the 18S and 28S ribosomal subunits due to NMR 28S 
being divided in two. Key, cam-camptothecin, chro-chromium (vi) oxide, con-control, dash (-) 
indicates no score was generated. 
    Mouse     NMR     
    Culture 1 Culture 2 Culture 3 Culture 1 Culture 2 Culture 3 
8hr cam 8.6 9 9.6 7 - 7.7 
  chro 8.2 8.2 9.2 6.8 - 3.9 
  con 8.5 8.2 9.5 8 - 6 
48hr cam 8.3 9.3 8.8 7 - 5 
  chro 9.1 8.1 9.6 8.9 7.9 6.7 
  con 7.8 9.4 9.2 7.2 7.3 5.8 
 
In mammalian cells rRNA accounts for 90% of the total cellular RNA (420). As we aimed to look 
at changes in gene expression, rRNA was removed from the samples to enrich them for mRNA. As 
NMR’s 28S is naturally fragmented into two species and due to low starting amounts of RNA a 
RiboZero™ Gold Kit (illumina) was used. To determine the effectiveness of this removal the samples 
were analysed in a 2100 Bioanalyzer again (Figure 4.4-4.5). From these graphs, we can see both the 
18s and all 28s peaks are greatly reduced meaning the samples are enriched for mRNA. 
 
Figure 4.4. Fragment size plot by 2100 Bioanalyzer of mouse RNA samples post-ribo depletion. 
Fragment size in nucleotides (nt) plot against fluorescent units (FU). Representative graph of control 
samples of the Mouse 2 primary cell culture (alpha cell stock). 
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Figure 4.5. Fragment size plot by 2100 Bioanalyzer of NMR RNA samples post-ribo depletion. 
Fragment size in nucleotides (nt) plot against fluorescent units (FU). Representative graph of control 
samples of the NMR 2 primary cell culture (alpha cell stock). 
4.4.2 Data analysis 
A total of 41,234 mouse genes and 30,556 NMR genes were sequenced as part of the RNAseq 
analysis, of these 12,508 homologous genes were found between NMR and mouse. The total number 
of reads sequenced for each sample is given in Table 4.4. The predicted coverage calculated by the 
formula ‘average read length multiplied by the number of reads divided by the haploid genome length’ 
is given in Table 4.5. The percentage of reads mapped to the appropriate genome is given in Table 4.6. 
 
Table 4.4. The number of reads sequenced on a HiSeq 2,500 at 2x50bp paired-end sequencing in the 
rapid run mode as part of the RNAseq analysis for each condition and cell culture. The average read 
length over all samples was 386bp with an average concentration of 26.9ng/µl. Key, con – control, 
cam – camptothecin, chro – chromium.  
    Mouse     NMR     
    Culture 1 Culture 2 Culture 3 Culture 1 Culture 2 Culture 3 
8hr cam 23,254,806 18,275,002 23,017,315 27,269,161 22,194,735 21,348,897 
  chro 21,108,723 24,156,943 22,954,573 25,561,563 22,330,800 22,787,996 
  con 25,150,051 19,292,317 19,714,514 26,709,122 22,014,809 20,170,712 
48hr cam 27,212,040 18,304,740 22,043,113 22,154,439 25,051,295 22,416,515 
  chro 20,766,259 18,149,393 25,431,317 23,090,066 24,870,279 18,705,381 
  con 26,912,903 21,664,828 25,936,412 23,457,149 25,308,882 16,437,557 
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Table 4.5. The predicted coverage for each sample. This was calculated by the formula: average read 
length multiplied by the number of reads (Table 4.4) divided by the haploid genome length (Mouse 
(GRCm38): 2,730,855,475bp, NMR (HetGla_female_1.0): 2,314,771,103bp). Key, con – control, cam – 
camptothecin, chro – chromium.  
    Mouse     NMR     
    Culture 1 Culture 2 Culture 3 Culture 1 Culture 2 Culture 3 
8hr cam 3.2 2.5 3.2 4.0 3.3 3.2 
  chro 2.9 3.3 3.2 3.8 3.3 3.4 
  con 3.5 2.7 2.7 4.0 3.3 3.0 
48hr cam 3.8 2.5 3.0 3.3 3.7 3.3 
  chro 2.9 2.5 3.5 3.4 3.7 2.8 
  con 3.7 3.0 3.6 3.5 3.8 2.4 
 
 
Table 4.6. The percentage of reads sequenced on a HiSeq 2,500 at 2x50bp paired-end sequencing in 
the rapid run mode as part of the RNAseq analysis that successfully mapped to either the mouse 
(GRCm38) or NMR (HetGla_female_1.0) genome. Total number of reads given in Table 4.4. Key, con – 
control, cam – camptothecin, chro – chromium.  
    Mouse     NMR     
    Culture 1 Culture 2 Culture 3 Culture 1 Culture 2 Culture 3 
8hr cam 86.0% 86.8% 88.9% 92.7% 92.1% 86.2% 
  chro 86.7% 88.6% 89.1% 92.4% 92.8% 85.6% 
  con 86.2% 88.4% 89.8% 92.6% 93.4% 87.0 % 
48hr cam 87.5% 87.8% 89.1% 92.5% 92.5% 87.1% 
  chro 87.8% 88.2% 87.7% 92.5% 92.1% 85.4% 
  con 87.6% 87.5% 88.9% 93.0 % 92.5% 85.5% 
 
The variation between primary cell cultures of the same species appeared greater than the 
variation between treatments, particularly in the naked mole rat. This is shown more clearly in a PCA 
plot (Figure 4.6-4.8). When all samples were considered, we saw a large separation between NMR and 
mouse samples as expected for two distanced species (Figure 4.6). However, even at this scale, we 
saw two distinct clusters for NMR samples (Figure 4.6) one made up of NMR cell line 1 and 3 and the 
other made up of NMR cell line 2 samples (Appendix Figure 9). By looking at each species separately, 
we saw three clusters, each one representing an individual primary cell culture (Figures 4.6-4.7). This 
would seem to suggest that variation between individuals of the same species is greater than the 
variation induced by treatment. This is unexpected as B6 mice, like most inbred mouse strains, are 
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almost completely genetically homogeneous (421). Similarly, NMRs from the same colony (as our cell 
donors were) are highly similar genetically due to inbreeding and colonies being predominantly made 
up of siblings (422, 423). Additionally, animals of the same species were likely housed in very similar 
conditions and so environmental effects on the epigenetics of the cell would likely be similar. NMRs 
do show variations within colonies with their position in the colony hierarchy which correlates with 
both body mass and testosterone levels, varying between animals which may account for some 
variation seen in the gene expression (424). If this is the case then based on these plots the NMR from 
which NMR cell line 2 was derived may have had a different position in the hierarchy, may have been 
mis-aged or potentially undergoing some stress such as injuries caused by bites which are common 
within NMR colonies which may explain its apparent dissimilarity from the other cell lines. However, 
the remaining cell lines also showed dissimilarity and so all cell lines will be kept within the analysis as 
no one cell line can be considered ‘wrong’ or unusual.  
 
 
Figure 4.6. PCA plot of RNAseq data for all samples. Each dot represents a single RNA sample used in 
the analysis. Mouse samples seem to form one large cluster on the left and NMR samples from two 
distanced clusters on the far right with NMR cell lines 1 and 3 making up the top cluster and NMR cell 
line 2 making up the bottom cluster (alpha cell stock). Key con - control, cam - camptothecin 
treatment, chro – chromium (vi) oxide treatment. PCA plot generated in R (332). 
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Figure 4.7. PCA plot of RNAseq data for NMR samples (alpha cell stock). Each dot represents a single 
RNA sample used in the analysis. There are three tight clusters which each represent a different 
primary cell culture (circled). They are labelled with which cell line they represent (NMR 1, 2 and 3). 
This shows far greater variation between primary cell cultures than treatments. Key con - control, 
cam - camptothecin treatment, chro – chromium (vi) oxide treatment. PCA plot generated in R (332). 
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Figure 4.8. PCA plot of RNAseq data for mouse samples (alpha cell stock). Each dot represents a 
single RNA sample used in the analysis. There are three loose clusters which each represent a 
different primary cell culture (circled). They are labelled with which cell line they represent (mouse 1, 
2 and 3). This shows greater variation between primary cell cultures than treatments. Key con - 
control, cam – camptothecin treatment, chro – chromium (vi) oxide treatment. PCA plot generated in 
R (332). 
4.4.2.1 Differential expression between treatments 
Deseq (407) was initially used to analyse the RNAseq data. As the variation in gene expression 
between primary cell cultures of the same species was greater than the variation caused by treatment 
with the DNA-damaging compounds, conventional methods of analysis indicated that only one gene 
was near significantly different (p<0.8 after multiple testing correction) between treatments. This was 
Ifit1 (Interferon-Induced Protein with Tetratricopeptide Repeats 1) in mouse cells after 48 hours post 
camptothecin treatment. Comparisons between species, however, yielded many significant genes (on 
average 6,635 genes between all treatments with a p-value less than p=0.05 after correcting for 
multiple testing). Deseq2 (416) was also used as this is thought to be less stringent and hence have a 
reduced type two error. This seemed to be the case as we find more genes with p-values of p<0.1 after 
multiple testing correction. In NMR cells there was only one gene significantly downregulated at the 
0.1 level, and that was R3hcc1 at 48 hours post camptothecin treatment. The only other gene that 
Mouse 2 
Mouse 1 
Mouse 3 
128 
 
nears this level of significance in NMR was the extracellular matrix protein TNC (Tenascin C) with an 
adjusted p-value of p<0.5, which was also downregulated. In mouse cells, three genes were significant 
at the 0.1 level. Ifit1 and Pmaip1 (Phorbol-12-Myristate-13-Acetate-Induced Protein 1) were both 
upregulated at 48 hours post camptothecin treatment, and Cenpf (Centromere Protein F) was 
downregulated at 8 hours post camptothecin treatment. 
R3hcc1 is a poorly studied gene. GO annotations related to this gene include nucleotide 
binding and nucleic acid binding suggesting a role in the nucleus. These terms are derived from the 
presence of an R3H motif in the protein; this motif is thought to bind nucleic acids (425).  
To overcome the issue of variability and extract useful information from the data, the fold 
change between control and treated samples were analysed for each primary cell culture separately. 
Genes were then selected as DE if they showed a fold change of at least 1.5 in at least two of the three 
primary cell cultures providing that the third did not show a fold change of 1.5 or more in the opposite 
direction. 
We saw a much larger difference in gene expression in all mouse comparisons compared to 
those in NMR (Table 4.7-4.8). This may be in part due to the lower amounts of RNA obtained from 
NMR samples (Table 4.2). 
 
Table 4.7. Genes up (↑) or down (↓) regulated in NMR between the listed conditions (left) and the 
number of these genes present in DAVID (right). Comparisons are in the form row vs. column.  
NMR  Camptothecin 
8hr 
Chromium 
8hr 
Control 
48hr 
Camptothecin 
48hr 
Chromium 
48hr 
Control 8hr 262/150↑ 
321/210↓ 
259/157↑ 
212/97↓ 
434/267↑ 
442/308↓ 
  
Camptothecin 8hr  365/239↑ 
286/149↓ 
 988/690↑ 
616/414↓ 
 
Chromium 8hr     590/313↑ 
752/534↓ 
Control 48hr    565/373↑ 
537/376↓ 
214/102↑ 
236/130↓ 
Camptothecin 
48hr 
    284/160↑ 
527/361↓ 
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Table 4.8. Genes up (↑) or down (↓) regulated in mouse between the listed conditions (left) and the 
number of these genes present in DAVID (right). Comparisons are in the form row vs. column. 
Mouse Up  Camptothecin 
8hr 
Chromium 
8hr 
Control 48hr Camptothecin 
48hr 
Chromium 
48hr 
Control 8hr 514/421↑ 
710/599↓ 
656/546↑ 
664/568↓ 
1,164/1,042↑ 
1,114 /958↓ 
  
Camptothecin 8hr  744/638↑ 
549/470↓ 
 1,749/1,571↑ 
791/665↓ 
 
Chromium 8hr     559/491↑ 
490/394↓ 
Control 48hr    973/854↑ 
422/362↓ 
454/371↑ 
518/471↓ 
Camptothecin 
48hr 
    687/556↑ 
1,349/1,208↓ 
 
To get an overview of how the cells respond, a functional enrichment (FE) analysis was 
performed on differentially expressed genes between control and treated cells using DAVID 6.7 with 
all homologous genes as the background and otherwise default parameters (330, 426). This tool 
groups similar genes into clusters based on factors such as Gene Ontology (GO) terms. These clusters 
are assigned a score based on the significance of the terms within the group. The greater the score, 
the more enriched the group. A score of 1.3 is equivalent to a p-value of p=0.05 (330).  
The functional enrichment reflected these lower number of genes as each NMR comparison 
had fewer enriched terms with some conditions having no terms enriched at all. The number of genes 
was further reduced as many NMR genes have not been annotated and hence have no mouse 
homologues. Additionally, not all known mouse genes are within the DAVID database. The final 
number of genes analysed by DAVID is given in Tables 4.7-4.8. 
When comparing control to camptothecin or chromium (vi) oxide treated NMR cells after 8 
hours there were no individual terms enriched to a statistically significant degree except for 
downregulated genes in camptothecin-treated cells (Table 4.9).  
Mouse cells treated with either camptothecin or chromium (vi) oxide showed a clear stress 
response at the 8-hour time point in upregulated genes (Table 4.10). We saw terms regarding the 
mitochondrial envelope being upregulated which hints at an apoptotic response in both treatments 
with chromium treatment also showing the term ‘xenobiotic metabolic process’, clearly indicating a 
response to the xenobiotic hexavalent chromium. Additionally, both conditions show a cluster 
referring to the ribosome with camptothecin also showing terms for transcription indicating that new 
proteins are being generated to either replace damaged ones or to facilitate changes in cellular 
activity.  
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In 8-hour camptothecin treatment of mouse cells, all of the top 5 downregulated FE clusters 
appear to be related to cell cycle progression, specifically mitosis, either directly referring to the 
process, or indirectly referring to specific aspects of mitosis such as spindle formation or the motor 
proteins involved in chromosome segregation. In chromium treatment at the 8-hour time point, we 
saw a cluster of terms regarding the downregulation of transcription which matches the upregulation 
of transcription we see in camptothecin. We do not, however, see any terms related to cell cycle or 
cell division directly, with terms regarding cytoskeleton appearing but not in the top 5 terms. What 
we did see was the terms Pleckstrin homology and SH3. These protein domains are found in many 
proteins involved in signal transduction or the cytoskeleton (427, 428). Additionally, a number of 
terms regarding GTPase activity were seen which tie in with one of the top five enriched terms 
GO:0030695~GTPase regulator activity. GTPases are involved in a wide array of signalling pathways. 
At 48 hours the similarity between treatments breaks down. Camptothecin-treated cells 
appear to still be under stress from the treatment with upregulation of a term regarding apoptosis 
and downregulation of terms regarding cell cycle and DNA replication. Strangely the term ‘DNA repair’ 
was also downregulated suggesting that a DNA damage response is winding down. Both treatments 
showed upregulation of the term glycoprotein and cell adhesion indicating changes at the cell surface. 
Chromium treatment otherwise appears to have elicited a somewhat different response as we did not 
see any downregulation of terms regarding the cell cycle but instead saw a term regarding the immune 
system indicating that the stress response was turning down. 
In NMR we saw a very different response after 8 hours. No terms from upregulated genes in 
either camptothecin or chromium treated cells were statistically significant after FDR correction, but 
some still had high enrichment scores (≥1.3) (330). There were no terms related to apoptosis as in 
mouse, but chromium treated cells did show a term regarding transcription similar to what we saw in 
mouse cells. However, the enrichment score was very low (<1.3) (Table 4.9). In camptothecin 
treatment, we saw a number of terms regarding the cell membrane which may suggest an alternative 
method of cellular protection from harsh external stimuli. The term ‘glycoproteins’ appeared in both 
treatments; glycoproteins are typically located at the cell surface supporting the idea for changes at 
the cell membrane. Chromium treatment showed the term ‘GO:0007188~G-protein signalling, 
coupled to cAMP nucleotide second messenger’ which may indicate cell signalling. Additionally, 
chromium showed the term ‘DNA-binding region:T-box’ at 8 hours post-treatment, however, this 
entire cluster only contained 3 genes. Camptothecin treatment resulted in the downregulation of 
terms regarding the cell membrane which taken with the upregulated terms indicating the same, 
suggest a major remodelling at the membrane. Chromium treatment seemed to have a similar effect 
with one term for the cell membrane. Both treatments show the term ‘IPR007110:Immunoglobulin-
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like’ as downregulated. This may indicate that an immediate stress response is ending at this early 
time point as these genes are downregulated to compensate for earlier high expression or that these 
cells are decreasing these genes as part of the initial stress response. 
At 48 hours in NMR cells, we saw something of a continuation of the response seen at 8 hours. 
Terms regarding the cell membrane were both up and downregulated in camptothecin-treated cells, 
and a downregulation of terms regarding the immune system was still seen. There was increased 
evidence of a stress response with the term ‘GO:0006955~immune response’ upregulated in 
camptothecin treatment and ‘GO:0009611~response to wounding’ upregulated in chromium 
treatment. This could suggest there was a delayed stress response that appears only later on, or that 
there was a prolonged stress response that was simply not detected at the earlier time point. 
Chromium treatment resulted in changes of expression of terms which may indicate cell membrane 
changes such as ‘GO:0060350~endochondral bone morphogenesis’ and ‘cognition’. Additionally, the 
term ‘GO:0005509~calcium ion binding’ may indicate changes in signalling as calcium ions often serve 
as cellular messengers. 
Clusters of terms involving glycoproteins and cell membrane frequently appeared in many of 
the conditions under study. This is similar to what is seen in Cordeiro et al.’s study (429) that exposed 
endothelial cells to ethylene glycol and performed a microarray analysis. The similarity in these 
profiles indicates a generalised stress response. As glycoproteins are frequently components of the 
plasma membrane, these terms indicate a focus at the cells’ surface. This could indicate a cellular 
response of preventing entry or removing the damaging agents. This was observed more prevalently 
in NMR cells. 
We can see from Table 4.7 and 4.8 that simply allowing cells to grow under control conditions 
for an additional 40 hours resulted in changes in gene expression. Functional enrichment was applied 
to these differentially expressed genes (Table 4.11). 
NMR cells showed no significantly enriched terms after 48 hours culture for upregulated 
genes. However, several functional enrichment clusters showed scores greater than 1.3. These 
included the term glycoprotein and terms relating to the plasma membrane that we saw for 
downregulated genes also. These terms were seen frequently enriched in response to the genotoxic 
treatments. This could suggest that this extended culture time could be harmful to the cells, possibly 
due to some depletion of nutrients in the media or build-up of toxic by-products. The fact that these 
terms are still enriched in the treatments at 48 hours would suggest further changes in such gene 
expression. It also suggests that such changes in gene expression require very little in term of stimulus 
to occur as the change in condition between 8 and 48 hours is likely to be very small relative to 
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treatment at an apparent LD50 dose of genotoxin. In addition, we saw upregulated terms enriched for 
the innate immune response including ‘Toll-like receptor signalling pathway’ and ‘innate immune 
response’ which may suggest a general stress response. The most upregulated gene was Efna5 (Ephrin 
A5) with an average fold change of 7.4 (upregulated in cell line 2 and 3). Efna5 encodes a surface-
bound protein that has been shown to be involved in bidirectional communication between cells and 
cell adhesion (430), likely contributing to the cell adhesion associated transcription profile discussed 
above. The most downregulated gene was Fam135b (family with sequence similarity 135 member B) 
with an average fold change of 0.08 (downregulated in cell line 1 and 3). Fam135b encodes a protein 
with no known function that has been associated with Oesophageal cancer in one study (431). It is not 
clear what role this gene has in the present study. 
Mouse cells showed enrichment for cell-surface-related genes in both up and downregulated 
genes. This enrichment of cell surface and adhesion genes was similar to what we saw in NMR cells 
exposed to the genotoxic treatment and a stark contrast to the profile we saw in mouse cells exposed 
to such stress, which showed terms more focused around apoptosis and DNA damage. This may 
indicate that the treatment is too stressful so that we go beyond this cell surface response and see 
more internal responses such as apoptosis and that the stress encountered from the increased culture 
time was less harmful and hence only this cell surface response is seen. Alternatively, the cells may 
just act differently over time, secreting extracellular proteins to make their environment more like 
they would experience naturally within an animal, particularly as a later time point may mean a higher 
cell density and hence more interaction and contact between the cells within the population. Terms 
relating to DNA damage repair and DNA replication being upregulated may indicate a stress response 
(the repair and replacement of damaged DNA) or may relate to DNA replication to produce new cells 
and may indicate that at the 8-hour time point the cells are still adjusting to their relatively new 
surrounding and hence are not yet dividing at as fast a rate. The most upregulated gene between 
these samples was Gas1 (Growth arrest-specific protein 1) with an average fold change of 21.9 
(upregulated in all cell lines). Gas1 prevents cellular proliferation to keep cells in G0 (432), indicating 
growth arrest in these cells which suggests that the observed gene expression profile was a result of 
stress. The most downregulated gene was Ostn (Osteocrin) with an average fold change of 0.04 (cell 
line 2 and 3). Ostn is a poorly studied gene that has been shown to act as a secreted signalling molecule 
in both the brain to regulate neuronal activity and in bones to regulate bone formation (433, 434). 
This may play into the idea that there are more cells to communicate with, though without knowing 
what role this gene plays in fibroblasts, it is difficult to speculate on its function here.  
As a follow up to these findings, an additional gene expression analysis could be performed 
over a simple time course, following the cells to assess how this gene expression changes. I would 
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hypothesis that three distinguishable profiles would be observed: an early profile associated with the 
cells adapting to the new surroundings, an intermediate profile in which the cells are growing 
optimally in the environment and an end profile in which overcrowding, depletion of nutrients and/or 
build-up of toxins results in a decline in growth and a shift towards senescence and apoptosis. Such a 
time course would help to identify time periods of stable gene expression and allow for more accurate 
evaluation of gene variation over time in response to our stimulus of study. As comparisons are 
between the controls at each time point and the treated cells at that time point, differences over time 
in untreated cells should be accounted for.  
A Venn diagram of homologous genes that are differentially expressed between 8 and 48 
hours of control treatment was generated (Figure 4.9). There is some commonality with 33 genes 
upregulated and 46 genes downregulated in both NMR and mice. Interestingly there were 28 genes 
upregulated and 11 genes downregulated in mice that show the opposite change in gene expression 
in NMRs. Performing a functional enrichment on these genes did not give statistically significant 
results due to the small sample size but did allow us to see that these genes downregulated in NMR 
but upregulated in mice were related to the terms such as ‘Glycoprotein’ and ‘cell membrane’. The 
genes upregulated in NMR but downregulated in mice relate to terms including ‘glycoprotein’, ‘cell 
membrane’ and ‘DNA binding’. This further supports the idea of differences at the cell membrane 
between these two species. 
In summary, mouse cells appeared to undergo changes in biological activity that changed 
between treatments over time as can be seen by differences in enriched terms between 8 and 48 
hours post stimuli between the two treatments. NMR cells, however, seemed more consistent with 
their response over time. Overall, the predominant activity in mouse cells seemed to indicate that 
initially the cells were becoming apoptotic and eliciting a stress response while exiting the cell cycle. 
Though this appeared to continue, we also saw a remodelling of the cell surface and a reduction in 
repair and immune terms indicating that the response to the stressors was ending. NMR cells however 
primarily showed remodelling of the cell membrane that continued through the observed time points. 
This response includes terms and genes involved in both cell adhesion and cell signalling. As this 
response was seen to a lesser extent at the later time point in mouse it may be that this membrane 
response being elicited greater and faster helps to protect the cell more readily from incoming 
damage.  
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Table 4.9. Functional enrichment (FE) results for NMR data. Representative terms from the top five FE 
clusters, with corresponding gene counts and FDR-corrected probability values and the enrichment 
score for the cluster. Terms were selected that best represented all the terms in the cluster, of these 
the term with the highest gene count and lowest FDR score was reported. 
NMR Term  Count FDR Enrichment 
Score 
Control vs. 
Camptothecin up 
8hr 
glycoprotein 44 4.45 2.25 
GO:0044459~plasma membrane part 26 3.86 2.14 
GO:0016021~integral to membrane 50 20.85 1.54 
GO:0008146~sulfotransferase activity 4 10.47 1.48 
GO:0044459~plasma membrane part 26 3.86 1.39 
Control vs. 
Camptothecin 
down 8hr 
GO:0031224~intrinsic to membrane 88 <0.001 5.87 
topological domain:Extracellular 56 <0.001 5.33 
GO:0044456~synapse part 15 0.0028 3.51 
IPR007110:Immunoglobulin-like 17 0.011 3.04 
GO:0045202~synapse 18 0.0044 2.77 
Control vs. 
Chromium (vi) 
oxide up 8hr 
DNA-binding region:T-box 3 14.94 1.87 
GO:0007188~G-protein signalling, coupled 
to cAMP nucleotide second messenger 5 2.09 
1.57 
Glycoprotein 44 10.49 1.47 
GO:0003700~transcription factor activity 15 9.57 1.22 
GO:0044459~plasma membrane part 22 22.81 1.21 
Control vs. 
Chromium (vi) 
oxide down 8hr 
PIRSF001630:serpin 3 9.19 1.42 
GO:0031224~intrinsic to membrane 32 5.83 1.35 
IPR007110:Immunoglobulin-like 7 14.43 1.27 
GO:0006821~chloride transport 3 43.17 1.15 
Glycoprotein 29 12.31 1.10 
Control vs. 
Camptothecin up 
48hr 
Glycoprotein 121 <0.001 4.92 
cell membrane (including ‘glycoprotein’) 64 0.01 4.16 
GO:0031226~intrinsic to plasma membrane 22 <0.001 2.03 
IPR000859:CUB 7 2.81 1.83 
GO:0006955~immune response 21 0.39 1.68 
Control vs. 
Camptothecin 
down 48hr 
GO:0007155~cell adhesion 49 <0.001 10.45 
signal peptide 117 <0.001 8.75 
Glycoprotein 136 <0.001 6.55 
IPR003961:Fibronectin, type III 20 <0.001 4.32 
IPR007110:Immunoglobulin-like 27 <0.001 3.79 
Control vs. 
Chromium (vi) 
oxide up 48hr 
Glycoprotein 33 5.67 2.42 
GO:0009611~response to wounding 7 23.19 1.65 
GO:0050877~neurological system process 11 3.90 1.62 
Cognition 8 8.21 1.55 
GO:0044421~extracellular region part 13 1.27 1.49 
Control vs. 
Chromium (vi) 
oxide down 48hr 
disulfide bond 32 <0.001 2.35 
IPR006026:Peptidase, metallopeptidases 4 <0.001 1.44 
GO:0005509~calcium ion binding 16 2.41 1.26 
GO:0060350~endochondral bone 
morphogenesis 3 16.92 
1.17 
GO:0050890~cognition 6 86.43 1.05 
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Table 4.10 Functional enrichment (FE) results for mouse data. Representative terms from the top five 
FE clusters, with corresponding gene counts and FDR-corrected probability values and the enrichment 
score for the cluster. Terms were selected that best represented all the terms in the cluster, of these 
the term with the highest gene count and lowest FDR score was reported. 
Mouse Term  Count FDR Enrichment Score 
Control vs. 
Camptothecin up 
8hr 
GO:0005740~mitochondrial envelope 19 0.16 2.66 
mmu03010:Ribosome 10 0.07 2.5 
growth factor 10 1.10 2.26 
GO:0006350~transcription 54 0.45 2.11 
GO:0008270~zinc ion binding 59 1.29 1.84 
Control vs. 
Camptothecin 
down 8hr 
GO:0000279~M phase 42 <0.001 15.96 
GO:0005856~cytoskeleton 67 <0.001 8.00 
mmu04110:Cell cycle 15 0.005 4.46 
IPR001752:Kinesin, motor region 10 0.004 4.28 
GO:0005694~chromosome 28 0.005 3.80 
Control vs. 
Chromium (vi) 
oxide up 8hr 
mmu03010:Ribosome 22 <0.001 9.72 
GO:0005198~structural molecule activity 30 0.002 3.27 
GO:0044455~mitochondrial membrane part 9 0.04 2.98 
GO:0044455~mitochondrial membrane part 9 0.04 2.78 
GO:0006805~xenobiotic metabolic process 4 5.68 1.88 
Control vs. 
Chromium (vi) 
oxide down 8hr 
GO:0005925~focal adhesion 13 <0.001 5.16 
IPR001849:Pleckstrin homology 20 0.12 3.54 
domain:SH3 15 0.48 3.14 
GO:0030695~GTPase regulator activity 28 0.001 3.01 
GO:0016481~negative regulation of 
transcription 23 0.50 
3.00 
Control vs. 
Camptothecin up 
48hr 
Glycoprotein 202 <0.001 5.49 
GO:0044421~extracellular region part 62 <0.001 4.52 
IPR011993:Pleckstrin homology-type 28 0.057 3.96 
GO:0007155~cell adhesion 40 0.27 3.08 
GO:0043068~positive regulation of 
programmed cell death 25 0.04 
2.82 
Control vs. 
Camptothecin 
down 48hr 
GO:0005694~chromosome 61 <0.001 18.79 
GO:0007049~cell cycle 55 <0.001 14.76 
GO:0006260~DNA replication 27 <0.001 14.45 
GO:0006281~DNA repair 26 <0.001 11.61 
GO:0000775~chromosome, centromeric 
region 19 <0.001 
6.89 
Control vs. 
Chromium (vi) 
oxide up 48hr 
cell adhesion 16 2.85 2.15 
Glycoprotein 88 0.25 1.76 
IPR005816:Secreted growth factor Wnt protein 4 5.54 1.72 
lipid synthesis 7 8.65 1.67 
GO:0051781~positive regulation of cell division 5 5.56 1.54 
Control vs. 
Chromium (vi) 
oxide down 48hr 
Glycoprotein 139 <0.001 8.57 
GO:0044421~extracellular region part 53 <0.001 8.55 
GO:0030247~polysaccharide binding 13 0.05 3.56 
GO:0044420~extracellular matrix part 11 0.05 3.05 
GO:0006955~immune response 27 0.02 2.65 
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Table 4.11 Functional enrichment (FE) results for NMR and Mouse data for 8-hour vs. 48-hour control 
samples. Representative terms from the top five FE clusters, with corresponding gene counts and 
FDR-corrected probability values and the enrichment score for the cluster. Terms were selected that 
best represented all the terms in the cluster, of these the term with the highest gene count and 
lowest FDR score was reported. 
Species Comparison Term Count FDR 
Enrichment 
score 
    
mmu04620:Toll-like receptor signalling 
pathway 8 0.12 2.09 
  
8hr control vs. 
48hr control up GO:0005886~plasma membrane 67 0.58 1.75 
    Glycoprotein 63 3.34 1.57 
    mmu04380:Osteoclast differentiation 8 0.86 1.56 
NMR   GO:0045087~innate immune response 10 12.61 1.45 
    Glycoprotein 101 <0.001 5.85 
  
8hr control vs. 
48hr control down Cell membrane 71 <0.01 3.59 
    GO:0030054~cell junction 27 1.25 2.62 
    GO:0045211~postsynaptic membrane 13 1.19 2.52 
    GO:0006811~ion transport 22 2.61 1.93 
    Glycoprotein 223 <0.001 7.41 
  
8hr control vs. 
48hr control up 
GO:0005578~proteinaceous 
extracellular matrix 45 <0.001 6.83 
    GO:0006260~DNA replication 22 <0.01 4.9 
    DNA repair 33 0.04 3.91 
Mouse   Copper 10 0.56 2.73 
    
IPR011993:Pleckstrin homology-like 
domain 41 0.04 3.02 
  
8hr control vs. 
48hr control down SH2 domain 16 0.18 2.99 
    GO:0030054~cell junction 56 0.16 2.68 
    domain:SH3 18 2.16 2.24 
    
GO:0007275~multicellular organism 
development 64 6.11 2.21 
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Figure 4.9 Venn diagram of differentially expressed homologous genes for 8-hour vs. 48-hour control 
comparisons in mouse and NMR (alpha stock). 
 
4.4.2.2 Differential expression between genes with the greatest fold change 
To identify genes with the largest fold change which may have an important role in responding 
to DNA damaging agents, the average fold change was calculated. This was done by averaging the fold 
change for each gene in which 2 or more of the primary cell cultures had at least 10 reads. The 10 
genes with the highest and lowest fold change were selected (Table 4.12). Genes present in the top 
10 genes from more than one condition particularly stand out for further analysis. These were Hoxc10 
(Homeoprotein C10), Pik3r6 (Phosphoinositide-3-Kinase Regulatory Subunit 6), and Muc5ac (Mucin-5 
Subtype AC, Tracheobronchial).  
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Table 4.12. The top 10 up and downregulated NMR genes and the average fold change. Star (*) 
indicates presence in more than one condition. Fold change calculated from normalised treated NMR 
sample read count over normalised untreated NMR sample read count.⁰ indicates genes selected 
based off fold changes from 2 out of 3 cell lines. 
 
 
 
Condition Up Fold change Down Fold change 
cam 8hr 
 
 
 
 
 
 
 
Pcdh10 10.42 Srrm4 -9.09 
Yjefn3 5.59 Nlgn4x -7.69 
Ptchd2 5.40 St8sia1⁰ -6.67 
Hoxc10* 5.11 Fam5c -6.67 
Tlr9⁰ 4.20 Hnf4g -5.88 
Slc16a5 4.13 Ksr2 -5.00 
Rpl3l 3.90 Adarb2 -4.76 
Gimd1⁰ 3.47 Grm1⁰ -4.76 
Pou2af1 3.26 Pik3r6*⁰ -4.55 
Psd2 2.81 Arhgap20⁰ -4.55 
chro 8hr 
 
 
 
 
 
 
 
Zbtb16 11.68 Pik3r6*⁰ -4.17 
Znf536⁰ 9.08 Kcna3 -3.70 
Efna5⁰ 7.55 Rgs1⁰ -3.13 
Nme5⁰ 6.20 Cntn3 -2.78 
Pax3⁰ 5.92 Gltpd2 -2.70 
Prph 5.77 Clca2⁰ -2.70 
Hoxc10* 5.32 Sh3tc2⁰ -2.50 
Tbx22 5.28 Slc35f2⁰ -2.50 
Il3ra 5.09 Tek⁰ -2.38 
Syngap1⁰ 4.95 Serpini1⁰ -2.33 
cam 48hr 
 
 
 
 
 
 
 
Grhl3 10.74 Tmem179⁰ -3.33 
Chst9 9.38 Tjp3 -2.94 
Itgbl1 8.92 Sox5 -2.86 
Clca2 8.75 Lpp -2.78 
Kctd8 8.34 Muc5ac*⁰ -2.70 
Arhgef15⁰ 7.10 Naaladl2 -2.56 
Rab3c 6.89 Glyat -2.56 
Ppp1r1c 6.84 Dpp10 -2.50 
Ddx4⁰ 6.81 Ca2⁰ -2.44 
Fpr1 6.72 Kcnip4 -2.38 
 
chro 48hr 
 
 
 
 
 
 
 
Nrk⁰ 7.18 Muc5ac*⁰ -4.17 
Kiaa0226l⁰ 3.62 Gpr128 -3.23 
Nol4⁰ 3.59 Figf -3.23 
Qrfp⁰ 3.34 Pygm⁰ -3.13 
Gsg1 3.31 Slc9c2⁰ -3.13 
Ubap1l⁰ 3.21 Zic4⁰ -2.94 
Trim55 3.07 Rd3⁰ -2.94 
Serpinb5⁰ 2.95 Cd80 -2.78 
Il36g⁰ 2.93 Scn3b⁰ -2.78 
Sbk2 2.81 Frzb -2.78 
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Hoxc10 encodes one of the hox proteins that are transcription factors involved in the 
development of body axis in the embryo (435). It has been shown in HeLa cells that Hoxc10 undergoes 
changes in expression that correlate with the cell cycle, accumulating in S phase, matching the 
expression of cyclin A (436). Hoxc10 levels are subsequently reduced through ubiquitination and 
proteolysis at the proteasome. If this destruction failed to occur, the transition between metaphase 
and anaphase was delayed indicating that Hoxc10 can act as a cell cycle regulator (436). As Hoxc10 
was upregulated at 8 hours in both treatments, it may be acting to halt the progression of the cell 
cycle to facilitate DNA damage repair (Table 4.12). Hoxc10 only appeared upregulated in mouse cells 
8 hours after camptothecin treatment. It is noteworthy that in Gabellini et al.’s study (436), northern 
blots were also undertaken that showed levels of Hoxc10 mRNA was present at constant levels. 
Perhaps the change in expression seen here allows for fine tuning of this response. 
Pik3r6 was downregulated in both treatments after 8 hours in NMR (Table 4.12). Pik3r6 is a 
PI3K regulator protein thought to particularly regulate the PI3Kᵧ (gamma) form. PI3Kᵧ is thought to act 
on the immune system with PI3Kᵧ mutants and drugs that target PI3Kᵧ reducing inflammatory 
responses in mice (437). PI3K positively regulates cell cycle progression from G1 to S phase and G2 to 
M phase (438). Inhibition of PI3K results in G1 arrest or G2 arrest in synchronised cells when treated 
with the PI3K inhibitor LY294002 at S phase (439, 440).  This may mean cell cycle progression is being 
blocked at either G1 or G2 and hence provide more time for accurate DNA damage repair. PI3K is 
involved in a wide array of signalling pathways that affect cell cycle progression, apoptosis, autophagy 
and DNA damage such as the FOXO or mTOR signalling pathways (441, 442). The downregulation of 
Pik3r6 which is required for PI3Kᵧ signalling may alter the activity of these processes in response to 
genotoxic stress in NMR. Pik3r6 only appeared downregulated in mouse cells 8 hours after 
camptothecin treatment.   
The upregulation of Hoxc10 and downregulation of Pik3r6 and hence potentially Pi3k both 
occurred after 8 hours post stimuli and indicate the cells may have been arresting at either G1 or G2. 
Muc5ac is a major airway mucin that has been shown to be overexpressed in response to 
oxidative stress in human airway epithelial and fibroblasts as a result of ERK1/2 signalling (443). 
Muc5ac is expressed in mouse embryonic fibroblasts (MEFs) in response to a number of toxic stimuli 
(444). This indicates that Muc5ac production is a typical stress response, but what the function of this 
protein would be for skin fibroblasts is not clear. Muc5ac was seen to be downregulated in both 
treatments after 48 hours (Table 4.12). This may indicate that the gene was upregulated at an earlier 
time point other than at 8 hours and hence was then downregulated to compensate for the high 
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protein levels. Alternatively, Muc5ac is constantly expressed and is specifically downregulated at 48 
hours as part of the long-term cellular response.   
To identify genes that may contribute to the NMR’s DNA damage resistance the genes with 
the largest fold change were looked at more thoroughly in the established literature. In addition to 
these genes, any gene that is present in multiple conditions was also assessed. The DE genes between 
control and treated cells were input into venny (445) to produce Venn diagrams of overlapping gene 
expression (Figure 4.10-4.14). This allows us to pick out changes in expression that were specific to 
each treatment and time point and which changes occur as a general stress response in both 
treatments. In NMR cells, there were significantly more DE genes in common between treatments at 
the same time point (median of 9% of the total genes compared) than there were between time points 
under the same treatment (median of 2% of the total genes compared) (U=0.00, p=0.029, N1=N2=4 ). 
This indicates that the time post-treatment determines the cell's response more than the difference 
in genotoxic insult received. The presence of such common genes suggests a core response 
mechanism that changes over time. This does not appear to be the case in mouse cells, as no 
significant difference is observed in the proportion of genes in common between treatments at the 
same time point (median of 9% of the total genes compared) than there were between time points 
under the same treatment (median of 3% of the total genes compared) (U=2, p=0.114, N1=N2=4). 
However, it should be noted that the small sample size reduces the accuracy of this analysis. 
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Figure 4.10. Number of genes that are upregulated between all treatments and time points as 
compared to controls in NMR skin fibroblasts (alpha stock). Abbreviations: cam – camptothecin, chro 
– chromium (vi) oxide, hr – hours. 
 
Figure 4.11. Number of genes that are downregulated between all treatments and time points as 
compared to controls in NMR skin fibroblasts (alpha stock). Abbreviations: cam – camptothecin, chro 
– chromium (vi) oxide, hr – hours. 
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Figure 4.12. Number of genes that are upregulated between all treatments and time points as 
compared to controls in Mouse skin fibroblasts (alpha stock). Abbreviations: cam – camptothecin, 
chro – chromium (vi) oxide, hr – hours. 
 
Figure 4.13. Number of genes that are downregulated between all treatments and time 
points as compared to controls in Mouse skin fibroblasts (alpha stock). Abbreviations: cam – 
camptothecin, chro – chromium (vi) oxide, hr – hours. 
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To identify genes that are important in a general response to genotoxic stress, genes that are 
either up or downregulated in three or more of the conditions and time points were selected (Table 
4.13- 4.14). 
Table 4.13. Upregulated NMR genes present in three or more conditions. Abbreviations: cam – 
camptothecin, chro – chromium (iv) oxide, hr – hours. 
 
 
 
 
 
 
 
 
 
 
 
Table 4.14. Downregulated NMR genes present in three or more conditions. Abbreviations: cam – 
camptothecin, chro – chromium (iv) oxide, hr – hours. 
 
 
 
 
 
 
 
 
 
 
 
Conditions Symbol   Gene name 
cam 8hr, chro 8hr, cam 48hr  
and chro 48hr  Gpr19 
 
G protein-coupled receptor 19 
cam 8hr, chro 8hr and cam 
48hr  
 
 
Ptchd2 patched domain containing 2 
Liph lipase, member H 
Cdkn1a 
cyclin-dependent kinase inhibitor 1A 
(P21) 
chro 8hr, cam 48hr and chro 
48hr  Sag 
S-antigen, retina and pineal gland 
(arrestin) 
cam 8hr, cam 48hr and chro 
48hr  
Slc16a5 solute carrier family 16, member 5 
Rspo1 R-spondin homolog (Xenopus laevis) 
Crabp1 cellular retinoic acid binding protein I 
Conditions Symbol Gene name 
cam 8hr, chro 8hr, cam 48hr 
and Chro 48hr  LOC101708733  
cam 8hr, chro 8hr and cam 
48hr  
 
 
 
 
LOC101726662  
Sox5 SRY (sex determining region Y)-box 5 
Htr2c 
5-hydroxytryptamine (serotonin) 
receptor 2C 
Grik2 
glutamate receptor, ionotropic, 
kainate 2 (beta 2) 
chro 8hr, cam 48hr and chro 
48hr  LOC101711364  
cam 8hr, cam 48hr and chro 
48hr  
Oc90 otoconin 90 
LOC101719188  
LOC101703905  
cam 8hr, chro 8hr and chro 
48hr  
Vstm2b V- containing 2B 
Sox18 
SRY (sex determining region Y)-box 
18 
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Gpr19 (G protein-coupled receptor 19) was the only gene upregulated in all treatments in NMR 
cells (based on 2 out of 3 cell lines in 8-hour chromium treatment). Gpr19 mRNA levels have been 
found to be high in both the germ cell layer of the developing embryo and in some lung cancers (446). 
Additionally, knockdown of Gpr19 mRNA levels depressed cell growth indicating a pro proliferation 
activity (446). However, this knockdown caused cell death in lung cancer cells and resulted in 
polylobed cells which may indicate premature entry into mitosis and hence mitotic catastrophe (446, 
447). This may indicate that Gpr19 may serve as a checkpoint protein prior to mitosis; this is also 
supported by an increase in homologous repair when this gene is knocked down in human cells (448). 
High mRNA levels do not necessarily indicate high activity, and as Gpr19 mRNA levels are regulated by 
the cell cycle, the high levels seen in all treatments may be a result of cell cycle arrest at a point when 
Gpr19 mRNA levels are highly expressed. Gpr19 mRNA expression peaks at s-phase but remains high 
through G2. Taken together these results indicate that NMR cells may be arresting at G2, potentially 
as an effect of Grp19 activity itself. There is also the possibility that high levels of Gpr19 are priming 
the cell to proceed through mitosis if Gpr19 is indeed a pro proliferation gene. Grp19 did not appear 
differentially expressed in any mouse comparisons. 
Cdkn1a (p21) was upregulated after 8 hours in both treatments and after 48 hours in 
camptothecin-treated NMR cells (based on 3 out of 3 cell lines for all samples). Camptothecin 
treatment is known to upregulate p21 and upregulation of p21 provides resistance to camptothecin 
treatment in rat cells (449). It has been shown that p21-/- HCT116 cells have reduced viability when 
treated with hexavalent chromium (450) and BJ-hTERT fibroblasts show increased p21 expression 
after 8 hours post chromium treatment as seen in this study and levels are still elevated after 18 hours 
(451). p21 is a known cell cycle regulator and can induce cell cycle arrest at G1 through interactions 
with CDK1, CDK2, cyclin E and cyclin A (452, 453). Additionally, p21 null MEFs were significantly 
deficient in their ability to arrest growth at G1 in response to DNA damage (454). Arrest at G2 is also 
mediated by p21 by interactions with CDK-activating kinase and cyclin B1 (455, 456). Cyclins A2 and 
B1 degradation is promoted by p21 in response to DNA damage to maintain G2 arrest (457, 458). This 
indicates that NMR may be undergoing cell cycle arrest at either G1 or G2. Additionally, p21 is thought 
to contribute to DNA damage repair directly through interactions with PCNA to control base excision 
repair (BER), nucleotide excision repair (NER) and homologous recombination (459). The localisation 
of p21 in these cells would be interesting to identify, as cytoplasmic p21 protects against apoptosis 
and nuclear p21 may promote apoptosis, temporary cell cycle arrest or irreversible senescence (460, 
461). In mouse cells, upregulation of p21 was only seen in camptothecin treatment at 48 hours (based 
on 2 out of 3 cell lines). 
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Grik2 (glutamate receptor, ionotropic, kainate 2) was downregulated in NMR cells 8 hours post-
treatment with either compound and at 48 hours post camptothecin treatment (based on 2 out of 3 
cell lines in 48-hour camptothecin treatment). In mouse cells, it was only downregulated at 48 hours 
post camptothecin treatment (based on 3 out of 3 cell lines). Grik2 encodes a subunit of a kainate 
glutamate receptor. Grik2 has been shown to be upregulated in p53 -/- mice (462) suggesting that p53 
downregulates Grik2. Grik2 has also been shown to be upregulated in old human skin fibroblasts when 
undergoing cellular stress, more so than younger fibroblasts exposed to the same stress (463). If we 
assume the cellular response of older cells is less effective than that of younger cells, this may suggest 
that decreasing Grik2 levels may be advantageous. Levels of l-glutamate are increased in inflamed 
skin, and hence glutamate signalling may be important for mediating an inflammatory response (464). 
Chronic inflammation has been linked to premature ageing in part through the stabilisation of DNA 
damage (465), and hence alterations in inflammatory responses could be at play in the NMR’s long 
lifespan. Grik2 is predicted to be regulated by various miRNAs which are upregulated in ionising 
radiation and Resveratrol treatment in human cancer cells (466, 467).  
 
Sox5 (SRY (sex determining region Y)-box 5) was downregulated in NMR cells 8 hours post either 
treatment and 48 hours post camptothecin treatment (based on 3 out of 3 cell lines for all samples). 
Sox5 is active during mammalian development where it is thought to regulate proliferation through 
opposing the Wntβ-catenin pathway (468). Downregulation of Sox5 reduced proliferation rates in 
human cancer cells (469). Taken together, these observations indicate that Sox5 can act as a pro-
proliferation gene, which may explain why it would be downregulated in response to the harmful 
stimuli. Sox5 was also downregulated in mouse cells after 8 hours with either treatment (based on 2 
out of 3 cell lines in 8-hour camptothecin treatment). 
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4.4.2.3 Rank product analysis 
An alternative method to identify which genes are important was to find the rank product of 
each gene, essentially ranking the genes in order of fold change size, taking into account the fold 
change of each gene in each primary cell culture. The top 10 genes identified by this ranking are given 
in Table 4.15. These results were similar to the top 10 genes sorted by average fold change as would 
be expected. However, the results do vary, which may highlight important DE genes. One such gene 
was Cdkn1c (Cyclin-Dependent Kinase Inhibitor 1C also known as p57) which was upregulated at 8 
hours in NMR under both treatments. P57 is a multifunctional protein that in part acts as a tumour 
suppressor inhibiting cyclin D1 and CDK2 (470) and hence acts similarly to p21. Of the genes present 
in the top ten genes from both methods Hoxc10 stands out as it is present in the top ten upregulated 
genes at 8 hours in both treatments under both analysis methods.  
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Table 4.14. The top 10 up and downregulated NMR genes identified by rank product analysis. 
Estimated E-values are given. Star (*) indicates presence in more than one condition. Hash (#) 
indicates presence in the top 10 genes based on average fold change counts. Fold changed calculated 
from normalised treated NMR sample read count over normalised untreated NMR sample read 
count.⁰ indicates averages based off fold changes from 2 out of 3 cell lines. 
Condition up E-value down E-value 
cam 8hr 
 
 
 
 
 
 
 
 
 
Pcdh10# 0 Adarb2# 0 
Yjefn3# 0 Grip1 0 
Rpl3l# 0 Zfpm2 0 
Psd2# 0 Kcnh8 0 
Gimd1# 0.1 Fam71e2 0.1 
Cdkn1c 0.4 Pou6f2 0.1 
Ptchd2# 0.5 Sox5*# 0.1 
Onecut2 0.5 Klhl1 0.1 
Hoxc10*# 0.8 Eya1 0.1 
Ckm 1 Erbb4 0.2 
chro 8hr 
 
 
 
 
 
 
 
 
 
Tmem150c 2 Cntn3# 0.2 
Stap1 2.2 Nlgn4x# 0.4 
Fcrla 2.9 Cdh12 1.6 
Panx2 3.7 Ptprr 2.2 
Hoxc10*# 4 Grm1# 2.3 
Fam83e 4.6 Srrm4# 2.9 
Rfx4 4.6 Nell1 3.1 
Tlcd2 4.6 Reln 3.3 
Evpl 6 Sh3gl3 3.9 
Syngap1# 6 Dach1 4.9 
cam 48hr 
 
 
 
 
 
 
 
 
 
Grhl3# 0 Sox5*# 0.1 
Clca2# 0 Lpp# 0.1 
Ascl2 0.1 Dpp10# 0.3 
Col17a1 0.1 Naaladl2# 0.3 
Slc16a5 0.2 Kcnv2 0.3 
Itgbl1# 0.3 Kcnip4# 0.4 
Kcnma1 0.3 Cacna1c 1 
Chst9# 0.4 Adam12 1.1 
Cacna2d4 0.4 Kcnmb2 1 
Ehf 0.4 Kif26b 1.1 
chro 48hr 
 
 
 
 
 
 
 
 
 
Gsg1#⁰ 0.1 Arr3 0.1 
Adcy8 0.4 Cldn6 0.4 
Trim55# 0.4 St6galnac5 0.4 
Gpr19 0.6 Lmx1a 0.6 
Luzp2 1.3 Hdc 0.8 
Masp1 1.4 Mmp25 4.5 
Ptpro 2.6 Lrrc3 4.5 
Znf385b 2.9 Dnhd1 4.7 
Serpinb2 3.1 Coch 4.8 
Cspg5 3.7 Kcnh3 5.4 
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4.4.2.4 Differential expression between genes with high read counts 
Though these genes stand out for their presence in multiple groups, it is important to consider 
the reliability of the data. Small changes in gene expression may well have large and important effects 
but the smaller the number of reads the more likely the difference is simply down to chance. If we 
employed an arbitrary cut off of 500 reads, we found only p21 remains from our selected genes with 
around 1,000-3,000 reads depending on the sample. Sox5, R3hcc1 and Grik2 can also be considered 
as they had only slightly less than 500 with around 100-400 reads in the samples.  
By applying the arbitrary cut off of 500 reads to the whole data set, we can select for genes 
that we are more confident are undergoing the fold change the data suggests (Figure 4.14-4.17). For 
NMR we found a total of 34 genes upregulated and 262 genes downregulated from all conditions. 
With at least 500 reads and in mice we find 399 genes upregulated and 467 downregulated. NMR 
genes DE in more than one treatment were selected (Table 4.16-4.17). Two of these genes, Dpp10 
(Dipeptidyl Peptidase Like 10) and Serpinb2 (Serpin Family B Member 2), were also present in the top 
ten genes selected by the rank product analysis (Table 4.15).  
 
 
Figure 4.14. Number of genes that are upregulated between all treatments and time points as 
compared to controls and have at least 500 reads in NMR skin fibroblasts (alpha stock). 
Abbreviations: cam – camptothecin, chro – chromium (vi) oxide, hr – hours. 
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Figure 4.15. Number of genes that are downregulated between all treatments and time points as 
compared to controls and have at least 500 reads in NMR skin fibroblasts (alpha stock). 
Abbreviations: cam – camptothecin, chro – chromium (vi) oxide, hr – hours. 
 
Figure 4.16. Number of genes that are upregulated between all treatments and time points as 
compared to controls and have at least 500 reads in mouse skin fibroblasts (alpha stock). 
Abbreviations: cam – camptothecin, chro – chromium (vi) oxide, hr – hours. 
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Figure 4.17. Number of genes that are downregulated between all treatments and time points as 
compared to controls and have at least 500 reads in mouse skin fibroblasts (alpha stock). 
Abbreviations: cam – camptothecin, chro – chromium (vi) oxide, hr – hours. 
 
Table 4.16. Upregulated NMR genes present in two or more conditions with at least 500 reads. 
Abbreviations: cam – camptothecin, chro – chromium (iv) oxide, hr – hours. 
Conditions Symbol Gene name 
cam 8hr, chro 8hr, cam 48hr Cdkn1a cyclin-dependent kinase inhibitor 1A (P21) 
cam 8hr, chro 8hr Phlda1 pleckstrin homology-like domain, family A, member 
1 
cam 8hr, cam 48hr  Il8 chemokine (C-X-C motif) ligand 15 
Rrm2 ribonucleotide reductase M2 
cam 48hr, chro 48hr Serpinb2 serine (or cysteine) peptidase inhibitor, clade B, 
member 2 
 
Table 4.17. Downregulated NMR genes present in two or more conditions with at least 500 reads. 
Abbreviations: cam – camptothecin, chro – chromium (iv) oxide, hr – hours. 
Conditions Symbol Gene name 
cam 8hr, cam 48hr  Mbnl1 muscleblind-like 1 (Drosophila) 
Smurf2 SMAD specific E3 ubiquitin protein ligase 2 
cam 48hr, chro 48hr Dpp10 dipeptidylpeptidase 10 
Foxo1 forkhead box O1 
Hspg2 perlecan (heparan sulfate proteoglycan 2) 
chro 8hr, cam 48hr Cadm2 cell adhesion molecule 2 
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Dpp10 was downregulated 48 hours post-treatment with either camptothecin or chromium 
(vi) oxide in NMR cells only (based off 3 out of 3 cell lines). Dpp10, the Dipeptidyl peptidase 10 lacks 
peptidase enzymatic active and modulates the activity of the potassium channel Kv4.2, increasing its 
ability to transport potassium ions without changes in protein level (471). Kv4.2 has been associated 
with youthful skin ageing through a genome-wide association study. However, this expression was 
suggested to be in Langerhans cells as opposed to skin fibroblasts (472). Cells’ permeability to 
potassium changes throughout the cell cycle being lowest at g2-m phase (473, 474). A decrease in 
Dpp10 and hence Kv4.2 permeability may be indicative of cell cycle arrest at G2. Dpp10 was not 
differentially expressed in mouse cells. 
 
Serpinb2 was upregulated 48 hours post-treatment with either camptothecin or chromium 
(VI) oxide in NMR cells only (based off 3 out of 3 cell lines). Serpinb2 is a member of the clade B family 
of serine protease inhibitors. It is one of the most upregulated genes in response to cellular stress and 
required for effective autophagy (475). Serpinb2 may aid the maintenance of the cell's proteome 
which may help confer resistance to the DNA damaging stimuli used in this study.  Serpinb2 may also 
reduce cancer metastasis (476) which may contribute to the NMR’s cancer resistant phenotype. 
Serpinb2 was not differentially expressed in mouse cells. 
 
Interestingly, Foxo1 also appeared downregulated 48 hours after treatment with either 
camptothecin or chromium (vi) oxide (based off 2 out of 3 cell lines for 48-hour chromium sample). 
Foxo1 has been shown to increase p21 expression when Foxo1 expression is increased either through 
fasting or experimental overexpression (477, 478). This is the opposite of our results that indicate that 
p21 is upregulated even after 48 hours post camptothecin treatment at which point Foxo1 appears 
downregulated. Foxo1 can act as a pro-apoptotic gene regulated by cyclin-dependent kinase 1 and 2 
(479, 480) and can promote cell cycle arrest at G1/S through interactions with smad proteins (481). 
Foxo1 has been implicated in the antineoplastic effect of caloric restriction in mice and is required for 
the lifespan extension of daf-2 and AGE-1 mutant in C. elegans (85, 92). Foxo1 was downregulated in 
mouse cells after 8 hours post camptothecin treatment (based off 2 out of 3 cell lines).  
 
 The genes examined in more detail are only a small subset of the total gene expression 
profiles. However, when taken together, they do show a similar theme of cell cycle regulation that 
was not detected by the FE analysis. This cell cycle regulation was seen in genes from 8 and 48 hours 
post stimuli. Additionally, we saw some genes known to be upregulated in cellular stress either in 
general or as has been specifically seen in camptothecin and/or chromium (vi) oxide treatment. This 
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would suggest that NMR cells undergo cell cycle arrest to a greater extent or for a longer period than 
mouse cells. It is not clear at what point of the cell cycle the cells are arresting as genes involved in G1 
and G2 arrest were differentially expressed. 
 
4.4.2.5 Differential expression between species 
Deseq (407) was used to analyse the RNAseq data between species. There was a large number 
of differentially expressed genes between the two species as we would expect (on average 6,635 
genes between all treatments) however there was very little variation between the number of 
differentially expressed genes in each treatment (total range of 199 genes) (Table 4.18). This may be 
a result of the high variation seen between primary cell cultures as discussed above. A large number 
of the differentially expressed genes were found to be consistently differentially expressed across 
treatments (Figure 4.18). There were 2,719 genes consistently upregulated, and 2,357 genes 
consistently downregulated in all 8hour samples. In the 48-hour samples, there were 2,713 genes 
consistently upregulated, and 2,428 genes consistently downregulated. The differentially expressed 
genes in the control sample can be thought to represent the base transcriptomic difference between 
the two species. 
Table 4.18. The number genes up (↑) or down (↓) regulated in NMR cells compared to mouse cells 
for different treatments and time points. Genes significant at the 0.05 level after correcting for 
multiple testing. 
 Control Camptothecin Chromium (vi) oxide 
8hr 3,437↑ 
3,107↓ 
3,630↑ 
3,074↓ 
3,570↑ 
3,103↓ 
48hr 3,618↑ 
3,077↓ 
3,564↑ 
3,122↓ 
3,328↑ 
3,177↓ 
 
To better identify biological activity, a functional enrichment was performed using David 
(Table 4.19-4.20) (330, 426). As there were too many genes to allow for the generation of functional 
clusters, enriched GO terms were analysed instead. 
Enriched GO terms for upregulated genes showed a large amount of similarity for all 8-hour 
treatments and 48-hour control samples (Table 4.19). This may indicate that 8 hours after the stimulus 
was not long enough for cells to show a significant transcriptional response, that the two species 
initially responded similarly, or that variations in cellular response were obscured by the large 
differences in gene expression already present between the two species. These samples showed 
upregulation of genes involved in the membrane. Terms such as ‘GO:0044459~plasma membrane 
153 
 
part’ and ‘GO:0016021~integral to membrane’ are significantly enriched in all of these conditions 
indicating significant variations between species in terms of the cell membrane. Downregulated terms 
for these conditions (Table 4.20), with the exception of 8-hour post chromium treatment, also showed 
a large similarity. Terms such as ‘GO:0007049~cell cycle’ and ‘GO:0000278~mitotic cell cycle’ 
repeatedly appeared indicating changes within the cell cycle between the two species. This may be a 
result of the different growth rates of the two species. Samples of 8-hour post chromium treatment 
were more distinct from the above but did show some overlap in terms with 
‘GO:0031974~membrane-enclosed lumen’ in this sample and both the control samples. 
Samples analysed 48 hours after treatment with camptothecin showed terms regarding DNA 
replication and cell cycle progression enriched for both up and downregulated genes (Table 4.19-
4.20). This may be indicative of a DNA damage response resulting in different progression through the 
cell cycle and may indicate cell cycle arrest preventing mitosis. Differences in such processes may 
underlie the NMR’s increased survival.   
Samples analysed 48 hours after treatment with chromium (vi) oxide showed few terms 
enriched for up or downregulated genes that are statistically significant (Table 4.19-4.20). The only 
term that is significant ‘GO:0019898~extrinsic to membrane’ was enriched in downregulated genes. 
Other not statistically significant terms also refer to the membrane. Taken together, this indicates 
differences between the two species in terms of their cellular surface.  
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Table 4.19. The top 5 most significant GO terms from the functional enrichment of upregulated genes 
for each treatment. Comparisons of mouse vs. NMR.  NMR – Naked mole rat. 
Treatment GO term  Count FDR 
8hr Control 
Mouse vs. NMR 
up 
GO:0005509~calcium ion binding 224 1.49E-03 
GO:0030054~cell junction 142 8.32E-03 
GO:0044459~plasma membrane part 374 9.44E-03 
GO:0044456~synapse part 76 1.10E-02 
GO:0016021~integral to membrane 912 1.99E-02 
8hr 
camptothecin 
Mouse vs. NMR 
up 
GO:0031224~intrinsic to membrane         1,037 2.48E-5 
GO:0016021~integral to membrane  992 4.44E-5 
GO:0005509~calcium ion binding   238 1.13E-4 
GO:0044456~synapse part  83 9.00E-4 
GO:0044459~plasma membrane part  401 0.002 
8hr chromium 
Mouse vs. NMR 
up 
GO:0031224~intrinsic to membrane 1,021 4.07E-06 
GO:0016021~integral to membrane 979 4.13E-06 
GO:0005509~calcium ion binding 228 0.004458 
GO:0044456~synapse part 78 0.012723 
GO:0044459~plasma membrane part 386 0.014098 
48hr Control 
Mouse vs. NMR 
up 
GO:0005509~calcium ion binding 239 7.17E-05 
GO:0016021~integral to membrane 980 1.04E-04 
GO:0031224~intrinsic to membrane 1,016 5.46E-04 
GO:0044459~plasma membrane part 389 2.35E-02 
GO:0007155~cell adhesion 155 4.49E-02 
48hr 
camptothecin 
Mouse vs. NMR 
up 
GO:0006260~DNA replication 65 6.82E-09 
GO:0007049~cell cycle 191 1.95E-08 
GO:0006259~DNA metabolic process 136 8.35E-08 
GO:0031974~membrane-enclosed lumen 305 2.51E-06 
GO:0043233~organelle lumen 292 2.66E-05 
48hr chromium 
Mouse vs. NMR 
up 
GO:0044456~synapse part 71 0.114035 
GO:0005509~calcium ion binding 206 0.146838 
GO:0016021~integral to membrane 878 0.198614 
GO:0008066~glutamate receptor activity 17 0.238145 
GO:0005261~cation channel activity 76 0.358067 
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Table 4.20. The top 5 most significant GO terms from the functional enrichment of downregulated 
genes for each treatment. Comparisons of mouse vs. NMR. NMR – Naked mole rat. 
Treatment GO term  Count FDR 
8hr Control 
Mouse vs. NMR 
down 
GO:0007049~cell cycle 179 8.77E-06 
GO:0031974~membrane-enclosed lumen 302 3.23E-05 
GO:0000278~mitotic cell cycle 85 3.98E-04 
GO:0005739~mitochondrion 286 8.87E-04 
GO:0043233~organelle lumen 286 9.69E-04 
8hr 
camptothecin 
Mouse vs. NMR 
down 
GO:0007049~cell cycle 195 1.30E-10 
GO:0006259~DNA metabolic process 134 7.46E-08 
GO:0000278~mitotic cell cycle 94 1.27E-07 
GO:0006260~DNA replication 61 3.68E-07 
GO:0051301~cell division 99 5.03E-07 
8hr chromium 
Mouse vs. NMR 
down 
GO:0000166~nucleotide binding 499 2.60E-17 
GO:0031974~membrane-enclosed lumen 302 3.08E-16 
GO:0043232~intracellular non-
membrane-bounded organelle 439 9.72E-15 
GO:0043228~non-membrane-bounded 
organelle 439 9.72E-15 
GO:0043233~organelle lumen 288 2.10E-14 
48hr Control 
Mouse vs. NMR 
down 
GO:0007049~cell cycle 193 4.99E-10 
GO:0000278~mitotic cell cycle 90 4.54E-06 
GO:0031974~membrane-enclosed lumen 301 7.29E-06 
GO:0043232~intracellular non-
membrane-bounded organelle 420 1.50E-05 
GO:0043228~non-membrane-bounded 
organelle 420 1.50E-05 
48hr 
camptothecin 
Mouse vs. NMR 
down 
GO:0006260~DNA replication 65 6.82E-09 
GO:0007049~cell cycle 191 1.95E-08 
GO:0006259~DNA metabolic process 136 8.35E-08 
GO:0031974~membrane-enclosed lumen 305 2.51E-06 
GO:0043233~organelle lumen 292 2.66E-05 
48hr chromium 
Mouse vs. NMR 
down 
GO:0019898~extrinsic to membrane 234 4.08E-04 
GO:0005794~Golgi apparatus 328 0.166067 
GO:0016192~vesicle-mediated transport 231 0.43551 
GO:0042995~cell projection 274 0.369391 
GO:0044459~plasma membrane part 667 0.779626 
 
There was a large overlap in gene expression between control and treated samples with an 
average of 5,670 genes (~77%) shared between each treatment and its appropriate control (Figure 
4.18). These overlapping genes were excluded, and the functional enrichment analysis was repeated 
in the hope of identifying important differences in responses to DNA damaging stimuli between mouse 
and NMRs. There were very few significantly enriched go terms and due to the lower number of genes 
a functional clustering analysis could be performed (Table 4.21). Additionally, a Venn diagram of genes 
differentially expressed under control conditions at 8 or 48 hours between the species was produced 
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(Figure 4.19). Here we saw the majority of the differentially expressed genes were conserved over 
time with no genes switching between being over or underexpressed.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.18. Venn diagrams of significantly (p<0.05) differentially expressed genes derived 
from comparisons between mouse and NMR in each of the labelled conditions. A) Upregulated genes 
in each treatment after 8 hours post-treatment. B) Downregulated genes in each treatment after 8 
hours post-treatment. C) Upregulated genes in each treatment after 48 hours post-treatment. D) 
Downregulated genes in each treatment after 48 hours post-treatment. 
A B 
C D 
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Figure 4.19. Venn diagram of genes up and downregulated between NMR and mice under 
control conditions after 8 and 48 hours.  
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Table 4.21. Functional enrichment (FE) results for either up or downregulated genes between mouse 
and NMR under the stated treatments. Genes found to be differentially expressed in control samples 
were removed from the gene lists used in this assay. Representative terms from the top five FE 
clusters, with corresponding gene counts and FDR-corrected probability values and the enrichment 
score for the cluster. Terms were selected that best represented all the terms in the cluster, of these 
the term with the highest gene count and lowest FDR score was reported. 
Treatment Term 
Coun
t FDR 
Enrichment 
Score 
cam 8hr up 
 
 
 
GO:0015031~protein transport 43 0.20 2.48 
GO:0006811~ion transport 39 0.46 1.56 
GO:0008092~cytoskeletal protein binding 25 10.72 1.29 
GO:0007267~cell-cell signalling 16 78.91 1.22 
GO:0050804~regulation of synaptic transmission 8 63.74 1.19 
cam 8hr down 
 
 
GO:0007049~cell cycle 34 0.38 2.91 
GO:0005694~chromosome 19 1.59 2.74 
domain:SH3 13 2.97 1.98 
GO:0015630~microtubule cytoskeleton 21 4.40 1.8 
IPR001849:Pleckstrin homology 15 18.17 1.69 
chro 8hr up 
 
 
 
GO:0031224~intrinsic to membrane 206 0.04 4.01 
Glycoprotein 158 0.41 2.09 
GO:0005887~integral to plasma membrane 30 5.61 1.89 
IPR000306:Zinc finger, FYVE-type 5 42.94 1.35 
IPR002110:Ankyrin 15 53.22 1.34 
chro 8hr down 
 
 
IPR001849:Pleckstrin homology 22 0.21 3.61 
sh3 domain 16 3.68 2.17 
GO:0030705~cytoskeleton-dependent intracellular 
transport 6 9.22 2.13 
domain:Ras-associating  6 6.31 2.02 
GO:0005856~cytoskeleton 47 3.36 2 
cam 48hr up 
 
 
 
GO:0005794~Golgi apparatus 26 3.53 2.49 
GO:0005773~vacuole 10 18.44 1.9 
GO:0042995~cell projection 17 1.84 1.62 
GO:0008092~cytoskeletal protein binding 16 29.75 1.4 
GO:0044463~cell projection part 7 70.12 1.38 
cam 48hr down 
 
sh3 domain 14 0.81 3.03 
GO:0031981~nuclear lumen 30 5.73 1.67 
IPR001715:Calponin-like actin-binding 6 16.55 1.55 
GO:0046872~metal ion binding 88 35.47 1.53 
GO:0002520~immune system development 14 22.00 1.42 
chro 48hr up 
 
 
GO:0043228~non-membrane-bounded organelle 68 6.37 2.11 
GO:0000502~proteasome complex 7 9.72 1.9 
GO:0005739~mitochondrion 43 48.51 1.63 
repeat:BNR 4 3 25.44 1.54 
GO:0006260~DNA replication 8 80.81 1.21 
chro 48hr 
down 
 
cell adhesion 31 0.04 3.58 
IPR001849:Pleckstrin homology 22 2.70 2.65 
sh3 domain 18 3.51 2.18 
GO:0032403~protein complex binding 9 12.90 1.99 
GO:0019838~growth factor binding 10 3.88 1.96 
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Though the enrichment scores for the clusters were still high (>1.3) few or no terms within 
the clusters were individually significant (Table 4.21).  
Camptothecin-treated cells analysed after 8 hours contained a number of upregulated 
clusters that together suggest the release of signalling molecules from the cell. These terms either 
relate directly to transport of ions or protein (e.g. ‘GO:0015031~protein transport’), the process by 
which they are moved (e.g. ‘GO:0008092~cytoskeletal protein binding’) or the process by which they 
are released or detected (e.g. ‘GO:0007267~cell-cell signalling’). Downregulated genes form clusters 
that refer to the cell cycle either directly or indirectly, suggesting NMR cells decrease proliferation 
after genotoxic insult, in agreement with previously reported data (179). Downregulated terms also 
included terms regarding Pleckstrin homology and SH3 protein domains. These protein domains are 
found in many proteins involved in signal transduction or the cytoskeleton (427, 428). 
Chromium treated cells analysed after 8 hours showed upregulated genes that produce 
functional clusters regarding the cell membrane including ‘GO:0031224~intrinsic to membrane’, the 
only term that was statistically significant in this treatment. As with camptothecin treatment, we saw 
terms regarding Pleckstrin homology and SH3 protein domains. Additionally, clusters regarding 
cellular transport via the cytoskeleton were differentially expressed.  
At 48 hours post camptothecin treatment, terms such as ‘GO:0005794~Golgi apparatus’ and 
‘GO:0005773~vacuole’ were upregulated suggesting increased protein synthesis and degradation. 
Terms regarding cellular projections and the cytoskeleton were also upregulated. These clusters 
included genes such as Myo1c (Myosin IC), a molecular motor protein involved in intracellular 
transport, and Ezr (Ezrin), a protein-tyrosine kinase substrate that acts as an intermediate between 
the plasma membrane and cytoskeleton and may be important for cell adhesion (482). Downregulated 
clusters again contained terms regarding the cytoskeleton such as ‘sh3 domain’ and 
‘IPR001715:Calponin-like actin-binding’ but also terms regarding the nuclear lumen and ion transport. 
Terms regarding the immune system potentially indicating a general stress response were also 
downregulated.  
At 48 hours post chromium treatment, a variety of terms are upregulated. The cluster with 
the highest score that contained the term ‘GO:0043228~non-membrane-bounded organelle’ also 
contained the term ‘GO:0005856~cytoskeleton’, indicating that these genes are primarily related to 
the cytoskeleton. Terms such as ‘GO:0000502~proteasome complex’ may indicate protein turn over 
and the terms such as ‘GO:0005739~mitochondrion’ may indicate changes in energy homeostasis or 
may relate to apoptosis. Downregulated genes produced clusters regarding the outside of the cell, 
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such as cell adhesion, and growth factor binding, as well as terms regarding Pleckstrin homology and 
SH3 protein domains which are downregulated in most conditions.  
In summary, this analysis seemed to suggest that mice and NMR under control conditions 
differ greatly in terms of the cell membrane with many up and downregulated terms regarding the 
cell surface. When we factored out genes seen as differentially expressed in control conditions we see 
that initially (8 hours) after treatment NMR cells show further increases in membrane-associated 
terms further supporting the significance of the membrane. These membrane terms seem to be more 
related to cellular signalling but include genes involved in cell adhesion. Proliferation was 
downregulated in NMRs, and so were aspects of the cytoskeleton which may have been a result of 
reduced mitosis. These differences in the membrane may have served to protect the NMR cells by 
increasing harmful compound efflux or decrease its uptake. This has been shown to be the most 
common reason for drug resistance in tumours (483) through changes in transporter activity or 
expression of uptake inhibiting glycoproteins (484). Alternatively, it has been suggested that 
membrane alterations can induce stress signalling and accumulation of heat shock proteins in or on 
cell membranes to correct misfolded proteins and alter the membrane structure (485, 486). Reduced 
proliferation may provide NMR cells more time to repair and respond to the treatment. Later (48 hours 
post stimuli), there seems to be an increase in protein synthesis and turnover in NMRs compared to 
mice. This may be to replace damaged proteins or may be indicative of a wider response. 
Downregulation of cytoskeleton components may also suggest reduced proliferation or motility in 
these cells. Taken together the results suggest activity at the membrane as a major component 
concerning observed differences between the NMR and mouse with potential importance of 
increased protein synthesis and turnover as part of the long-term response or recovery of these cells.  
 
4.4.2.6 Differences in DNA damage associated genes 
To identify if genes involved in DNA repair are more expressed in NMR than mouse a list of 
136 genes involved in DNA repair were compiled from (193) and REPAIRtoire, a database of DNA repair 
pathways (487). More of these genes appeared upregulated in mice (Table 4.22). By performing a 
Wilcoxon paired sample signed-rank test (performed in SPSS version 22.0) on these genes that were 
differentially expressed (Appendix Table 3), we find that they were expressed significantly higher in 
48-hour control and in both 8 and 48-hour camptothecin-treated mouse samples (Figure 4.20). 
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Table 4.22. The number of DNA repair genes up (↑) or down (↓) regulated in NMR cells compared to 
mouse cells for different treatments and time points. Genes significant at the 0.05 level, after 
correcting for multiple testing. 
 Control Camptothecin Chromium (vi) oxide 
8hr 35↑ 
46↓ 
32↑ 
56↓ 
39↑ 
47↓ 
48hr 36↑ 
51↓ 
33↑ 
55↓ 
40↑ 
42↓ 
 
 
Figure 4.20. Normalised gene expression of 136 genes involved in DNA repair. These genes 
were identified from (193) and REPAIRtoire (487). Circles indicate outliers (1.5 to 3 times the 
interquartile range out) and stars indicate far outliers (greater than 3 times the interquartile range 
out). Hash (#) indicates statistically significant levels of gene expression between mouse and NMR as 
determined by Wilcoxon paired sample signed-rank test (performed in SPSS version 22.0). Controls 
after 48 hours post-treatment and both camptothecin-treated show significantly greater expression 
in mouse cells then NMR ((Z score: -2.019, p=0.044), (Z score: -3.004, p=0.003), (Z score: -3.104, 
p=0.002), respectively). The gene Ddb1 has been excluded from these figures. Abbreviation Hr – hour. 
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Ddb1 in mouse had the highest expression of all the DNA damage-related genes studied with 
an average read count of approximately 28,150 (average fold change of 7.91). DDB1 in conjunction 
with DDB2 detects UV induced DNA damage and acts to promote the degradation of p21 in response 
to a low dose of UV radiation to mediate appropriate DNA repair (488). Perhaps the lower levels of 
Ddb1 in NMR facilitate a more p21 based repair mechanism and perhaps this low level reflects the 
NMR’s susceptibility to UV induced DNA damage (175).  
 
To identify if particular DNA repair mechanisms are expressed differently, genes involved in 
non-homologous end join, homologous recombination, nucleotide excision repair, base excision 
repair and mismatch repair (discussed in Section 1.3) (as defined in REPAIRtoire) were analysed by 
Wilcoxon paired sample signed-rank test (performed in SPSS version 22.0) (Appendix Table 4). The 
only statistically significant difference was found for nucleotide excision repair genes in both (8 and 
48-hour) control samples and camptothecin samples after 48 hours ((Z score: -2.068, p=0.039), (Z 
score: -2.138, p=0.033), (Z score: -2.103, p=0.035), respectively). In addition to these samples, all 
samples showed reduced expression of NER associated genes in NMRs.  
 
Though the overall levels of expression of BER genes were similar, there was still a total of 14 
differentially expressed genes over all the conditions, which could reflect important changes in this 
pathway. Of the 7 upregulated genes, 6 were glycosylases or associated with glycosylases whereas 
only 3 of the 7 downregulated genes were glycosylases. Only 1 polymerase, POLL (DNA Polymerase 
Lambda), was upregulated, but 4 are downregulated. The role of glycosylases in BER is to is to detect 
and remove DNA legions whereas polymerases act later to replace the removed DNA (discussed in 
Section 1.3). This may indicate that the NMR is more primed to detect and remove legions due to this 
increased glycosylase expression. It is of note that POLL is thought to act principally in NHEJ (489, 490) 
and hence its upregulation may have related to its role in this DNA damage repair pathway and not 
BER. Increased glycosylase activity has been observed previously (491) providing consistency to this 
finding. 
 
In addition to POLL which was upregulated in chromium treated samples and 8hour control 
samples, the only other NHEJ associated gene upregulated wasNhej1 (Non-homologous end-joining 
factor 1). Nhej1 had increased expression in all NMR samples relative to those from mice. Nhej1 has 
been shown to affect hematopoietic stem cell ageing with knock out mice showing reduced stem cell 
renewal and decreased functional capacity in transplantation assays (492). Additionally, studies in 
human induced pluripotent stem cell model of Nhej1 deficiency confirm this reduced stem cell 
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renewal (493). This may suggest stem cell maintenance is improved in NMRs. The only downregulated 
NHEJ associated gene was Lig4 (DNA Ligase 4) which was downregulated in NMRs relative to mice in 
all samples. Lig4 religates the broken strand in NHEJ, and it is not clear what this lower expression 
would mean in this context, but might suggest that homologous recombination is prioritised. 
 
Similar to BER genes, homologous recombination genes did not show significant differences, 
but still had a total of 11 genes differentially expressed across all treatments. There was no clear trend 
of function within up and downregulated genes as we saw in BER genes. However of note is the gene 
Brca1. Brca1 is involved in both checkpoint control and repair and is seen upregulated in chromium 
treatment after 48 hours. It was one of only two checkpoint genes seen to be upregulated in this assay, 
and it was not clear if it is its role as a checkpoint or a homologous recombination protein or both that 
explains its upregulation here.  
 
Genes associated with DNA damage signalling, also termed checkpoint control genes (as 
defined by REPAIRtoire) were also analysed by Wilcoxon paired sample signed-rank test (performed 
in SPSS version 22.0) (Appendix Table 4). NMRs showed significantly lower expression in these genes 
in all samples (Z score: <-1.6, p<0.05). This is counter-intuitive, as we would expect cells that appear 
more resistant to DNA damage to be primed to respond to such damage with increased expression on 
genes involved in detecting such damage and altering cell cycle activity in response to such damage. 
This finding suggests that in this instance, resistance to DNA damaging agents is likely down to 
mechanisms other than DNA damage repair and may indicate more preventative measures for DNA 
damage.  
 
There appeared to be little variation in DNA damage gene expression between each treatment 
suggesting the variation between species is masking the variation due to the treatment or that the 
treatment itself is having a low impact on this gene expression.  
 
These results are a stark contrast to previous work (193) in NMR liver cells. It was shown that 
in liver cells from NMRs had significantly greater expression in DNA damage signalling and MMR and 
non-significantly more expression of homologous recombination and NHEJ genes (193). An increase 
in double-strand break repair would have explained an increased resistance to camptothecin that 
specifically causes single and double-strand breaks, though the lack of difference may reflect the small 
difference in observed resistance. Elevated levels of oxidative stress characterize chronic liver disease, 
and the liver is a target for a number of DNA damaging compounds which may particularly be the case 
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in the NMR which feeds on toxic tubers (494, 495). This may explain the observed differences, as skin 
fibroblasts are less exposed to DNA damaging agents and hence do not require such high levels of DNA 
repair gene expression. As NMR are subterranean, they have little exposure to sunlight. Mice on the 
other hand, though nocturnal and covered in fur may experience higher light exposure. This is 
supported by studies showing that NMR cells are susceptible to UV radiation (175). UV induced DNA 
damage is primarily repaired by nucleotide excision repair (496). Lower levels of such genes in the 
NMR may reflect the difference in UV susceptibility of the organisms under study and likely reflect 
evolutionary redundancy of such repair in subterranean living.   
 
The tumour-related protein p53 was significantly upregulated between all conditions that 
matched what has previously been reported. However Nrf2, which has also been reported as being 
highly expressed in NMR, only had significantly higher expression in NMR cells after chromium 
treatment or 48 hours post control treatment (179). One explanation for p53’s higher expression is 
that it primes the cell to respond to stress. The protein would simply need to be activated as opposed 
to transcribed in order to elicit a response. However, if we consider the results of our senescence 
assay which showed high base levels of senescence in NMR cells, the high p53 expression may simply 
be indicative of this. If this is the case, then it may be due to accumulation of senescent cells due to 
the low frequency of cellular passaging in the slow-growing NMR cells, or it may indicate that the cells 
are undergoing chronic stress due to improper culture conditions. As NMRs are a relatively new model, 
culture conditions may still need further optimisation.  
 
These results indicate that the total expression of DNA repair genes is either less relevant than 
the specific profile with an appropriate combination of a few genes being more effective than high 
activity of a less appropriate combination. Alternatively, it would suggest that NMRs are not repairing 
DNA damage in a fashion greater than in mice, but are instead taking a longer time to repair the 
damage, an idea supported by the presence of differentially expressed cell cycle-associated genes. 
Another potential explanation is that NMRs could be negating the effect of DNA damaging compounds 
through alternative means such as preventing the damage occurring. 
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4.4.2.7 Differences in cell adhesion associated genes 
 Our functional enrichment analyses indicated pronounced differences in the membrane 
proteome between NMR and mice. A key aspect of a cell’s surface chemistry that affects cancer 
susceptibility is the presence of cell adhesion molecules (466, 497, 498). To determine if there are 
significant differences in cell adhesion molecule expression, a list of 176 genes listed as ‘cell adhesion 
molecules’ were taken from the KEGG (Kyoto Encyclopedia of Genes and Genomes) database (Release 
78.2) (441, 499). Of these genes, 94 were present in our dataset (appendix Table 5). A higher 
proportion of these genes were upregulated in NMR cells relative to mouse cells (Table 4.23). The 
number of differentially expressed genes was similar between treatments with a range of 6 
upregulated genes and 9 downregulated genes. There was a large amount of overlap between control 
and treated cells with an average of 40 genes (73%) present in both the treatment and the appropriate 
control indicating this difference in cell adhesion was not induced by the treatment. A paired Wilcoxon 
signed rank analysis was performed on the expression of these genes that were found to be 
differentially expressed. Control (8-hour: Z score: -2.1, p=0.035, 48-hour: Z score: -2.4, p=0.018) and 
camptothecin (8-hour: Z score: -3, p=0.002, 48-hour: Z score: -2.1, p=0.031) treated NMR cells showed 
significantly more expression than cells from mouse under these conditions 8 and 48 hours post-
treatment.  Chromium treatment did not show significant differences in adhesion molecule 
expression. However, 8-hour post-treatment did show near significance (Z score: -2, p=0.051). 
 
 
Table 4.23. The number of cell adhesion genes up (↑) or down (↓) regulated in NMR cells compared 
to mouse cells for different treatments and time points. Genes significant at the 0.05 level after 
correcting for multiple testing. 
 Control Camptothecin Chromium (vi) oxide 
8hr 35↑ 
18↓ 
35↑ 
13↓ 
33↑ 
14↓ 
48hr 32↑ 
14↓ 
33↑ 
18↓ 
29↑ 
22↓ 
 
 
 The biggest difference in expression was consistently in the gene Selplg (Selectin P Ligand) 
with an average fold change of 14 between all conditions (range: 3.1). Selplg is the ligand of P-selectin, 
though it can be bound by other selectins (500-502). Selplg is present on endothelial cells and allows 
tethering and extravasation of circulating immune cells (501, 502). As such, this may be an indicator 
that the cells are trying to recruit immune cells as part of a general stress response. P-selectin and its 
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ligand have been implicated in cancer with knockouts resulting in decreased growth and metastasis 
(503). This is in part due to immunoregulatory effects of Selplg present on the surface of T cells (504). 
However, p-selectin has been shown to contribute to metastasis (505). As such it is surprising that a 
cancer-resistant model such as the NMR would have such high expression levels compared to the 
cancer-susceptible mouse. Fibroblasts expressing Selplg may make themselves too sticky for 
metastasising cells to pass through, preventing them from spreading, or may help recruit an 
appropriate immune response.  
 
 Significant differences in cell adhesion may be essential in the NMR’s cancer resistance. As we 
will discuss in Chapter 5.1, cell adhesion is thought to affect cancer by regulating proliferation and 
both facilitating and preventing metastasis. As such, increased expression of cell adhesion genes may 
either limit cellular proliferation and possibly facilitate the early contact inhibition observed in NMR 
or could make cells too sticky for metastasising cancer cells to escape local tissues, preventing the 
spread of tumours.  
 
4.4.3 Quantitative PCR validation 
To validate our data the expression of 9 genes of interest were quantified through qPCR.  
Primer dimer, whereby the PCR primers anneal to each other, results in amplification of the 
primers. This would generate an amplification signal (increased CYBR green fluorescence) in the 
absence of their target making accurate detection of the target impossible. Similarly, amplification of 
multiple genes also made it impossible to determine whether or not changes in the signal you detect 
is due to changes in your target gene’s expression level or that of the unspecific target. To test if our 
primers (Table 4.1) are specific to our target and do not form primer dimers, control RNA was 
converted into cDNA and amplified by qPCR, and the product was analysed by gel electrophoresis on 
a 3% agarose gel. The majority of primers produced a single clear band indicating successful 
amplification of the specific target. However, primer pair 2, designed to target p57 in mouse, gave two 
distinct bands (Figure 4.21). Due to the size of these bands (both >100bp) which are too large for 
amplification of primer dimers (typically no longer than 50bp) these primers were likely amplifying a 
non-specific target such as another gene, or potentially a variation of p57. Fortunately, primer pair 1 
designed to target p57 gave a single band and will be used for future assays.  
A number of the primer pairs produced faint or apparently absent bands or conversely in the 
case of the primer designed to detect mouseHprt1, a very bright and broad band that could represent 
multiple overlapping species (Figure 4.21-4.22). To test these primers, the PCR product was loaded 
onto another gel with a higher load (25ul) and wider narrower wells (Figure 4.23). From this assay, 
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four primers were found not to produce any bands and hence no amplification. These were both 
primer pairs that targeted Dpp10 in mouse and Grik2 in NMR. The absence of any amplification 
indicates that either the primers simply didn’t work, or that the gene target was expressed very poorly 
or not at all. By looking into the RNAseq data, we see that for both genes there is very low expression. 
Dpp10 in mouse shows 0 to 0.9 reads, and Grik2 in NMR has 45 to 535 reads after normalisation under 
control conditions, varying between primary cell cultures, which would explain the absence of bands 
here. The primer pair targeting mouse Hprt1 still appears very bright but on closer inspection appears 
to be a single band. The predicted product size (Table 4.1) matches the size present on the gel, further 
supporting that these bands represent the desired amplification product. For this study primers listed 
as ‘p1’ were used with the exception of mouse p21, NMR R3hcc1 and NMR Sox5 which used the primer 
listed as ‘p2’ (Table 4.1). 
 3% Agarose, 6µl Midori Green 
Lane Sample Predicted 
size (bp) 
Load  
 
 
1 Ladder 100-1,000 5µl 
2 M p21 p1 112 10µl 
3 M p21 p2 111 10µl 
4 M Sox5 p1 124 10µl 
5 M Sox5 p2 113 10µl 
6 M Grik2 p1 145 10µl 
7 M Grik2 p2 134 10µl 
8 M R3hcc1 p1 100 10µl 
9 M R3hcc1 p2 103 10µl 
10 M Serpinb2 p1 131 10µl 
11 M Serpinb2 p2 140 10µl 
12 M Dpp10 p1 148 10µl 
13 M Dpp10 p2 107 10µl 
14 M FOXO p1 124 10µl 
15 M FOXO p2 116 10µl 
16 M P57 p1 141 10µl 
17 M P57 p2 145 10µl 
18 M Hprt1 p1 195 10µl 
19 M Tbp p1 109 10µl 
Figure 4.21. PCR products produced with different primers in control mouse cDNA samples. These 
were run on a 3% agarose gel containing 0.006% Midori Green. The size of each band on the ladder is 
given to the left of the image. RNA derived from mouse cell line 1 from the beta cell stock. 
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 3% Agarose, 6µl Midori Green 
Lane Sample Predicted 
size (bp) 
Load  
        
1 Ladder 100-1,000 5µl 
2 N p21 p1 114 10µl 
3 N p21 p2 101 10µl 
4 N Sox5 p1 136 10µl 
5 N Sox5 p2 137 10µl 
6 N Grik2 p1 102 10µl 
7 N Grik2 p2 128 10µl 
8 N R3hcc1 p1 113 10µl 
9 N R3hcc1 p2 145 10µl 
10 N Serpinb2 p1 107 10µl 
11 N Serpinb2 p2 112 10µl 
12 N Dpp10 p1 110 10µl 
13 N Dpp10 p2 104 10µl 
14 N FOXO p1 111 10µl 
15 N FOXO p2 146 10µl 
16 N P57 p1 141 10µl 
17 N P57 p2 141 10µl 
18 N Hprt1 p1 215 10µl 
19 N Tbp p1 208 10µl 
20 Ladder 100-1000 5µl 
Figure 4.22. PCR products produced with different primers in control NMR cDNA samples. These were 
run on a 3% agarose gel containing 0.006%m Midori Green. The size of each band on the ladder is 
given to the left of the image. RNA derived from NMR cell line 2 from the beta cell stock. 
 3% Agarose, 6µl Midori Green 
Lane Sample Predicted 
size (bp) 
Load  
          
1 Ladder 100-1,000 5µl 
2 M p21 p1 112 10µl 
3 M Grik2 
p2 
134 10µl 
4 M Dpp10 
p1 
148 10µl 
5 M Dpp10 
p2 
107 10µl 
6 M Hprt1 
p1 
195 10µl 
7 N Sox5 p1 136 10µl 
8 N Sox5 p2 137 10µl 
9 N Grik2 
p1 
102 10µl 
10 N Grik2 
p2 
128 10µl 
Figure 4.23. PCR products produced with different primers in control mouse cDNA samples. These 
were run on a 3% agarose gel containing 0.006% Midori Green. The size of each band on the ladder is 
given to the left of the image. RNA derived from mouse cell line 1 and NMR cell line 2 from the beta 
cell stock. 
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To validate the results of the RNAseq experiment, qPCR was employed (Figure 4.24). Genes of 
interest were chosen to be tested (Table 4.1). Due to limited volumes of leftover RNA, only mouse 
RNA samples used for the RNAseq could be used for this validation. For most samples, the change in 
gene expression is the same in both RNAseq and qPCR. However, R3hcc1 after 8-hour chromium 
treatment and Foxo1 after 48-hour camptothecin treatment in mouse primary cell culture one showed 
a decrease fold change in the qPCR dataset and increase fold change in the RNAseq dataset.  
Additionally, P21 in 8-hour post chromium treated mouse 1 cells showed a much larger increase in 
expression than in the RNAseq. All samples that failed to reach the 95-105% efficiency cut off 
(appendix Figure 10) showed similar expression between RNAseq and qPCR. Overall the direction of 
change was largely similar between the two methods. However, when interpreting the RNAseq data 
caution must be taken as variation between the two techniques is observed. 
Figure 4.24. The fold change in gene expression between control and treated samples as determined 
by RNAseq (red) and qPCR (blue). For most samples the change in gene expression is the same in both 
RNAseq and qPCR. However, R3hcc1 after 8-hour chromium treatment and Foxo1 after 48-hour 
camptothecin treatment in mouse primary cell culture one, show a decrease fold change in the qPCR 
dataset and increase fold change in the RNAseq dataset. Samples from the alpha cell stock. Tbp was 
used as the housekeeping gene for this analysis. 
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 Melt curves were produced and examined for multiple peaks. No cases of multiple peaks were 
detected indicating specific amplification (Figure 4.25). The PCR products from these reactions were 
loaded onto a 3% gel and examined for multiple bands (Figure 4.26-4.27). No double bands were 
detected confirming specific amplification; additionally, each gene produced the same size band 
regardless of the sample used indicating consistency of the primers (Figure 4.26-4.27). Control wells, 
which contain all components except the cDNA, test for contamination of the reagents. As 
amplification was detected in several of these wells; these samples were also loaded onto a gel as 
before (Figure 4.28). Bands can be seen for both p57 and Hprt1 indicating contamination. These 
samples among others were run again at a higher load (25ul) to check this (Figure 4.29). The faint band 
previously seen for p57 is not present. However, the band for Hprt1 is (Figure 4.29). This indicates 
contamination in the reagent that may confound data using Hprt1 as such Tbp will be used as the only 
housekeeping gene for these samples. Gels of the m2 mouse primary cell culture pcr products were 
also analysed by gel electrophoreses and produced no double bands (Appendix Table 6 and 7). Some 
contamination of 8-hour Tbp was detected which may mean inaccuracies in the 8-hour post-treatment 
m2 samples as Tbp was used to normalise the data (Appendix Table 6). The ct values of the 
housekeeping genes (Appendix Table 2) were input into a one way ANOVA using SPSS to assess if there 
was significant variation between samples. In all cases except control vs. chromium in m1 and m2 at 
8 hours post-treatment, there was a statistically significant difference suggesting these genes are not 
suitable housekeeping genes. However, the actual observed differences were small, and these 
differences are likely due to between-sample-and-run variation, particularly samples within each run 
that had less than a 2 ct range. The biggest variation was seen between 8 and 48 hours of both cell 
lines. This could indicate differences in expression over time or may reflect that 8-hour and 48-hour 
samples were run and originally harvested on different days. Were this study to be repeated a 
collection of at least 5 candidate housekeeping genes would be selected, and qPCR would be run using 
primers designed for these genes in control and treated conditions. These genes could then be 
assessed with publicly available software such as ‘NormFinder’ and ‘RefFinder’ to select the most 
appropriate and most stably expressed reference gene (506, 507). This approach has the benefit that 
all the genes should be stable in theory, and so the external variation should be consistent within 
these genes, and hence unstable genes should stand out even in a variable experimental background. 
Hprt1 and Tbp were chosen as housekeeping genes as they have been used as such in NMR cells 
studied previously (192). 
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Figure 4.25. Representative Melt curve plot. Melt curve plot of mouse 1 (alpha stock) p21, 48 hours 
post-treatment. Red lines represent control samples; orange lines represent camptothecin-treated 
samples and yellow indicate chromium (vi) oxide treated samples. All these samples show a single 
clear peak indicating only one amplification product. 
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 3% Agarose, 6µl Midori Green 
Lane Sample Predicted 
size (bp) 
Load  
            
1 Ladder 100-1,000 5µl 
2 p21 control 111 8µl 
3 p21 cam  111 8µl 
4 p21 chro 111 8µl 
5 p57 control 141 8µl 
6 p57 cam  141 8µl 
7 p57 chro 141 8µl 
8 Hprt1 control 195 8µl 
9 Hprt1 cam  195 8µl 
10 Hprt1 chro 195 8µl 
11 Tbp control 109 8µl 
12 Tbp cam  109 8µl 
13 Tbp chro 109 8µl 
14 R3hcc1 control 100 8µl 
15 R3hcc1 cam  100 8µl 
16 R3hcc1 chro 100 8µl 
17 Sox5 control 124 8µl 
18 Sox5 cam  124 8µl 
19 Sox5 chro 124 8µl 
20 Grik2 control 145 8µl 
21 Grik2 cam  145 8µl 
22 Grik2 chro 145 8µl 
23 FOXO1 control 124 8µl 
24 FOXO1 cam  124 8µl 
25 FOXO1 chro 124 8µl 
Figure 4.26. PCR products produced with different primers in cDNA samples from the m1 mouse 
primary cells (alpha stock) after 8 hours post-treatment with either camptothecin (cam) or chromium 
(vi) oxide (chro) in media with 2% DMSO or media with 2% DMSO as control. These were run on a 3% 
agarose gel containing 0.006% Midori Green. The size of each band on the ladder is given to the left 
of the image. 
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 3% Agarose, 6µl Midori Green 
Lane Sample Predicted 
size (bp) 
Load 
          
1 Ladder 100-1,000 5µl 
2 p21 control 111 8µl 
3 p21 cam  111 8µl 
4 p57 control 141 8µl 
5 p57 cam  141 8µl 
6 Hprt1 control 195 8µl 
7 Hprt1 cam  195 8µl 
8 Tbp control 109 8µl 
9 Tbp cam  109 8µl 
10 R3hcc1 control 100 8µl 
11 R3hcc1 cam  100 8µl 
12 Sox5 control 124 8µl 
13 Sox5 cam  124 8µl 
14 Grik2 control 145 8µl 
15 Grik2 cam  145 8µl 
16 FOXO1 control 124 8µl 
17 FOXO1 cam  124 8µl 
Figure 4.27. PCR products produced with different primers in cDNA samples from the m1 mouse 
primary cells (alpha stock) after 48 hours post-treatment with camptothecin (cam) in media with 2% 
DMSO or media with 2% DMSO as control. These were run on a 3% agarose gel containing 0.006% 
Midori Green. The size of each band on the ladder is given to the left of the image. 
 3% Agarose, 6µl Midori Green 
Lane Sample Predicted 
size (bp) 
Load  
       
1 Ladder 100-1,000 5µl 
2 p21 8hr 111 8µl 
3 p57 8hr 141 8µl 
4 Hprt1 8hr 195 8µl 
5 Tbp 8hr 109 8µl 
6 R3hcc1 8hr 100 8µl 
7 Sox5 8hr 124 8µl 
8 Grik2 8hr 145 8µl 
9 FOXO1 8hr 124 8µl 
10 p21 48hr 111 8µl 
11 p57 48hr 141 8µl 
12 Hprt1 48hr 195 8µl 
13 Tbp 48hr 109 8µl 
14 R3hcc1 48hr 100 8µl 
15 Sox5 48hr 124 8µl 
16 Grik2 48hr 145 8µl 
17 FOXO1 48hr 124 8µl 
Figure 4.28. PCR products produced in blank samples that lack cDNA. These were run on a 3% 
agarose gel containing 0.006% Midori Green. The size of each band on the ladder is given to the left 
of the image. 
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 3% Agarose, 6µl Midori Green 
Lane Sample Predicted 
size (bp) 
Load  
       
1 Ladder 100-1,000 5µl 
2 p21 48hr 111 25µl 
3 p21 48hr 111 25µl 
4 p57 48hr 141 25µl 
5 p57 48hr 141 25µl 
6 Hprt1 48hr 195 25µl 
7 Hprt1 48hr 195 25µl 
8 Tbp4 48hr 109 25µl 
9 Tbp 48hr 109 25µl 
Figure 4.29. PCR products produced in blank samples that lack cDNA. These were run on a 3% 
agarose gel containing 0.006% Midori Green. The size of each band on the ladder is given to the left 
of the image. 
 
4.5 Summary 
Previous work on the NMR has suggested that their resistance to cancer is in part down to 
constitutively high expression of p53 and Nrf2 as well as increased expression of DNA damage repair 
genes (179). Our study shows that while p53 is expressed at a higher level in NMR compared to mice, 
Nrf2 does not seem to be, and DNA damage repair genes seem to be expressed at similar or lower 
levels than in mice. The most prominent difference observed between these species is the expression 
of cell adhesion genes which were significantly higher in the NMR. It has been shown that cell adhesion 
can promote p53 expression (508) and that this expression is required for the early contact inhibition 
seen in NMR (184). Additionally, pRB was also shown to be required for this early contact inhibition 
(184). In addition to being a cell cycle regulator pRB may also act to promote cell adhesion through 
focal adhesions (509) and hence pRB’s essential function in early contact inhibition may be through 
its effect on adhesion molecules and not its effect on the cell cycle. Hence the high expression of cell 
adhesion molecules detected in this analysis may facilitate the observed early contact inhibition in 
NMRs. Alternatively, differences in cell adhesion may affect cancer more directly by inhibiting the 
movement of metastasising cancer cells.  
 
Additionally, differences in cell cycle progression were detected. A previous study has shown 
that NMR cells show prolonged growth arrest after genotoxic insult, and our results seem indicative 
of this (179). Though it is not clear how this change in cell cycle progression is achieved, it likely 
involves the cell cycle regulator p53 which shows consistently high expression in NMR. Additionally, 
1             2             3             4             5             6            7             8            9  
1,000bp 
900bp 
800bp 
700bp 
600bp 
500bp 
400bp 
300bp 
 
200bp 
 
100bp 
175 
 
p21 is also upregulated in response to the DNA damaging stimuli and often shows significantly higher 
expression in NMR than mice. Genes related to checkpoint control seem significantly downregulated 
in NMRs which is surprising as we would expect decreased proliferation to go hand in hand with 
increased checkpoint control. The relatively smaller checkpoint response may simply mean this 
response requires less transcriptional activity in NMR. It is of note that some such genes showed 
increased transcriptional activity in chromium treatment hence showing some checkpoint based 
response.  
 
This RNAseq analysis provides not only useful information used in this analysis but also 
provides raw data that can be later ‘mined’ for additional information by future researchers. This is 
particularly useful in relatively poorly studied organisms such as the NMR. 
 
A number of caveats must be considered when analysing this data. RNAseq analyses the level 
of mRNA but changes in RNA abundance do not necessarily mean changes in protein abundance, due 
to post-translational mechanisms such as miRNA suppression of mRNA, and protein degradation (303-
305). Furthermore, even if the expression does reflect the protein level, the presence of a protein does 
not necessarily correlate with protein activity as post-translational modification may render the 
protein inactive. RNAseq works under the assumption that in general mRNA reflects protein activity, 
but to truly understand the system under study further work looking at the protein level (e.g. western 
blot analysis) is required. 
In RNAseq, there is a bias for longer transcripts to be detected as the longer the sequence, the 
more likely a given read will encompass part of that transcript and hence be detected. For our analysis, 
this means that short transcripts may be missed and hence differences in such gene’s expression could 
also be missed. Lower numbers of reads would reduce the statistical power of our analysis, for 
example, the difference between 10 and 30 reads is a less convincing example of differential 
expression than 1,000 and 3,000 reads. This could be rectified by increasing the coverage or 
sequencing ‘depth’ of the analysis by sequencing more reads.  This would increase the cost of the 
analysis but also the statistical power of the assay and increase the likelihood of reads mapping to 
short transcripts. The coverage used in this analysis was fairly low at 2.4-4 (Table 4.5) meaning that 
theoretically the genome should be sequenced 2.4-4 times in our analysis. This low coverage was used 
principally to minimise costs. As we are comparing the same transcripts between samples, this bias 
should not affect our differential expression analysis beyond the potential loss of short transcripts 
from our data set and the reduction in statistical power previously mentioned. 
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A further limitation of this study is that only one cell type was studied in cell culture. Different 
cell types are not only exposed to different environmental cues but are epigenetically programmed to 
express a different subset of genes and undertake different functions. Cells grown in culture 
experience a vastly different environment to cells in vivo, particularly cells grown in 2D cell culture 
which poorly represents the complex 3D niche cells would normally occupy. Different cell types and 
cells derived directly from the organism as opposed to cells grown in cell culture can show different 
gene expression profiles. This can be seen in a previous study looking at liver cells taken directly from 
sacrificed NMRs which showed a markedly different gene expression profile resulting in the author 
concluding that NMRs show significantly higher expression of DNA damage genes which was not seen 
in the present study (193).  
These limitations must be considered when assigning biological significance to observations 
of the generated data. However, RNAseq still possesses the ability to provide meaningful insights into 
the transcriptome that can be built upon and validated through further analysis.  
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Chapter 5: Phenotypic evaluation of cell cycle and adhesion in fibroblasts 
5.1 Introduction 
 The RNAseq analysis in the previous chapter indicated that cell adhesion molecules (CAM) 
showed greater expression in skin fibroblasts derived from NMRs than those from mice. This was 
determined through functional enrichment which showed that CAMs were over-represented in the 
data sets and through analysing expression levels of CAMs which showed significantly higher 
expression in NMRs. Additionally, genes involved in cell cycle progression were also differentially 
expressed as identified from the functional enrichment analysis.  
 The aim of this chapter is to determine whether or not the differences in gene expression 
reflect differences in the cellular phenotype. Detecting differences in cellular adhesion or cell cycle 
progression post cellular stress in these primary cell cultures would provide phenotypic confirmation 
of our results. Additionally, cell adhesion has been associated with a wide arrange of biological 
processes and may influence the NMR’s cancer-resistant phenotype.  
 To determine if differences in cell adhesion can be detected a trypsin-based detachment assay 
was conducted to identify how long it takes to remove each cell type from a culture plate using trypsin 
and EDTA. To complement that assay an attachment assay was performed to determine how quickly 
the cells would attach to a culture plate. Finally to evaluate the rate of cell cycle progression flow 
cytometry was performed. 
5.1.1 Cell adhesion 
Cell adhesion is important in cell growth, migration and differentiation. CAMs are proteins at 
the cell surface that mediate cell-cell interactions and interactions between the cell and the 
extracellular matrix. CAMs are thought to be integral to a wide variety of cellular processes including 
inflammation, cellular communication, and apoptosis (510). There are many different types of CAM, 
but these mostly fall into one of several superfamilies. These can be calcium dependent such as the 
integrins, cadherins and selectins (511-513) or calcium independent such as the immunoglobulin 
superfamily. The CAMs claudins and occludins may be dependent on intracellular but not extracellular 
calcium (514). 
CAMs play a central role in metastasis. Metastasis is the process by which cancer cells leave 
their tumour of origin and relocate to another part of the body where they can proliferate to form a 
secondary tumour. This process can be divided into three key stages: invasion, intravasation and 
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extravasation. Invasion is when the cells become motile, passing through the extracellular matrix. Loss 
of cell adhesion in cancer cells facilitates this by allowing the cells to leave the primary tumour and 
move to other areas of the body. Motility of the cell also requires CAM activity. Intravasation is the 
process of entry into the vasculature by cells. Once inside the circulatory system cancer cells can be 
transported great distances. In order to leave the vasculature through the process of extravasation, 
CAMs need to adhere to the endothelium.  
 Tight junctions are connections made by claudins and occludins between two cells. These 
junctions close the intracellular space essentially creating an intracellular fence between the two cells 
(515). This barrier can serve to physically block metastasising cells from entering tissues (516). 
Additionally, these junctions stick cells together and can prevent their release and spread by 
metastasis (517). Studies have shown decreased activity of tight junction proteins in breast cancer 
cells and background tissues indicating their clinical relevance (498). 
 Adherens junctions are another cell-to-cell adhesion structure. Cadherins are the primary 
component of these junctions with E-cadherin being the most abundant of these. The structure of 
these junctions varies between cell types, but in fibroblasts, they seem to form distinct spots on the 
cell surface (518). E-cadherin is downregulated in most epithelial cancers (497) and generating these 
E-cadherin adhesion sites has been shown to prevent the invasion of cancer cells (519, 520). 
 Disruption of adhesion to the extracellular matrix has been shown to be able to induce 
apoptosis through integrin-mediated signalling (521, 522). Similarly, the Deleted in Colorectal Cancer 
(Dcc) gene encodes a cell surface adhesion molecule in the Ig superfamily. Inactivation of this gene 
has been associated with cancer progression in humans, and its activity promotes apoptosis or cell 
cycle arrest (523). Hence such CAMs could prevent cancer by preventing growth or inducing apoptosis 
of cancer cells with abnormal interactions to the extracellular matrix or other cells, particularly in cells 
undergoing metastasis which would have no such interactions while traversing the vasculature. 
Coxsackie and adenovirus receptor (CAR) is an Ig-like molecule with cell adhesion properties that has 
been shown to inhibit tumour cell proliferation and induce accumulation of p21 (524).  
 CAMs may also act to promote cancer. Studies of integrin αv show increased expression in 
cancer cells that were more prone to metastasis (525) and knock down of integrin αv decreased cancer 
cells’ capacity for metastasis (526). These studies propose that integrin αv acts during motility and 
extravasation. E-selectin has also been shown to be capable of facilitating extravasation (527).  
 Collectively the above studies clearly show a strong role for CAMs in cancer formation and 
progression. It is interesting that our RNAseq analysis showed a large amount of differential expression 
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of genes at the cell surface including CAMs between mouse and NMRs. It is tempting to speculate that 
this may be a contributing factor to the NMR’s apparent cancer resistance. To determine if changes in 
cell adhesion between the two species could be detected a simple trypsinisation assay was performed. 
In cell culture, cells attach to the culture vessel initially through electrostatic interactions 
between the cell and the culture vessel surface. This interaction facilitates integrin binding. The cells 
which were spherical in suspension become flatter due to both natural deformation and active 
reorganisation of the cellular structure providing a greater surface for attachment. Re-organisation of 
the actin cytoskeleton takes place and focal adhesions form (528, 529). Focal adhesions are highly 
organised structures that connect the binding substrate to the cytoskeleton and are important in cell 
signalling and proliferation among other cellular functions (530, 531). The longer the cell remains 
attached to the surface the more adhesion molecules can bind and the greater the strength of 
attachment up to a point presumably when there is no room for additional adhesion molecules to act 
(529). 
To detach a cell that has adhered to a culture flask, trypsin is typically added. Trypsin is a serine 
protease that cleaves peptide chains primarily at the carboxyl side of either arginine or lysine residues 
(532). This results in the CAMs (and any other susceptible protein on the cell surface) being cleaved, 
cutting the connection to the plate’s surface and hence detaching them. An alternative method to 
remove the cells is to use a calcium chelating agent such as EDTA or sodium citrate. This works because 
integrins (and various other CAMs) are calcium dependent in their binding activity and the removal of 
available calcium results in the bonds being broken without damaging the surface proteins (533). 
Typically a combination approach is used in which trypsin and EDTA are added together. The more 
CAMs connecting the cell to the culture plate surface, the stronger the connection and presumably 
the longer it will take to detach the cell with trypsin or EDTA. By monitoring how long it takes cells 
from both species to be detached in response to trypsin and EDTA differences in CAM abundance can 
be inferred.  
5.1.2 Cell cycle  
The cell cycle is essentially the life cycle of the cell. It is comprised of multiple different stages 
that a cell may undergo. Interphase, a period of cellular growth and DNA synthesis makes up the 
majority of the cell cycle and is comprised of 3 distinct phases (Figure 5.1).  
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Figure 5.1. Stages of the cell cycle. Points of Cyclin/CDK activity have been indicated. Taken 
with permission from (534). 
G1 or Gap 1 is the primary growth phase. During this phase, the cell synthesises new proteins 
and organelles (such as mitochondria) and increases in size. As these are divided between the two 
new daughter cells, this phase allows these components to be replaced. This phase also contains the 
G1 checkpoint that ensures that everything is ready for DNA synthesis, arresting the cell cycle if this is 
not the case. Cell cycle checkpoints are principally controlled by cyclins and cyclin-dependent kinases 
(CDKs). These CDKs are highly functionally conserved between species (535). At the G1 checkpoint, 
cyclin D is essential (536). Cyclin D binds to CDK 4 or 6 and once activated by CDK-activating-kinase, it 
phosphorylates Rb in the nucleus. Phosphorylation of Rb prevents its usual inhibitory activity on the 
E2F transcription factors that in turn promote the transcription of a variety of genes that promote 
transition into S phase. These include cyclin E and CDK2 which phosphorylates Rb, forming a positive 
feedback loop (536, 537). Upon detection of DNA damage or other defects, this process can be 
disrupted to result in cell cycle arrest and prevent entry into S phase. ATM (ataxia telangiectasia 
mutated) and ATR (ataxia telangiectasia and rad3-related protein) are activated in response to DNA 
damage and in turn, activate checkpoint kinase 1 and 2 (CHK1 and 2). These ultimately inhibit cyclin 
E/CDK2 to prevent cell cycle progression. Additionally, CHK1 and 2 stabilise and activate p53 which in 
turn promotes transcriptional activation of p21 which inhibits cyclin E/CDK2 and hence inhibits entry 
into S phase. Alternatively, p21 may be activated by accumulation of p16 (538).  
Providing no inhibitory signals are detected the cell will continue into S phase, the synthesis 
phase during which all the DNA in the cell is duplicated. This stage is in part regulated by cyclin A which 
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binds CDK 2, replacing cyclin E. This complex regulates DNA synthesis through phosphorylation of 
components of the DNA replication machinery (539). While the DNA undergoes replication, it is 
vulnerable. Single-strand DNA is more susceptible to chemical modification, and replication forks are 
prone to stall or collapse if blocked. Defects in DNA synthesis during this phase (and also DNA defects 
in the other stages) can be detected through the detection of long strands of ssDNA coated in RPA 
that serves as a warning signal (540). This process acts via ATR and results in a temporary halt in S 
phase progression (540). It is thought that ATR can act at the replication fork to stabilise it and prevent 
further unwinding of the DNA until replication has completed (541, 542). Should the replication fork 
stall due to defects in the DNA strand, ATR acts through phosphorylation of CHK1 to protect the 
replication fork (540).  
Once the cell’s DNA has successfully been replicated, the cell enters the G2 or Gap 2 phase. 
G2 is another period of protein synthesis and cellular growth, however, it appears not to be essential 
as some cell types and cancers bypass G2 and transition from S phase directly into mitosis (543, 544). 
Through G2, cyclin B accumulates, binding to and activating CDK1 (545). CDK1 is phosphorylated and 
inactivated by WEE1 (WEE1 G2 checkpoint kinase), but activated CDK1 inactivates WEE1 and activates 
CDC25 (cell division cycle 25A) which dephosphorylates and hence activates CDK1 forming positive 
feedback loops (546). Such positive feedback loops ensure commitment of cells transitioning between 
stages of the cell cycle. Once the required concentration of activated cyclin B/CDK1 has been reached, 
it translocates to the nucleus and phosphorylates a number of targets including histone proteins and 
centrosomal proteins to facilitate mitosis (545). DNA damage results in activation of the transcription 
factor p53 that promotes the expression of p21, Gadd45 (growth arrest and DNA damage inducible 
alpha) and 14-3-3σ which inhibit the activity of cyclin B/CDK1 by preventing cyclin B and CDK1 binding 
(Gadd45), sequestering inactive cyclin B/CDK1 in the nucleus (p21), or sequestering active cyclin 
B/CDK1 in the cytoplasm (14-3-3σ) (547). Additionally, p53 transcriptionally inhibits CDK1 (547). ATR 
and ATM also act in response to DNA damage and act through CHK1 which promotes the degradation 
of CDC25 and hence inactivation of CDK1 (548). ATR and ATM also activate p53 (547). These pathways 
that inactivate cyclin B/CDK1 result in cell cycle arrest at G2.  
Once cells pass through G2, they enter M phase, which is mitosis. Mitosis consists of 4 key 
stages, prophase, metaphase, anaphase and telophase. Prophase is dominated by chromatin 
condensation, a process that condenses the DNA into tightly bound chromosomes. Additionally, the 
nucleolus disperses, and the centrosomes separate, moving to the poles of the cell. An intermediate 
phase referred to as prometaphase is the period in which the nuclear membrane breaks apart and 
newly synthesised microtubules attach to the kinetochores of each chromosome. In metaphase, the 
chromosomes align at the metaphase plate, a line equidistant to each of the centrosomes. This 
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alignment is due to the counterbalance of each microtubule’s polling force. This tension indicates 
appropriate spindle attachment, without which the cell would not progress into anaphase, and hence 
serves as a checkpoint. Detection of this results in activation of anaphase-promoting complex which 
degrades securin, which functions to inhibit seperase (549). Seperase is an enzyme that breaks down 
cohesins, the proteins responsible for binding the two sister chromatins together (550). The enzymatic 
cleavage of this bond releases the two sister chromatids which then move to opposite ends of the cell, 
towards the centrosomes. Anaphase consists of this chromatid movement. Additionally, the non-
kinetochore bound spindle fibres push against each other to elongate the cell.  
The final stage of mitosis is telophase. The nuclear membrane reforms, chromatids unwind 
into chromatin and nucleoli reform. Additionally, the remaining microtubules de-polymerise and the 
cell splits in two through cytokinesis. In animals, cytokinesis acts through a contractile ring of myosin 
II and actin filaments that forms equatorially. This ring contracts, pulling the cell membrane with it to 
divide the cell. The process of abscission finalises this process by cleaving the cell in two at the 
contracted point.  
In addition to G1, S, G2 and M phase the cell can exit the cell cycle and enter G0. Cells in G0 
are either quiescent or senescent. Quiescent cells are not dividing nor preparing to divide; this may 
be a temporary delay or a permanent exit from the cell cycle. Senescence is considered an alternative 
to apoptosis as it removes damaged cells that may produce defective progeny from the cell cycle 
permanently. An important concept that is often overlooked is that senescent cells, though no longer 
dividing, are still performing their cellular function, and communicating with other cells. In the case of 
senescent cells, this can have negative consequences (406). 
5.1.2.1 Flow cytometry 
A flow cytometer can simply be considered a liquid pump that takes cell solutions and passes 
them through a small channel with a sensor that detects the cell. This sensor can detect changes in 
electrical opposition, known as electrical impedance or changes in fluorescence. The flow cytometer 
then counts the number of ‘events’ or times a signal is detected to infer the number of cells to pass 
the sensor. The sensor can also monitor the level of fluorescence detected. By staining DNA with a 
fluorescent dye, we can not only count the number of cells but also assess the DNA content of the cell. 
Different stages of the cell cycle have different DNA contents. G1 has the normal DNA content for a 
species; G2 will have double this amount, and hence the fluorescence of such cells would be twice as 
bright. Cells in S phase will have an intermediate amount of DNA and hence fluorescence as only a 
part of the DNA will be synthesised. Cells in G0 are typically indistinguishable from those in G1 as they 
typically have the same DNA content. Apoptotic cells have a lower DNA content as they undergo DNA 
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fragmentation. Additionally, senescent cells may lose DNA content, and hence these cells will have 
lower fluorescence (551-553). 
5.2 Aims 
 Cell cycle checkpoint controls are important factors in DNA damage repair. As discussed 
previously these checkpoints allow the cell to check for DNA damage and respond appropriately. The 
position of a cell in the cell cycle can affect damage repair. For example, homologous recombination 
can only occur if an extra copy of the cell’s DNA is present, namely during G2. By identifying differences 
in cell cycle progression between NMR and mouse we can speculate about differences in DNA damage 
responses and repair. 
 Cell adhesion genes have been shown to influence cancer, both inhibiting and facilitating its 
development. By identifying differences in cell adhesion between the NMR and mouse we aim to 
confirm the results of the RNAseq analysis that suggested such differences and identify a potential 
causal factor in the NMR’s cancer-resistant phenotype.  
 
5.3 Materials and methods 
5.3.1 Culture conditions 
 Cells were cultured as described in Chapter 3.3.1. In short, cells were cultured at 35ᵒC, 3% 
oxygen and 5% carbon dioxide in MEM supplemented with 15% FBS, 1% Penicillin streptomycin, and 
0.1% fungizone. Only the beta cell stocks were used in this assay. 
5.3.2 Detachment and attachment assays 
 Cells were plated in t25 culture flasks. Low cell numbers were used (mouse ~10,000, NMR 
~4,000) to ensure normal growth and no overlap between the cells that may affect trypsin activity. 
Fewer NMR cells were used due to limited availability. Cells were given 24 hours to attach before being 
treated with either LD50 camptothecin (NMR: 128µM mouse: 57µM), chromium (NMR: 94µM mouse: 
49µM) or control conditions for 2 hours. Cells were allowed to recover for 24 hours. The plates were 
visually inspected to ensure there was no significant overlap or contact between cells. 
 The detachment assay was run as described in (554). In short, each dish was rinsed with PBS 
then 0.5% trypsin 2.21mM EDTA (Sigma Aldrich: 03620). This was collected and replaced after 1, 2, 3 
and 5 minutes. Care was taken to minimise agitation and trypsin was pipetted gently to prevent the 
cells being washed off. After 5 minutes the plates were inspected to ensure all cells had detached. The 
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cells were spun down at 1,000rpm for 10 minutes and resuspended in 200µl fresh media and counted 
using a haemocytometer. This was performed twice per cell line in one experiment.  
 For attachment assay, the cells were trypsinised with 0.5% trypsin 2.21mM EDTA. These were 
spun down at 1,000rpm for 10 minutes and resuspended in fresh media. Each condition was plated in 
duplicate into a well of 4 96-well plates (one per time point of analysis). Approximately 200 cells were 
added per well. After 1, 2, 4, or 6 hours the media containing unattached cells was removed and 
replaced with 70% ethanol (Sigma Aldrich: E7023) to fix the attached cells for at least 10 minutes at 
4ᵒC. The ethanol was aspirated and replaced by Hematoxylin Solution (sigmaMHS80). This was allowed 
to stain for 1 minute to aid cell counting. The cells were then rinsed twice with 200µl PBS, and cells in 
each well were counted manually. This was performed twice per cell line in one experiment. 
5.3.3 Initial cell surface area prediction 
 Images were taken of at least 3 cells per primary cell culture for each treatment. The radius of 
each cell was measured twice (horizontally and vertically) to calculate an average value. These values 
were averaged across each primary cell culture of the same species for each treatment (total of 9 
cells). The species average radius was used to predict the species average surface area using the 
equation, 4πr2 (r=radius). For the purpose of this estimation, cells were assumed to be perfect spheres.  
5.3.4 Flow cytometry 
 Initially, 24 and 6 well plates were used to grow the sample cells but provided too few cells 
for the analysis and hence T25 culture flasks were used. Cells for flow cytometry were treated for 2 
hours at LD50 while at near confluency and allowed to recover for 24 hours. These were then removed 
from the plate with trypsin. Cells were centrifuged at 1,000g for 10minutes, resuspended in 1ml PBS 
to rinse, and then centrifuged again at 1,000g for 4 minutes. The cells were then resuspended in 70% 
ice cold ethanol and left for 1 hour at 4ᵒC to fix before transfer to -18ᵒC freezer for storage until use. 
Cells were centrifuged at 1,000g for 4 minutes and resuspended in 200µl fresh PBS and transferred to 
a 96 well plate. To each well, 25µl Triton X 0.9% (Sigma Alderich T8787), RNase A 0.9mg/ml (Sigma 
Alderich R4875), Propidium Iodine (Sigma Alderich P4170) 0.1mg/ml in PBS was added. The plate was 
immediately transferred to the flow cytometer and analysed using Guava Cell Cycle Analysis software. 
The total number of cells analysed for each cell line and treatment is given in Appendix Table 8. This 
was performed twice per cell line in two independent experiments. 
 Median forward scatter (FSC) values were calculated by manually changing the gating with 
the guava cell cycle software until only half the cells were included. Cells that fell into G0 were not 
included in this assay to prevent changes in cell size due to cell death affecting the analysis. FSC was 
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found to be consistent through all other cell stages, and hence these were not differentiated within 
the analysis.  
5.4 Results 
5.4.1 Cell adhesion assays 
 To assess adhesion strength the time taken to detach cells with trypsin and EDTA was 
determined (Figure 5.2). Mouse cells appeared to detach faster, though this was only statistically 
significant in stressed cells after 3 hours and this difference was very small. Chromium and 
camptothecin-treated NMR cells (chromium: 91.2%, camptothecin: 97.5%) showed a significantly 
lower percentage of detached cells at three hours compared to mouse cells (chromium: 99.4%, 
camptothecin: 99.6%) under the same treatment (chromium: t(4)= 4.2 p=0.014 , camptothecin: t(4)= 
8.3 p=0.001). Similarly, stressed cells also appeared to detach more slowly particularly in NMR cells 
however this is not statistically significant.  
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Figure 5.2. Percentage of cells (beta stock) that detach after varying levels of trypsin exposure after 
24 hours of cell culture post-treatment for 2 hours with genotoxic insult or control conditions. Cells 
were exposed to 0.5% trypsin 2.21mM EDTA. After 3 hours exposure to trypsin, genotoxin treated 
NMR cells show a significantly lower percentage of cells as some cells remained attached while 
complete detachment was seen in mouse cells (camptothecin: t(4)=8.28 p=0.001, chromium: t(4)= 
4.16 p=0.014). No other significant differences in detachment patterns between times or species 
were observed. However genotoxic treatment seemed to delay the rate of initial cell detachment in 
both species (after 1 minute of trypsin exposure) though this delay is not significant. Abbreviations, 
con – control, cam – camptothecin, and chro – chromium. Error bars indicate ± one standard error of 
the mean between three different cell lines (each cell line value is the average of 2 replicates in one 
experiment). Star (*) indicates significance at the p<0.05 level. All counts consisted of ~100 cells for 
samples with less than 100% detachment. 100% indicates the following total number of cells per 
sample, mouse control – 112,888 cells, mouse camptothecin-treated – 94,667 cells, mouse chromium 
(vi) oxide treated – 90,778 cells, NMR control –16,333 cells, NMR camptothecin-treated – 13,444 
cells, and NMR chromium (vi) oxide treated – 14,666 cells. 
 In addition to detachment, the time for trypsinised cells to re-attach to a standard 96 well 
culture plate was determined (Figure 5.3). NMR cells under control conditions appeared to adhere 
slower than mouse control cells though this was not statistically significant. Treatment with either 
genotoxic compound decreased the rate of attachment in NMR cells though not significantly.  
Similarly, treatment with either compound appeared to increase the rate of cellular attachment in 
mouse cells thought this was only statistically significant at 2 hours for chromium treatment (control: 
55.5% chromium: 94.3%, t(3)=-3.3 p=0.047) though camptothecin showed near significance after 2 
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hours (p=0.066). A two-way analysis of variants (ANOVA), taking time point as one factor and 
treatment and species as another showed significant variation between the treatment and species 
condition (f(5, 35)=18.4, p=0). Post hoc Turkey test showed NMR cells treated with either compound 
had significantly lower attachment than all mouse conditions (p<0.05) and mouse cells treated with 
either compound had significantly higher attachment than all NMR conditions (p<0.05). 
 
Figure 5.3. Attachment rate of mouse and NMR cells (beta stock) exposed to genotoxic insult. 
Treated cells from each species were significantly different from cells of the other species regardless 
of treatment. Mouse cells appear to attach faster than NMR cells, especially after genotoxic 
treatment. Mouse cells treated with control conditions showed significantly lower attachment to 
chromium treated cells (t(3)=-3.3 p=0.047) and near significance to camptothecin-treated cells (t(4)=-
2.5 p=0.066) after 2 hours. NMR cells appear to attach slower after genotoxic treatment though this 
is not statistically significant. Abbreviations, con – control, cam – camptothecin, and chro – 
chromium. Error bars indicate ± one standard error of the mean between the three cell lines within 
each species (each cell line value is the average of two replicates in one experiment). Solid error bars 
indicate mouse samples and dashed error bars indicate NMR samples. 100% indicates the following 
total number of cells and cells counted for each of the following, mouse control – 796 cells, mouse 
camptothecin-treated – 603 cells, mouse chromium (vi) oxide treated – 411 cells, NMR control – 502 
cells, NMR camptothecin-treated – 375 cells, and NMR chromium (vi) oxide treated – 355 cells. 
 
 To assess whether differences in cell surface associated gene expression are due to variations 
in cell size between NMRs and mice, the average surface area was initially predicted for each species 
under each condition by measuring the diameter of a small sample of imaged cells (Appendix Figure 
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11) as a preliminary indicator of cell size (Table 5.1). NMR fibroblasts (1,082.0um2) have a significantly 
smaller surface area than those derived from mice (1,610.8um2) (t(16)=3.8, p=0.001) (Figure 5.4) 
based on this data. There was no significant difference between treatments in either species. 
 
Table 5.1. The average surface area of mouse and NMR skin fibroblasts in µm2. 
 Mouse NMR 
con 1,489.0 1,101.7 
cam 1,422.6 1,061.9 
chro 1,920.7 1,082.4 
 
 
Figure 5.4. Visual representation of predicted cell size of fibroblasts derived from mice and NMRs. 
As a follow-up analysis, the flow cytometry data presented in Section 5.4.2 was utilised. 
When the laser in the flow cytometer shines onto a cell passing through the detector, the light is 
scattered. Light that passes through the cell and is scattered less than ~2⁰ relative to the original 
path of the laser is called forward scatter (FSC). The scattering of light by a cell is a result of the cells 
size, shape, structure and the refractive index (and absorption) of the contents of the cell (491). FSC 
is closely related to the size of the cell as this light passes through the entirety of the cell, the greater 
the FSC, the greater the size of the cell providing no other factors that affect light scattering change. 
As such for this analysis we assume that all the cells vary only in size and not their reflective index. 
This is a reasonable assumption as these are cells of the same type, though variation between 
species may exist. Median FSC (Table 5.2) did not vary significantly between treatments within 
species. This matches our preliminary analysis of cell size. However, though no statistically significant 
difference exists it is of note that camptothecin-treated cells consistently showed slightly higher FSC 
and chromium treated cells showed slightly lower FSC. This may suggest these cells are reacting 
differently. This difference was greater in mice with NMRs showing less variation between 
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treatments. NMR cells showed significantly lower FSC than mouse cells (t(13)=-4.40, p=0.001) and a 
one way ANOVA with turkey post hoc analysis showed significant differences (F(5, 9)= 7.81, p=0.004) 
between camptothecin-treated mouse cells and any NMR sample (p<0.05) and near significance 
between control cells of both species (p=0.06). Again, this confirms the preliminary analysis that 
suggests that NMR cells are smaller than mouse cells.  
Table 5.2. The median forward scattering (FSC) of Mouse or NMR cells treated with camptothecin 
(cam), chromium (vi) oxide (chro) or under control conditions (con). 
 Median FSC 
Total cell 
count Std dev 
Mouse con 1,730.67 1,8567 40.67 
Mouse cam 1,855.17 1,6142 106.50 
Mouse chro 1,635.33 1,0283 59.07 
NMR con 1,464.00 552 125.87 
NMR cam 1,523.00 318 80.61 
NMR chro 1,504.50 1,015 106.77 
 
5.4.2 Flow cytometry 
 To assess the progression of the cells through the cell cycle, flow cytometry was performed 
(Appendix Figure 12 - 14). There were no significant differences between species or treatment. NMR 
cells treated with camptothecin appeared to show increased arrest at G2 (control: 14.5% 
camptothecin: 25.3%), however, this was not statistically significant (Figure 5.5). It is of note that a 
large increase in cells arresting at G2 (97.7%) was seen in one replicate. This was not reproduced in 
subsequent assays. However, all subsequent assays used a lower number of cells (Appendix Table 8) 
that may reduce the accuracy of these results. ANOVA analysis indicated that each component of the 
cell cycle differed significantly (F(2, 36)=55.4 p=0) with G2 showing the greatest accumulation, and S 
phase the smallest. 
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Figure 5.5. The percentage of living cells at each position in the cell cycle for mouse and NMR cells 
(beta stock) after 24-hour post-treated with genotoxic compounds after 24 hours of cell culture. Each 
position of the cell cycle showed significant variation from each other stage for both species (F(2, 
36)=55.4 p=0). There was no significant variation between species or treatment, however, NMR cells 
treated with camptothecin seemed to show greater arrest in G2, however, this was not statistically 
significant. Abbreviations, con – control, cam – camptothecin, and chro – chromium. Error bars 
indicate ± one standard error of the mean between three cell lines (each composed of two average of 
two independent experiments). Total number of cells examined is given in Appendix Table 8. 
 
 Additionally, the proportion of cells that did not fall within G1, S or G2 was assessed (Figure 
5.6). These cells that had a lower DNA content than at G1 comprised primarily apoptotic cells, though 
they may also include senescent cells. Camptothecin treatment in NMR cells appears to have resulted 
in an increase in such cells however this is not significant (control: 62.4%, camptothecin: 74.2%). The 
proportion of these cells was the same for both species after treatment which we would expect as 
both species were treated with LD50. There was no significant increase in these cells after treatment 
relative to controls indicating a similar number of apoptotic or potentially senescent cells. 
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Figure 5.6. The percentage of senescent and/or apoptotic mouse or NMR cells (beta stock) 24 hours 
after genotoxic treatment. Statistically, there was no significant difference between any of the 
samples or treatments. However, NMR cells appear to show more senescence and/or apoptotic cells 
than mouse cell after camptothecin treatment. Abbreviations, con – control, cam – camptothecin, 
and chro – chromium. Error bars indicate ± one standard error of the mean between three cell lines 
(each are the average of two independent experiments). Total number of cells examined is given in 
Appendix Table 8. 
5.5 Discussion 
 In the previous chapter, it was demonstrated that NMRs’ fibroblasts have greater levels of 
gene expression of cell adhesion genes than fibroblasts derived from mice. Here we demonstrate 
phenotypic variations in cell adhesion. NMR cells appear to show slower attachment than mouse cells. 
This difference was not significant in control condition but was in cells treated with genotoxic 
compounds. Both NMR and mouse cells showed opposite responses with NMR cells showing slower 
attachment and mouse cells having accelerated attachment in response to the stress. This observation 
disproves our initial hypothesis that NMR cells are too ‘sticky’ to metastasise or develop into tumours. 
However such differences in adhesion may influence the differences in cancer incidence observed in 
mouse and NMRs. Cancer cells rely on cellular adhesion to facilitate motility and extravasation during 
metastasis. Cells that bind to surfaces less readily would be slower or less capable of metastasising. A 
lack of metastasis would limit any cancerous cells to the primary tumour and hence would be 
considered benign and would be more difficult to detect. Once the cells have attached to a substrate, 
there does not appear to be any difference in cell attachment strength as both NMR and mouse cells 
took similar times to detach in response to trypsin treatment. NMR cells did seem to take a little longer 
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to detach though this was only significant at 3 minutes in treated cells and only a very small difference 
was observed (a difference of 2% (camptothecin), and 8% (chromium) difference between species) 
and hence is likely not biologically significant. NMR cells appear smaller than mouse cells, hence these 
cells will have a smaller surface area in contact with the attachment surface, and there for the 
increased expression of cell adhesion genes may simply compensate for this to give similar levels of 
cell adhesion between differently sized cells. As our data suggests similarities in cell cycle progression, 
the observed difference in cell size should not be due to cells being in different parts of the cell cycle.  
 Statistically, there was no difference in cell cycle progression between species or treatments. 
This is unusual considering the differences in expression of a number of cell cycle regulating genes 
such as p53 and p21 observed in the RNAseq data. One replicate did, however, show a large 
accumulation of NMR cells in G2 after treatment with camptothecin. This observation would match 
the gene expression profile observed in the previous chapter that showed a number of genes known 
to induce arrest at G2 were differentially expressed. Increased arrest in G2 may facilitate superior 
repair of double-strand breaks due to the presence of two sets of genomic DNA that allows for 
homologous recombination. Were more time available the results of this assay would be checked by 
repeating the assay with a greater number of cells. As no difference in cell cycle progression is 
observed, we must conclude that after 24 hours post-treatment there is no remaining growth arrest. 
Perhaps a sooner time point after treatment would provide more insight into any differences in cell 
cycle progression. Were more time available more time points post stimulus would be studied to 
ensure differences in cell cycle progression were not being missed.  The proportion of cells in G0 is the 
same both between treatments and species. These cells in G0 represent cells undergoing cellular 
senescence and apoptosis. We would expect the treatment at LD50 to drastically increase the 
proportion of apoptotic cells. However, this is not observed indicating that the cells killed by the 
genotoxic treatment have already died and been removed from our test population. Similar levels of 
G0 match the previously observed amount of cellular senescence after 24 hours post-stress between 
species in Chapter 3.4. However, we would expect to see an increase in stressed mouse cells relative 
to mouse controls as a drastic increase in cellular senescence was observed in Chapter 3.4 between 
untreated and LD50 treated cells. This indicates that cells in G0 are not representative of levels of total 
cellular senescence.  
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Chapter 6: General discussion 
6.1 Discussion 
 In this study, we have used a transcriptomic approach to guide research into successful ageing. 
Two opposite approaches were taken to gain a broad overview of life-extending processes. Firstly, the 
examination of whole organisms experiencing a lifespan and health-span extending intervention in 
the form of C. elegans undergoing caloric restriction or treatment with caloric restriction mimetics. 
Secondly, we studied in detail differences at the cellular level between a long (H. glaber) and short (M. 
musculus) lived organism through cell culture studies. These two approaches looking between and 
within species to study changes of health-span and lifespan provide a complementary view of these 
aspects. 
 Firstly, microarray analysis of C. elegans undergoing caloric restriction or treatment with the 
caloric restriction mimetics rapamycin and allantoin was conducted in Chapter 2. This analysis showed 
that the newly discovered caloric restriction mimetic allantoin induced a similar gene expression 
profile to caloric restriction, helping to confirm its status as a caloric restriction mimetic. This similarity 
was greater than was seen in the well-established caloric restriction mimetic, rapamycin. Functional 
enrichment analysis of these caloric restriction mimetic treated worms showed enrichment of 
differentially expressed genes related to development. Genes that act early on in development to 
promote rapid growth and survival may continue to act inappropriately in later life and result in 
ageing. Hence alterations in such activity may promote successful ageing. Rapamycin treatment and 
caloric restriction are known to inhibit cellular growth (555, 556) and delay development in a variety 
of model organisms including C. elegans (557-561). These changes in development are not equal 
between treatments showing different levels of lifespan extension pathways activity despite similar 
changes in lifespan (72). It is not clear if these developmental factors are a cause or consequence of 
the anti-ageing activity of these treatments. Allantoin and rapamycin treatment produced different 
transcriptional profiles with a large number of differentially expressed genes being identified between 
these two treatments. This suggests that these compounds act differently.  
 Additionally, differentially expressed genes relating to the cell surface and the cell cycle were 
also enriched. Differences in cell cycle progression could prolong lifespan in accordance with the 
‘reproductive-cell cycle theory of ageing’. As has been discussed in Chapter 2.5, this theory states that 
early processes that promote required cellular growth early in life continue to act in later life when 
such growth is not required. This inappropriate growth is considered a driving force in ageing. More 
appropriate cell growth may allow for conserving of resources, and more rigorous checking of cellular 
damage to prevent propagation of cellular defects. Changes in cell cycle may act to prolong ageing in 
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the same way as changes in development, or may simply be a consequence of changes in 
development. Differences at the cell membrane may be a result of the changes described above or 
may be due to the cell surface being directly exposed to the compounds with which the worms were 
treated. Cell surface proteins are typically involved in cellular signalling or cell adhesion. Cellular 
signalling may be essential in successful ageing to communicate external signals such as life-extending 
treatments or cellular signals from other cells exposed to such treatment to coordinate a global 
response.  
 Were this study to be continued, the compounds of interest would be administered to older 
worms to avoid the possibility that the compounds are simply delaying the rate at which the worms 
are developing. A longer period of drug treatment could be studied to identify the effects of chronic 
exposure and how this affects normal age-associated changes in gene expression. 
 Secondly, we studied in detail skin fibroblasts derived from the NMR and mice. In Chapter 3 
we found that NMR fibroblasts were significantly more resistant to two DNA-damaging compounds, 
camptothecin and chromium (vi) oxide. The NMR cells required a higher dose of these compounds to 
kill half the cells in the sample. Additionally, treatment with these compounds resulted in a large 
increase in cellular senescence in mouse but not NMR cells. An increased capacity to handle genotoxic 
stress may contribute to the NMR’s long lifespan and cancer-resistant phenotype. DNA damage is 
largely considered a key cause of ageing and cancer. Cells that prevent the accumulation of DNA 
damage through quick or successful repair of this damage or by otherwise successfully managing such 
damage will age slower and will be less inclined to become cancerous. Senescent cells which are 
irreversibly exited from the cell cycle are often considered to be simply off. This is not the case; such 
cells continue to perform their cellular function and signal to neighbouring cells.  Senescent cells can 
secrete pro-inflammatory cytokines, and growth factors that disrupt normal cellular architecture and 
function and have been found to promote cancer development (562). Additionally, senescent cells 
often show increased secretion of metalloproteinases, disrupting extracellular proteins and promoting 
cancer as a result (563). Furthermore, senescent cells have been associated with ageing and other 
ageing related pathologies (406, 564) with one study that selectively removed senescent cells from a 
prematurely ageing mouse model resulting in delays in ageing-associated disorders (565). As such, 
reduced accumulation of senescent cells could delay ageing and cancer onset. Higher base levels of 
senescent cells were seen in NMRs, however, this may be a result of such cells accumulating between 
less frequent passages due to slower growth in NMRs or sub-optimal growth conditions in the 
relatively new model organisms. To assess this, cells taken directly from mice or NMRs should be 
assessed to evaluate the number of senescent cells found in vivo. 
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 An RNAseq analysis of NMR and mouse primary skin fibroblasts responding to treatment with 
these genotoxic stressors was performed in Chapter 4. A large difference in cell surface proteins, 
particularly cell adhesion proteins, was observed between mouse and NMR cells under all conditions. 
NMRs show significantly higher expression of cell adhesion genes. Functional enrichment showed 
similar differences between control and treated NMR cells, potentially indicating a role in the stress 
response. Cell adhesion is involved in an array of different cellular processes as well as cancer 
development and prognosis (510, 516). Differences in such gene expression may explain the NMR’s 
pronounced cancer-resistant phenotype. Increased cell adhesion may physically inhibit the growth of 
a tumour, and can prevent metastasis (516, 517). A decrease in cell adhesion may prevent 
metastasising cells from establishing in new areas of the body (519, 520). These differences in cellular 
adhesion in the skin of NMRs may have originally evolved to aid skin elasticity for squeezing through 
tight tunnels, or to aid defence and repair of bite wounds that NMRs often inflict upon one another 
to assert dominance and maintain the colonies hierarchy (566). A previous RNAseq study found the 
most highly upregulated gene in NMRs to be EPCAM a cell adhesion molecule which further hints at 
the importance of cell adhesion molecules in the NMR (192). 
 This analysis found that NMRs had either significantly lower or similar expression of DNA 
damage repair associated genes than mice. Given the finding that NMRs appear more resistant to DNA 
damaging agents, we would expect the opposite to be true. Additionally, this finding is a direct 
contradiction of previous work (193). This work suggested that NMR showed greater levels of gene 
expression relating to homologous recombination, NHEJ, MMR and DNA damage response signalling. 
However, our results show no significant difference between NHEJ, MMR or homologous 
recombination and showed that genes they termed DNA damage response signalling and NER had 
significantly lower expression in NMRs. This difference may be explained by the difference in cell type, 
as the previous study used liver cells. This highlights a potential issue with using only one cell type, as 
factors affecting an organism’s lifespan may be due to the activity of specific organs or tissues that are 
not studied in this thesis. The finding that NMRs are more susceptible to NER may explain why NMRs 
appear sensitive to UV-induced DNA damage that has been observed in previous studies (175) as this 
type of DNA repair is the key means of repairing such damage. This work brings into question the 
prevailing theory that NMR’s long life, cancer resistance and DNA damage resistance is due to increase 
DNA damage repair gene expression.  
 Additionally, cell-cycle-related genes were enriched in differentially expressed genes. This 
may be indicative of the slower growth rate of NMR cells. As discussed above, differences in cell cycle 
may contribute to increases in lifespan. Particularly, increased delays in cell cycle progression may 
indicate and facilitate increased DNA damage detection and repair, preventing damage being 
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transferred to daughter cells.  As mitosis can result in mutations becoming permanent in daughter 
cells, preventing this damage from being passed on is vital to ensure the integrity of the genome within 
a population of cells. 
 In response to the results of the RNAseq analysis, assays to detect variations in cell adhesion 
and cell cycle progression were performed in Chapter 5. Cell attachment and detachment assays were 
conducted. It was found that, despite the increased expression of cellular adhesion genes, NMR cells 
showed significantly slower attachment than mouse cells after genotoxic treatment. NMR cells 
treated with genotoxic stressors appeared to show slower attachment than control cells, but mouse 
cells showed the opposite trend, though these observations were not statistically significant. Such 
slow attachment may contribute to the NMR’s cancer resistance by inhibiting metastasising cells from 
establishing new tumours. Attachment assays indicated a slight increase in adhesion strength of NMR 
cells, but this was very small (2%-8% difference). As discussed above, increases in cell adhesion can 
inhibit cancer growth and may contribute to the NMR’s cancer-resistant phenotype. Increased 
resistance to cancer, a key source of mortality in mice (567), would help facilitate increased lifespan. 
These assays serve as a phenotypic validation to our RNAseq analysis. Flow cytometry indicated no 
significant difference in cell cycle progression, though NMR appeared to show an increase in the 
proportion of cells in G2 in one replicate, this was not repeatable. It is surprising that no difference in 
cell cycle progression was observed as this has been shown in mouse cells previously. However, this 
was using different doses and exposure times (568). Further work is needed to validate these results 
and if this experiment were to be repeated, different time points post-genotoxic insult would be 
analysed to ensure differences in cell cycle progression were not being overlooked. 
 This project has made use of transcriptomic techniques that are becoming increasingly 
accessible to direct research into successful ageing. Particularly we have identified a potentially key 
difference between the long-lived NMR and short-lived mouse that has not been studied in detail. The 
differences in cell adhesion between these two species may serve as a key factor in cancer resistance 
in the NMR. It will be of interest to perform gene expression analyses on tissues directly extracted 
from whole organisms to determine if these differences are still present when cells are grown in their 
native environment. Ideally, the expression of cell adhesion protein would be confirmed through 
western blot analysis. Excellent work is being done using chick embryos as a model to study metastasis 
of cancer cells (569). Such a system could be used to evaluate differences in metastasis between 
transformed NMR and mouse cells. Malignant mouse cells with changes in cell adhesion gene 
expression to mimic NMR cells, by increasing Selplg expression, for example, could be generated and 
the cells’ capacity to leave the primary tumour and form secondary tumours would be evaluated.  
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 The overall aim of this thesis was to better our understanding of successful ageing and 
avoidance of age-related morbidities, notably cancer. The work that makes up this thesis has 
addressed this aim in a number of ways. The work has identified a number of candidate genes that 
may be important in successful ageing. Differences in cellular adhesion between the long-lived, 
cancer-resistant NMR and the short-lived, cancer-prone mouse were discovered. Based on this 
observation and the established literature that has shown a complex role of cellular adhesion in 
cancer, we hypothesise that this cellular adhesion plays a key role in the NMR’s cancer resistance. The 
idea that differences in cell cycle progression are responsible for differences in DNA damage resistance 
has been challenged by the observed similarities in the proportion of cells in each stage of the cell 
cycle. Furthermore, our understanding of NMR cell biology has improved with assays never before 
performed on this organism, such a flow cytometry, being undertaken as well as validation of the 
available literature. Finally, vast amounts of data that are available for others to study has been 
generated. 
 In summary, we have identified a number of candidate genes that may be integral to 
successful ageing, and have identified cellular adhesion as a key component in the long-lived rodent, 
the NMR.  
 
6.2 Future work 
Were this work to be repeated or continued, a number of experiments would be changed, 
repeated or added to the set of work outlined in this thesis. A number of such experiments have 
been outlined throughout this thesis. Key experiments already discussed will be repeated in brief 
here and additional experiments proposed. 
High baseline levels of senescence were observed in the NMR, which was not seen in mice. 
This could be a caveat of the NMR’s slow growth that would result in more time for such cells to 
accumulate between the less frequent passaging required to maintain the cell stocks. Alternatively, 
this could imply suboptimal growth conditions. Were this work to be repeated or continued, the 
effect of growth conditions on growth rate and senescence would be evaluated. Key factors to be 
assessed would include FBS content, temperature and oxygen content. Other variables to assess 
could include culture media pH, starting cell density and the frequency with which the media was 
replaced. Using traditional experimental approaches, the above work would be a major undertaking, 
however by using a definitive screening design all 6 of the above variables can be analysed as well as 
assessing interactions between the variable in only 14 experimental conditions (Appendix Figure 15). 
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The number of experimental runs this type of design of experiment (DoE) requires is two times the 
number of variables to assess plus one, providing the number of variables is greater than or equal to 
6 (for more detail of definitive screening design the reader is directed to (570)). Cells would be 
grown under the conditions detailed in Appendix Figure 15, and the growth rate and level of 
baseline senescence would be recorded. This would be input into a statistical package, and a model 
generated based on the data. This model would predict the effect of each variable and second-order 
effects (the effect of one variable on another) on senescence and growth rate. The design could be 
extended to include treatment with either the DNA-damaging agent studied in this thesis or even 
species could be included as a variable so that one study would be taken as opposed to running the 
design twice (once per species). Midpoints are included to allow the assessment of curvature within 
the variable effect. Such curvature is likely as cells grow best at an optimal condition (top of the 
curve) and this growth deteriorates as the cells move away from this condition. This analysis would 
help predict optimal growth conditions for both cell lines that would facilitate future work. By 
comparing and contrasting how this varies between species we can make predictions about how the 
conditions within the animals themselves may vary. If including the frequency of media change as a 
variable in this analysis this would give insight not only to rate of nutrient depletion and waste 
accumulation but may also relate to the release of proteins into the growth media by the cells that 
may help or hinder cell growth. By including DNA-damaging agents in the study, we could identify 
optimal conditions to avoid DNA damage which may play into the mechanisms used by the 
organisms to avoid such damage. This model will assign statistical significance values to each 
variable. Those that are insignificant are considered to be having little or no impact on the rate of 
growth and can be kept constant for further work. Those that are deemed significant are having an 
effect on the rate of growth or senescence in the cells. More traditional experimental methods 
would be employed to look into specific conditions of interest to fine tune the conditions. Taking 
values from NMR and mice allows the identification of an optimal compromise as conditions that 
maximise the growth rate of both species can be selected which is ideal for small labs that only have 
limited access to incubators. 
 This thesis focuses on only one cell type, and though such an approach can provide general 
insights, it may result in biased conclusions as we have not factored in variation due to cell type. For 
example, a key finding in this thesis is that NMRs show similar or lower gene expression than mice. 
However, a previous study looking at liver cells found the opposite to be true (193), indicating 
variation between these cell types. The easiest way to address this is to extend the scope of this 
analysis to other cell types from both mice and NMRs. This would prove logistically challenging to 
obtain such cells from NMR, but once cell stocks were obtained such work would be relatively simple 
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to perform. As a minimum, I would extend this study to include hepatocytes which have been shown 
to have a different gene expression profile to that observed in skin fibroblasts in this study. 
 This study only utilised two DNA damaging agents: chromium (vi) oxide which causes a large 
array of DNA damage and camptothecin which specifically causes single-strand and double-strand 
breaks. As discussed in Section 3.5.1 camptothecin acts in a topoisomerase 1 dependent fashion, 
and hence differences in resistance to camptothecin may be dependent on differences in 
topoisomerase 1 activity. To assess this, the resistance to compounds such as bleomycin which 
specifically causes single-strand DNA damage in a topoisomerase 1 independent fashion, should be 
assessed. Additionally inducing other forms of DNA damage to mouse and NMR cells and monitoring 
how the cells respond would also prove interesting, especially given our results that showed lower 
or equal levels of gene expression in genes associated with each type of DNA damage repair 
mechanism. 
 We have looked at gene expression in detail, but the obvious next step would be to confirm 
these findings at the protein level through western blot analysis. Additionally, such an approach 
could be used to identify post-translational modifications by using antibodies specific to such 
modifications, which if present could indicate the activity of the protein of interest. By performing 
immunohistochemistry, we could also identify the cellular localisation of our protein of interest 
which could also give us an indication of activity. If we were studying a transcription factor, for 
example, a nuclear localisation might indicate activity, and a cytosolic localisation may indicate 
inactivity or alternate activity. A combination of these techniques would provide more insight into 
what is actually happening within the cell. Gene expression profiling does not take into account post-
translational modifications or translational repression of transcripts by factors such as RNA 
interference. 
To build on the findings that adhesion-associated genes are upregulated in the NMR and the 
hypothesis that these genes are, in part, responsible for the NMR’s cancer resistance, a number of 
approaches could be taken. Firstly, altering the expression of such genes in mice and monitoring the 
effect on ageing and cancer incidence or the spread of induced tumours. This could include reducing 
expression through knock down/out studies of genes thought to be beneficial and assaying for a 
negative impact, or increasing such expression and monitoring for benefits. Though possible a more 
feasible alternative, particularly as a starting point to assess which specific gene to manipulate 
would be to perform such manipulations on a short-lived animal. Assessing the effects of ageing on 
mice is difficult and expensive due to the need to maintain mice for a long period of time. 
Performing such work on short-lived animals such as C. elegans would be faster, cheaper and could 
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be done with greater sample sizes to give robust results. This approach could be applied to other 
genes of interest such as the DNA damage repair associated genes that were upregulated in NMR for 
example. 
An alternative approach outlined in Section 6.1 could utilise the chick embryo as a model of 
study to directly monitor metastasis of cancerous cells with modifications in our adhesion gene of 
choice. As I hypothesise that alteration of adhesion genes could act principally to affect cancer 
development and progression, such an approach would be ideal to confirm this. By injecting 
genetically modified cells (to increase or decrease the gene expression of the selected adhesion 
gene) we would see if this modification aided or impeded the cell’s ability to metastasise. It is of 
note that these cells would need to be transformed into cancerous cells prior to injection. 
Alternatively, genetically modified chick embryos could be produced so that normal cancer cells are 
transplanted into tissue that has altered expression of the adhesion gene of choice. If the cancer 
cells showed reduced metastasis, we would know that metastasis required any gene that had its 
expression reduced and is impeded by any gene that had its expression increased.  
If such genetic interventions showed promise the next logical step would be to treat model 
organisms in a manner that is applicable to humans. Typically, genetic modification in animal 
requires alteration of embryos and selective breeding. Such methods would not be possible in 
humans, and so alternative methods would be required such as the use of viral vectors to genetically 
modify a subset of cells or the extraction of key cells to facilitate genetic modification before 
transplanting back into the patient. For adhesion genes, we would likely wish to target fibroblasts 
and hence would ideally extract and modify MSCs which would then go on to produce modified 
fibroblasts in the patient. If the alteration of adhesion genes proved successful in preventing tumour 
cells from spreading and growing, one could hypothetically compromise by genetically modifying 
cells in specific areas to form barriers or traps to reduce the spread of cancerous cells and facilitate 
conventional anti-cancer treatments. Such hypothetical approaches could be tested in mouse 
models. 
A preferable approach would be to treat patients with a drug or protein that would promote 
the expression of our gene of choice while having minimal effects on other genes’ expressions. Such 
a compound would likely be difficult to identify, however. 
A different approach that could build on this thesis work is to look at the environment of the 
cells after treatment with genotoxic stressors. A number of genes identified through the functional 
enrichment studies are secreted and hence examining these proteins may prove beneficial. The first 
experiment would be to collect conditioned media (this was already performed throughout the 
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above work and frozen for future experimentation) that cells recovering from genotoxic insult were 
grown in. Cells could then be grown in this conditioned media and treated with genotoxic insults and 
the level of mortality and senescence evaluated relative to cells grown in unconditioned media. If 
cells grown in the conditioned media showed reduced mortality and/or senescence, this would 
indicate that the cells are secreting something that protects the cells and/or aids recovery of the 
damaged cells. Identifying what proteins are produced would be difficult, but by producing knock 
out cell lines for secreted proteins identified as highly expressed in the expression data presented in 
Chapter 4 and monitoring how this affects the ability of media conditioned by these cells to aid wild-
type cells exposed to genotoxic stress beneficial proteins could be identified. If a protein was 
identified through this method, its usefulness could be confirmed by upregulating the gene’s 
expression and monitoring how this affects cell survival in response to stress. In addition, condition 
media could be collected and purified through column chromatography to isolate the protein of 
choice. This could then be administered to cell media to create conditioned media that lacks other 
secreted proteins to confirm that the protein under study is actually causing the effect. This would 
likely require upregulation of the gene to increase protein content in the media. Secreted proteins 
that provide beneficial effects to DNA damage resistance, cancer or ageing would be useful as they 
could simply be administered to individuals directly to gain the beneficial effect. The protein could 
be expressed in E. coli for example, and produced in a fermenter. This would then be purified and 
sterilised before being administered to patients. Such a treatment would need to show efficacy in a 
model organism, but the process would require little alteration to be performed in humans if it was 
shown to be effective.  
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Appendix 
 
Appendix Figure 1. Representative images of untreated mouse and NMR cells from the beta cell 
stock. Grown for 48 hours before imaging. Mouse cell line 2 and NMR cell line 2 displayed. 
 
 
 
Appendix Figure 2. Percentage survival of NMR or mouse skin fibroblast (alpha cell stock), treated 
with sodium chromate. Error bars indicate +/- one standard error of the mean between three cell 
lines, each cell line value consisted of one replicate only. 
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Appendix Figure 3. Non-representative images of Mouse and NMR cell line 1 (beta cell stock) after 2-
hour treatment with control conditions, 160µM chromium (vi) oxide or 120µM camptothecin and 
incubated in beta galactosidase staining solution at pH6  for 3 days at 37°C at atmospheric CO2. Cam 
– camptothecin, Chro – chromium (vi) oxide. Marker indicates approximately 50µm. Despite the 
prevalence of stained cells in camptothecin-treated mouse cells, the only clear images taken did not 
contain any such cells hence the absence of staining in the image. 
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Appendix Figure 4. Standard curves generated from control cDNA samples from mouse cell line 1 
after 8 hours post genotoxin treatment. Missing points in samples are due to poor amplification 
during the qPCR analysis. Concentration in ng. 
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Appendix Figure 5. Standard curves generated from control cDNA samples from mouse cell line 1 
after 48 hours post genotoxin treatment. Missing points in samples are due to poor amplification 
during the qPCR analysis. Concentration in ng. 
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Appendix Figure 6. Standard curves generated from control cDNA samples from mouse cell line 2 
after 8 hours post genotoxin treatment. Missing points in samples are due to poor amplification 
during the qPCR analysis. Concentration in ng. 
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Appendix Figure 7. Standard curves generated from control cDNA samples from mouse cell line 2 
after 8 hours post genotoxin treatment. Missing points in samples are due to poor amplification 
during the qPCR analysis. Concentration in ng. 
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Appendix Figure 8. The proportion of cells alive relative to untreated controls of treated samples after 
48 hours. This count was performed prior to RNA extraction for RNAseq. Key, cam - camptothecin, 
chro – chromium (vi) oxide, con - control. 
 
Appendix Figure 9. PCA plot of mouse and NMR RNA samples. Mouse samples can be seen to cluster 
to the left, while NMR samples from two distinct clusters of the right, the top being formed by NMR 
cell lines 1 and 3 and the bottom being made of NMR cell line 2 samples. 
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Appendix Figure 10. The fold change in gene expression between control and treated samples as 
determined by RNAseq (red) and qPCR (blue) for samples that failed to meet the cut off for efficiency 
(95-105%) and/or R2 (≥0.98). For most samples the change in gene expression is the same in both 
RNAseq and qPCR however m1 samples from camptothecin-treated samples after 8hrs for Grik2 
show reduced expression from qPCR and increased expression from RNAseq. The following samples 
are not included due to excessively large fold changes; all showed a decrease in both RNAseq and 
qPCR, but qPCR samples showed a much greater decrease: m2 8hr Sox5 camptothecin-treated and 
48hr treated with chromium for Sox5 and Foxo1. Tbp was used as the housekeeping gene in this 
analysis. 
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Appendix Table 1. Amplification efficiency of each primer pair used in the qPCR analysis. 
Cell line Sample Gene Efficiency 
    P21 113.6785 
    p57 4325722 
  8hr Hrtp1 83.2893 
    Tbp 95.39685 
    r3hcc1 95.37401 
   sox5 83.16966 
M1   grik2 64.64504 
    foxo1 107.5429 
    p21 106.6799 
    p57 105.2602 
  48hr Hrtp1 117.1203 
   tbp1 103.278 
    r3hcc1 108.6054 
    sox5 186.168 
    grik2 105.9982 
    foxo1 79.63653 
    p21 105.4449 
    p57 88.57742 
  8hr Hprt1 108.0498 
    Tbp 91.5449 
M2   R3hcc1 97.08169 
    Sox5 93.49261 
    Grik2 1.75E+17 
    Foxo1 86.57605 
    p21 111.4221 
    p57 91.46765 
  48hr Hprt1 108.3708 
    Tbp 99.69742 
    R3hcc1 97.46531 
    Sox5 298.625 
    Grik2 510.7375 
    Foxo1 70.27874 
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Appendix Table 2. Ct values for housekeeping genes Tbp and Hprt1. Key, m1 - mouse cell line 1, m2 - 
mouse cell line 2. 
   Tbp Hprt1 
Cell line Sample time Treatment Mean ± SD Mean ± SD 
    control 26.6 ± 0.38 26.29 ± 0.05 
  8hour camptothecin 25.94 ± 0.37 25.82 ± 0.27 
m1   chromium  27.22 ± 0.02 26.71 ± 0.13 
    control 23.79 ± 0.13  23.36 ± 0.06 
  48hour camptothecin 25.27 ± 0.1 23.94 ± 0.01 
    control 26.04 ± 0.23 23.34 ± 0.2 
m2 8hour camptothecin 27.36 ± 0.02 23.81 ± 0.06 
    control 20.87 ± 0.32 22.76 ± 0.04 
  48hour chromium  21.69 ± 0.04 23 ± 0.1 
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Appendix Table 3. All DNA repair genes that are present in the NMR RNAseq dataset. Arrows indicate 
up (↑) and down (↓) regulation between mouse and NMR cells in the presented conditions, dash (-) 
indicates the gene was not significantly differentially expressed at the p=0.05 level. Continues over 
three pages. 
  8 hour post stimuli 48 hour post stimuli 
Gene Control Camptothecin 
Chromium (vi) 
oxide  
Control Camptothecin 
Chromium (vi) 
oxide  
Alkbh2 ↑ ↑ ↑ ↑ ↑ ↑ 
Alkbh3 - - - - - - 
Apex1 - - - - - - 
Apex2 - - - - - - 
Aplf ↓ ↓ ↓ ↓ ↓ ↓ 
Aptx - - ↓ - - ↓ 
Atm ↓ ↓ ↓ ↓ ↓ ↓ 
Atr ↓ ↓ ↓ ↓ ↓ ↓ 
Atrip ↓ ↓ ↓ ↓ ↓ ↓ 
Brca1 - - - - - ↑ 
Brca2 - ↓ - ↓ ↓ - 
Brip1 - ↓ - ↓ ↓ - 
Ccnh - - - - - - 
Cdkn1a - - ↑ ↑ - ↑ 
Chaf1a ↓ ↓ - ↓ ↓ - 
Chek1 - - - - - ↑ 
Chek2 - - ↑ - - - 
Clk2 - - - - - - 
Cops5 ↓ ↓ ↓ ↓ ↓ ↓ 
Cul4a - - - - - - 
Dclre1a - - ↑ - - ↑ 
Dclre1b - - - - - - 
Dclre1c ↑ ↑ ↑ ↑ ↑ ↑ 
Ddb1 ↓ ↓ ↓ ↓ ↓ ↓ 
Ddb2 - - - - - - 
Dmc1 ↑ ↑ ↑ ↑ ↑ ↑ 
Dut ↓ ↓ ↓ ↓ ↓ ↓ 
Eme1 - - - - - - 
Endov ↓ ↓ ↓ ↓ ↓ ↓ 
Ercc1 - - - - - - 
Ercc2 - - - - - - 
Ercc3 ↓ ↓ ↓ ↓ ↓ ↓ 
Ercc4 ↑ ↑ ↑ ↑ ↑ ↑ 
Ercc6 ↓ ↓ ↓ - ↓ - 
Ercc8 - - - - - - 
Exo1 - ↓ - - ↓ - 
Fan1 ↑ ↑ ↑ ↑ ↑ ↑ 
Fanca - - - - - - 
Fancb ↓ ↓ ↓ ↓ ↓ ↓ 
Fancc ↓ ↓ ↓ ↓ ↓ ↓ 
Fancd2 ↑ ↑ ↑ ↑ ↑ ↑ 
Fancg - - - - - - 
Fanci - - - - - - 
Fancl - - - - ↓ - 
Fen1 ↓ ↓ - ↓ ↓ - 
Gen1 ↑ - ↑ ↑ - ↑ 
Gps1 ↓ ↓ ↓ - - - 
Gtf2h1 ↓ ↓ ↓ ↓ ↓ ↓ 
Gtf2h3 ↓ ↓ ↓ ↓ ↓ ↓ 
Gtf2h4 - ↓ - - - - 
Helq ↓ ↓ ↓ ↓ ↓ ↓ 
Hltf ↑ ↑ ↑ ↑ ↑ ↑ 
Hus1 - - - - - - 
Lig3 - - - - - - 
Lig4 ↓ ↓ ↓ ↓ ↓ ↓ 
Mad2l2 ↑ - ↑ ↑ ↑ ↑ 
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 8 hour post stimuli 48 hour post stimuli 
Gene 
Control Camptothecin 
Chromium (vi) 
oxide  
Control Camptothecin 
Chromium (vi) 
oxide  
Mbd4 ↑ ↑ ↑ ↑ ↑ ↑ 
Mdc1 - - - - - - 
Mgmt - - ↓ - - ↓ 
Mlh1 ↑ ↑ - ↑ ↑ - 
Mlh3 ↑ ↑ ↑ ↑ ↑ ↑ 
Mms19 - - - - - - 
Mnat1 ↓ ↓ ↓ ↓ ↓ ↓ 
Mpg ↑ ↑ ↑ ↑ ↑ ↑ 
Mre11a ↓ ↓ ↓ ↓ ↓ ↓ 
Msh2 ↓ ↓ ↓ ↓ ↓ - 
Msh3 ↑ - - - - - 
Msh4 - - ↑ - - - 
Msh5 - - - - - - 
Msh6 - - - - - - 
Mus81 - - - - - - 
Mutyh ↓ ↓ ↓ ↓ ↓ ↓ 
Neil1 ↑ ↑ ↑ ↑ ↑ ↑ 
Neil2 ↑ ↑ ↑ ↑ ↑ ↑ 
Neil3 - - - - - - 
Nhej1 ↑ ↑ ↑ ↑ ↑ ↑ 
Nthl1 ↑ ↑ ↑ ↑ ↑ ↑ 
Nudt1 ↑ ↑ ↑ ↑ ↑ ↑ 
Ogg1 - - - - - - 
Parp3 ↓ ↓ ↓ ↓ ↓ ↓ 
Pcna ↓ ↓ - ↓ ↓ - 
Per1 ↑ ↑ ↑ ↑ ↑ ↑ 
Pms2 - - - - - - 
Pnkp - - ↓ - - ↓ 
Polb - - - - - - 
Pold1 - ↓ - ↓ ↓ - 
Pole - ↓ - ↓ ↓ - 
Polh ↓ ↓ ↓ ↓ ↓ ↓ 
Polk ↓ ↓ ↓ ↓ ↓ ↓ 
Poll ↑ - ↑ - - ↑ 
Polm - - - - - - 
Polq - ↓ - - ↓ - 
Prkdc - - - - - - 
Prpf19 - - - - - - 
Rad1 ↓ ↓ ↓ ↓ ↓ ↓ 
Rad17 - - - - - - 
Rad18 ↓ ↓ ↓ ↓ ↓ ↓ 
Rad23b - - - - - - 
Rad50 - ↓ - ↓ ↓ - 
Rad51 - - - - - - 
Rad51b ↑ ↑ ↑ ↑ ↑ ↑ 
Rad51d ↑ ↑ ↑ ↑ - - 
Rad52 - - - - - - 
Rbbp8 ↓ ↓ ↓ ↓ ↓ ↓ 
Rfc1 - - - - - - 
Rfc2 ↓ ↓ ↓ ↓ ↓ - 
Rfc3 ↓ ↓ - ↓ ↓ - 
Rfc5 - - - - - - 
Rif1 ↑ - ↑ ↑ - ↑ 
Rnf168 ↓ ↓ ↓ ↓ ↓ ↓ 
Rnf4 ↓ ↓ ↓ ↓ ↓ ↓ 
Rpa1 - - - - ↓ - 
Rpa2 - - ↑ ↑ - ↑ 
Rpa3 ↓ ↓ ↓ ↓ ↓ ↓ 
Shprh ↓ ↓ ↓ ↓ ↓ ↓ 
Slx4 ↑ ↑ ↑ ↑ ↑ ↑ 
Smug1 ↓ - ↓ ↓ - ↓ 
Tdg - - - - - - 
Tdp1 ↑ ↑ ↑ ↑ ↑ ↑ 
Topbp1 ↓ ↓ ↓ ↓ ↓ ↓ 
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 8 hour post stimuli 48 hour post stimuli 
Gene 
Control Camptothecin 
Chromium (vi) 
oxide  
Control Camptothecin 
Chromium (vi) 
oxide  
Trex1 - - - - - - 
Trex2 ↑ ↑ ↑ ↑ ↑ ↑ 
Trp53 ↑ ↑ ↑ ↑ ↑ ↑ 
Ube2a ↑ ↑ ↑ ↑ ↑ ↑ 
Ube2b ↓ ↓ ↓ ↓ ↓ ↓ 
Ube2n ↓ ↓ ↓ ↓ ↓ ↓ 
Ung - - - - - ↑ 
Uvssa - - - - - - 
Wrn - - - ↓ ↓ - 
Xab2 ↓ ↓ ↓ ↓ - ↓ 
Xpa - - ↓ - - ↓ 
Xpc ↑ ↑ ↑ ↑ ↑ ↑ 
Xrcc1 - - - - - - 
Xrcc4 - ↓ ↓ - ↓ ↓ 
Xrcc5 - - - - - - 
Xrcc6 - - - - - - 
 
 
Appendix Table4The number of DNA repair genes associated with a given pathway up (↑) or down 
(↓) regulated in NMR cells compared to mouse cells for different treatments and time points. Genes 
significant at the 0.05 level after correcting for multiple testing. Key, NHEJ, non-homologous end join, 
HR homologous recombination, MMR miss match repair, NER nucleotide excision repair, BER base 
excision repair, DDS DNA damage signalling. 
 
  Control Camptothecin Chromium (vi) oxide 
 NHEJ 2↑ 1↓ 1↑ 1↓ 2↑ 1↓ 
8hr HR 3↑ 3↓ 3↑ 4↓ 4↑ 4↓ 
 MMR 3↑ 1↓ 2↑ 4↓ 1↑ 0↓ 
 NER 1↑ 4↓ 1↑ 7↓ 1↑ 4↓ 
 BER 6↑ 5↓ 5↑ 6↓ 6↑ 5↓ 
 DDS 0↑ 13↓ 0↑ 14↓ 1↑ 12↓ 
 NHEJ 1↑ 1↓ 1↑ 1↓ 2↑ 1↓ 
 HR 3↑ 5↓ 2↑ 5↓ 3↑ 3↓ 
48hr MMR 2↑ 2↓ 2↑ 4↓ 1↑ 0↓ 
 NER 1↑ 6↓ 1↑ 7↓ 1↑ 4↓ 
 BER 5↑ 7↓ 5↑ 6↓ 7↑ 5↓ 
 DDS 0↑ 13↓ 0↑ 13↓ 2↑ 10↓ 
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Appendix Table 5. All cell adhesion molecule genes from KEGG that are present in the NMR RNAseq 
dataset. Arrows indicate up (↑) and down (↓) regulation between mouse and NMR cells in the 
presented conditions, dash (-) indicates the gene was not significantly differentially expressed at the 
p=0.05 level. Continues over two pages. 
  8 hour post stimuli 48 hour post stimuli 
Gene Control Camptothecin Chromium (vi) oxide  Control Camptothecin Chromium (vi) oxide  
Vtcn1 ↑ ↑ ↑ ↑ ↑ - 
Vcan ↑ ↑ ↑ ↑ ↑ ↑ 
Vcam1 ↓ - ↓ ↓ ↓ ↓ 
Tigit ↑ ↑ ↑ ↑ ↑ ↑ 
Spn - - ↓ - - ↓ 
Siglec1 - - - - - - 
Selplg ↑ ↑ ↑ ↑ ↑ ↑ 
Selp ↓ ↓ ↓ ↓ ↓ ↓ 
Sele ↓ ↓ - ↓ ↓ ↓ 
Sdc3 - - - - - ↓ 
Sdc2 ↓ ↓ ↓ ↓ ↓ ↓ 
Sdc1 - - ↑ - - - 
Pvr ↓ - - - - - 
Ptprf - - - - - ↓ 
Ptprc - - - - - - 
Pdcd1 ↑ ↑ ↑ ↑ ↑ ↑ 
Ocln - - - - - - 
Ntng2 ↑ ↑ ↑ ↑ ↑ ↑ 
Ntng1 ↑ ↑ ↑ ↑ ↑ ↑ 
Nrxn2 - - - - - - 
Nrcam - - - - - - 
Nlgn3 - ↑ - - - - 
Nlgn2 - - - - - - 
Nlgn1 ↑ ↑ ↑ ↑ ↑ ↑ 
Nfasc ↑ ↑ - ↑ ↑ - 
Neo1 ↓ ↓ ↓ ↓ ↓ ↓ 
Negr1 - - - - - ↓ 
Ncam2 ↑ ↑ ↑ ↑ ↑ ↑ 
Ncam1 ↑ ↑ - ↑ ↑ - 
Mpzl1 - - ↑ - - ↑ 
Mpz - - - - - - 
Mag - - ↑ - - ↑ 
Lrrc4c ↓ ↓ - ↓ ↓ ↓ 
Lrrc4 ↓ - - - ↓ - 
L1cam - - - - - - 
Jam3 - - - - - - 
Jam2 ↓ ↓ ↓ ↓ ↓ ↓ 
Itgb8 ↑ ↑ ↑ ↑ ↑ ↑ 
Itgb7 ↓ ↓ ↓ ↓ ↓ ↓ 
Itgb2 - - - - - - 
Itgb1 ↓ - ↓ ↓ ↓ ↓ 
Itgav ↓ - ↓ - ↓ ↓ 
Itgal ↑ ↑ ↑ ↑ ↑ ↑ 
Itga9 ↑ ↑ - ↑ ↑ ↓ 
Itga8 ↓ ↓ ↓ ↓ ↓ ↓ 
Itga6 ↑ ↑ - - ↑ - 
Itga4 ↑ ↑ ↑ ↑ ↑ ↑ 
Icos - - - - - - 
Icam2 ↑ ↑ ↑ ↑ ↑ ↑ 
Icam1 ↑ ↑ ↑ ↑ ↑ ↑ 
Glg1 ↑ - ↑ - - ↑ 
F11r ↓ ↓ ↓ ↓ ↓ ↓ 
Esam ↓ - - - ↓ ↓ 
Ctla4 - - - - - - 
Cntnap1 ↓ ↓ - ↓ ↓ - 
Cntn2 - - - - - - 
Cntn1 ↑ ↑ - - - - 
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  8 hour post stimuli 48 hour post stimuli 
Gene Control Camptothecin Chromium (vi) oxide  Control Camptothecin Chromium (vi) oxide  
Cldn9 - - - - - - 
Cldn8 - - - - - - 
Cldn7 - - ↑ - - - 
Cldn6 ↑ ↑ ↑ ↑ ↑ ↑ 
Cldn5 - - - - - - 
Cldn22 ↑ ↑ ↑ ↑ ↑ ↑ 
Cldn2 ↑ ↑ ↑ ↑ ↑ ↑ 
Cldn19 - - - - - - 
Cldn18 - - - - - - 
Cldn17 - - - - - - 
Cldn16 ↑ ↑ ↑ ↑ ↑ ↑ 
Cldn15 - ↓ - - - ↓ 
Cldn14 - - - - - - 
Cldn11 - - - - - - 
Cldn10 ↑ ↑ ↑ ↑ ↑ ↑ 
Cldn1 ↑ ↑ ↑ ↑ ↑ ↑ 
Cdh5 ↑ ↑ ↑ ↑ ↑ ↑ 
Cdh4 ↑ ↑ ↑ ↑ ↑ - 
Cdh3 - - - - - ↓ 
Cdh2 ↑ ↑ ↑ ↑ ↑ ↑ 
Cdh15 ↑ ↑ ↑ ↑ ↑ ↑ 
Cdh1 - - - - - - 
Cd8a - - - - - - 
Cd86 - - - - - - 
Cd6 - - - - - - 
Cd40lg - - - - - - 
Cd40 ↑ ↑ ↑ ↑ ↑ ↑ 
Cd4 - - - - - - 
Cd34 ↓ ↓ ↓ ↓ ↓ ↓ 
Cd28 - - - - ↓ - 
Cd276 ↓ ↓ ↓ ↓ ↓ ↓ 
Cd274 ↑ ↑ ↑ ↑ ↑ ↑ 
Cd226 - - - - - - 
Cd22 - - - - - - 
Cd2 - - - - - - 
Cadm3 ↑ ↑ ↑ ↑ ↑ ↑ 
Cadm1 ↑ ↑ ↑ ↑ ↑ ↑ 
Alcam ↑ ↑ - ↑ ↑ - 
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Appendix Table 6. PCR products produced with different primers in cDNA samples from the m2 mouse 
primary cells after 8hr treatment with camptothecin (cam) in media with 2% DMSO or media with 2% 
DMSO as control. These were run on a 3% agarose gel containing 0.006% Midori Green. Single bands 
indicate that no unspecific amplification has taken place. Bands in Hprt1 and Tbp blank samples 
indicate DNA contamination. The size of each band on the ladder is given to the left of the image. 
 3% Agarose, 6µl Midori Green 
Lane Sample Predicted 
size (bp) 
Load 
        
1 Ladder 100-1,000 5µl 
2 P21 control 111 8µl 
3 P21 camptothecin 111 8µl 
4 P57 control 111 8µl 
5 P57 camptothecin 141 8µl 
6 Hprt1 control 141 8µl 
7 Hprt1 
camptothecin 
141 8µl 
8 Tbp control 195 8µl 
9 Tbp camptothecin 195 8µl 
10 R3hcc1 control 195 8µl 
11 R3hcc1 
camptothecin 
109 8µl 
12 Sox5 control 109 8µl 
13 Sox5 
camptothecin 
109 8µl 
14 Grik2 control 100 8µl 
15 Grik2 
camptothecin 
100 8µl 
16 FOXO1 control 100 8µl 
17 FOXO1 
camptothecin 
124 8µl 
18 P21 blank 124 8µl 
19 P57 blank 124 8µl 
20 Hprt1 blank 145 8µl 
21 Tbp blank 145 8µl 
22 R3hcc1 blank 145 8µl 
23 Sox5 blank 124 8µl 
24 Grik2 blank 124 8µl 
25 FOXO1 blank 124 8µl 
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Appendix Table 7. PCR products produced with different primers in cDNA samples from the m2 mouse 
primary cells after 48hr treatment with chromium (vi) oxide (chro) in media with 2% DMSO or media 
with 2% DMSO as control. These were run on a 3% agarose gel containing 0.006% Midori Green. 
Single bands indicate that no unspecific amplification has taken place. Bands in p21 and Hprt1 blank 
samples indicate DNA contamination. The size of each band on the ladder is given to the left of the 
image. 
 3% Agarose, 6µl Midori Green 
Lane Sample Predicted 
size (bp) 
Load  
        
1 Ladder 100-1,000 5µl 
2 P21 control 111 8µl 
3 P21 camptothecin 111 8µl 
4 P57 control 111 8µl 
5 P57 camptothecin 141 8µl 
6 Hprt1 control 141 8µl 
7 Hprt1 camptothecin 141 8µl 
8 Tbp control 195 8µl 
9 Tbp camptothecin 195 8µl 
10 R3hcc1 control 195 8µl 
11 R3hcc1 
camptothecin 
109 8µl 
12 Sox5 control 109 8µl 
13 Sox5 camptothecin 109 8µl 
14 Grik2 control 100 8µl 
15 Grik2 camptothecin 100 8µl 
16 FOXO1 control 100 8µl 
17 FOXO1 
camptothecin 
124 8µl 
18 P21 blank 124 8µl 
19 P57 blank 124 8µl 
20 Hprt1 blank 145 8µl 
21 Tbp blank 145 8µl 
22 R3hcc1 blank 145 8µl 
23 Sox5 blank 124 8µl 
24 Grik2 blank 124 8µl 
25 FOXO1 blank 124 8µl 
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Appendix Figure 11. Representative images of trypsinised Mouse and NMR samples under each 
treatment prior used to estimate cell surface area. Cam – camptothecin treatment, Chro – chromium 
(vi) oxide treatment. White bar indicates ~50um. 
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Appendix Figure 12. Representative histograms of Mouse and NMR samples under each treatment 
from flow cytometry. Mouse samples shown are of mouse cell line 3, NMR samples are of NMR cell 
line 3. NMR samples have been scaled up 3 fold to make the image clearer. Cells relating to a given 
section of the cell cycle have been highlighted. Pink indicates G1, green indicates S phase, blue 
indicates G2 and olive green indicates G4. Cam – camptothecin treatment, Chro – chromium (vi) 
oxide treatment. 
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Appendix Figure 13. Representative scatter plots of Mouse and NMR samples under each treatment 
from flow cytometry. Mouse samples shown are of mouse cell line 3, NMR samples are of NMR cell 
line 3. Cam – camptothecin treatment, Chro – chromium (vi) oxide treatment. 
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Appendix Figure 14. Representative images of trypsinised Mouse and NMR samples under each 
treatment prior to flow cytometry. Cam – camptothecin treatment, Chro – chromium (vi) oxide 
treatment. White bar indicates ~50um. 
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Appendix Table 8. The total number of cells analysed through flow cytometry for each cell line and 
treatment. Con – control, cam – camptothecin, chro – chromium (vi) oxide. 
  
Mouse 
1 
Mouse 
2 
Mouse 
3 NMR 1 NMR 2 NMR 3 
con 24,374 15,070 10,937 3,215 10,518 250 
cam 13,046 18,149 8,474 2,847 18,532 262 
chro 19,274 7,470 9,108 3,692 6,518 235 
 
 
Appendix Figure 15. A definitive screening design to evaluate the effect of growing conditions on the 
cell. By default, a block is added to define which experiment should be carried out at the same time. 
Due to limitations with the incubator availability, this would be removed, and the temperature and 
oxygen content would dictate the blocking. Cells would be grown under the above conditions, and 
the growth rate and levels of senescence would be evaluated. These data points would be used to 
create a model to predict the effects of each condition. 
 
 
 
 
 
 
 
